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Failure to repair injured sarcolemmal membranes leads to muscular dystrophy, a 
degenerative disorder that results in increasing weakness and gradual wasting of skeletal 
muscles. Mutations in the gene encoding dysferlin are causative for limb girdle muscular 
dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM) forms of the disease. 
Dysferlin is a Ca2+-sensitive membrane repair protein involved in trafficking of proteins 
and vesicles around injured membranes in skeletal muscle cells. It is a cytosolic-facing, 
membrane bound protein composed of seven intermittently spaced C2 domains (C2A-
C2G). Dysferlin activity is mediated by the Ca2+-dependent actions of the C2 domains. The 
main goals of this thesis were to characterize the structure, dynamics and Ca2+-binding 
mechanisms of the C2 domains, and assess the impact of pathogenic substitutions on the 
C2 domains. 
 
First, the dynamics of the C2A domain in both Ca2+-free and Ca2+-bound state was 
comprehensively probed using NMR spectroscopy, which revealed a remarkable flexibility 
change in the loop region upon Ca2+ binding. The Ca2+-binding properties of the C2A 
domain was studied on the basis of the crystal structure of the Ca2+-bound C2A, which 
determined the stoichiometry, binding sites and affinities. Further, mutagenesis study 
revealed the important role of the electrostatic potential contributed by non-Ca2+-
coordinating residues, which provides novel insights into the mechanism of Ca2+ binding 




To understand the consequences of pathogenic mutations, three substituted C2A proteins 
were generated and analyzed. It was demonstrated that there is dramatic decrease in 
stability resulted from the substitutions. The unfolding or improper folding of the 
substituted C2A domain is predicted to be responsible for impaired dysferlin function in 
the membrane repair process, and consequently the wasting of skeletal muscles in muscular 
dystrophy patients.  
 
Finally, proteins encompassing the C2B and C2C domains of dysferlin were designed and 
generated using a combination of computational and experimental methods. The precise 
domain boundaries of the C2B and C2C domains were determined, which will provide 
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Summary for Lay Audience 
 
 
The cell membrane separates the interior of cells from the outside environment and helps 
maintain the well-being of cells. However, when cells are subject to physical tearing (which 
happens frequently), the membrane can be damaged, leading to the damage of the 
equilibrium of cell. This is why a membrane repair system mediated by proteins is required 
for cell survival. Proteins are biological molecules that can perform an array of functions 
within living organisms. Each protein has its specific three-dimensional structure, and the 
function is directly related to the structure.  
 
One protein that regulates cell membrane repair is dysferlin. Abnormalities of dysferlin 
caused by gene mutations lead to muscle diseases with detrimental consequences. In cells, 
dysferlin functions with the help of calcium ions. Calcium ions play a vital role in the 
physiological processes of organisms and cells, usually by selectively and reversibly 
binding to partner proteins. This binding causes changes of the protein structure, thereby 
activating the protein function. Thus, knowing when and how calcium ions bind to 
dysferlin is important to the understanding of its functions, and the mechanisms of inherited 
muscle diseases. 
 
In this thesis, the 3-D structure of a calcium-binding region in dysferlin was determined by 
biophysical techniques. Not only the calcium-binding sites within this region were clearly 
observed at atomic level, how calcium changes the dysferlin structure was also elucidated. 
It was discovered that this structural change is directly related to the function of dysferlin 
 
 v 
in membrane repair. Furthermore, we were able to artificially generate the abnormal forms 
of dysferlin protein when gene mutation occurs. We found that some properties of dysferlin 
were altered. This helps the analysis for the cause of function loss in membrane repair, that 
subsequently leads to muscle diseases. Finally, an additional region of dysferlin was 
explored, which may have a distinct role in regulating the function of dysferlin. 
 
This work represents an important step forward in fully explaining the mechanisms of 
membrane repair by dysferlin. The structural and biochemical study here will have a 
significant impact on the understanding of related diseases and the development of drug 
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Introduction and Background 
 
 
1.1 Calcium signaling in cells 
 
Historically, calcium was first found to be essential for heart contraction by Sydney Ringer 
in 1883 (Ringer, 1883). An inadvertent use of tap water led to the astonishing finding that 
isolated rat hearts contracted perfectly in tap water, but failed to beat in distilled water. 
Ringer quickly realized that the contraction was attributed to residual calcium ions (Ca2+), 
which was present at 38.3 parts per million, in the tap water supplied by London New River 
Water Company,. Although calcium was already known to be one of the most abundant 
elements in the skeleton and teeth, this unexpected finding recognized the important role 
of calcium as a fundamental carrier of chemical signals. In the 1940s, the concept of 
“calcium signaling” became prevalent, when Heilbrunn (Heilbrunn, 1940) and Bailey 
(Bailey, 1942) found that Ca2+ ions caused contraction of frog muscles and stimulated the 
ATPase activity of myosin. Since then, calcium has been identified to be involved in nearly 
every aspect of body activities. 
 
The calcium signaling system operates in a variety of ways to regulate cellular processes 
that function over a wide dynamic range. In cells, a 20,000-fold gradient is maintained 
between the intracellular (~100 nM) and extracellular (mM) concentrations (Clapham, 
2007; Tsien, 1981). The flow of Ca2+ in and out of the cells has to be precisely controlled 
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by specialized calcium pumps and channels at any moment in time. The internal stores of 
Ca2+ reside within the membrane systems of the endoplasmic reticulum (ER) or the 
sarcoplasmic reticulum (SR) of muscle cells. Cytosolic Ca2+ ions act as “secondary 
messengers” combined with a variety of effectors to stimulate and mediate numerous Ca2+-
dependent cellular processes including exocytosis, metabolism, transcription and 
proliferation. Berridge et al. divided the calcium signalling network into four functional 
steps (Berridge et al., 2000) (Figure 1.1):  
1) Signalling is triggered by a stimulus that generates various Ca2+-mobilizing signals. 
The stimuli bind to a variety of cell-surface receptors, such as G-protein-linked 
receptors and receptor tyrosine kinases (RTK), and generate signals, including 
inositol-1,4,5-trisphosphate (IP3), cyclic ADP ribose (cADPR) and nicotinic acid 
dinucleotide phosphate (NAADP). These signals determine whether Ca2+ can 
activate channels on the plasma membrane and intracellular organelles.  
2) The signals activate the ON mechanisms that feed Ca2+ into the cytoplasm. The ON 
mechanisms depend on Ca2+ channels that control the entry of external Ca2+ or the 
release of Ca2+ from internal stores. Ca2+ channels include voltage-gated Ca2+ 
channel (CaV) and ligand-gated channel (TRP) located on the plasma membrane, 
and IP3R channel spanning on the membrane of ER. 
3) Ca2+ functions as a messenger to stimulate various Ca2+-sensitive processes. A wide 
variety of Ca2+ binding proteins respond to the Ca2+ release into the cytoplasm and 
activate numerous cellular processes.  
4) Finally, the OFF mechanisms, composed of pumps and exchangers, remove Ca2+ 









Figure 1. 1 Ca2+ signaling in cells. 
A 20,000-fold gradient is maintained between the intracellular (~100 nM) and extracellular 
(mM) concentrations. Ca2+-mobilizing signals (blue), including IP3, cADPR and NAADP, 
are generated by stimuli acting through cell-surface receptors. ON mechanisms (green) 
include Ca2+ channels on plasma membrane and ER/SR, which control the entry of external 
Ca2+ or the release of Ca2+ from internal stores. The Ca2+ released into the cytoplasm by 
these ON mechanisms activates different Ca2+ binding proteins, which augment a wide 
range of cellular processes. A uniporter transmembrane complex transports Ca2+  into 
mitochondria. OFF mechanisms (grey) pump Ca2+ out of the cytoplasm: the Na+/ Ca2+ 






the cytoplasm once Ca2+ carried out its signaling functions. The plasma membrane 
Ca2+-ATPase (PMCA) pumps and Na+/Ca2+ exchangers extrude Ca2+ out of the cell 
and the sarco-endoplasmic reticulum ATPase (SERCA) pumps return Ca2+ back 
into the internal stores. 
 
In the third step, calcium takes on the role of a near universal signaling molecule recognized 
by numerous calcium-binding proteins in eukaryotes, prokaryotes and even viruses 
(Permyakov, 2009; Permyakov and Kretsinger, 2011; Zhou et al., 2009).The  calcium  ion, 
with an ionic radius of 0.99 Å, can accommodate  4 - 12  oxygen atoms  in  its  primary  
coordination  sphere,  with  6 - 8 being most common (Clapham, 2007). Calcium binding 
proteins use the oxygen atoms of carboxyl and carbonyl groups to coordinate binding to 
Ca2+. The majority of calcium-binding sites in proteins consist of seven oxygen atoms 
surround Ca2+ at ~2.5 Å  in a pentagonal bipyramid configuration (Strynadka and James, 
1989) (Figure 1.2). It is worth mentioning that not all oxygen ligands in the Ca2+ 
coordination sphere are provided by amino acid residue side chains; main-chain carbonyl 
oxygen atoms and water molecules also participate (Katz et al., 1996). Hundreds of cellular 
proteins have adapted to selectively and reversibly bind Ca2+ through specific motifs. The 
binding occurs over a million-fold range of affinities (nM to mM) and the distinctive nature 
of each Ca2+-mediated pathway is closely associated with this broad range of affinities. 
Substitutions or abnormalities in proteins involved in Ca2+ signaling can lead to a diverse 
array of diseases, including muscular dystrophy, congestive heart failure, diabetes, 
hypertension, maniac depression, cancers, and neurodegenerative diseases including 












Figure 1. 2 Ca2+ coordination sphere. 
Ca2+ is normally coordinated by seven oxygen atoms (five in the plane of the green 
pentagon and two perpendicular to the plane, thus forming a bipyramidal pentagon). All 
oxygen ligands in the Ca2 coordination sphere are provided by amino acid residue side-




et al., 2000; Stewart et al., 2015). For example, disruption of the gene for calpain III, a 
calcium-dependent protease, causes limb girdle muscular distrophy type 2A; Defects in the 
genes for the PMCA pumps have been found to lead to hearing deficits (Carafoli, 2002). 
 
Two major calcium binding motifs within cellular proteins have been extensively studied: 
EF-hand (eg. calmodulin, S100 family) and C2 domains (eg. synaptotagmin, PKC, ferlin 
family). Both mediate intracellular Ca2+ signals and direct diverse physiological events. 
The EF-hand motif is the most common Ca2+-binding motif found in proteins. The EF-
hand motif usually consists of 30 amino acids that fold into a helix-loop-helix structure. Its 
structure resembles a right hand fist, with the index finger and thumb extended. The loop 
between the helices comprises ~12 conserved residues that can coordinate a Ca2+ ion. 
Binding of calcium to this globular domain leads to a dramatic conformational change from 
“closed” to “open,” exposing a hydrophobic surface that permits the interaction with target 
proteins in a Ca2+-regulated manner. Calmodulin is the best known EF-hand protein: it has 
four EF-hand binding motifs, and the molecular mechanism by which it decodes the Ca2+ 
signal has been clarified. It interacts with hundreds of proteins in the cell, and acts as a 
regulator or an effector molecule in a wide variety of cellular functions (Ikura, 1996).  
 
 
1.2 C2 domains 
 
The C2 domain was originally discovered as the second of two conserved domains in 
classical protein kinase C (PKCs) responsible for calcium-dependent membrane binding. 
The C2 domain was proposed to be responsible for Ca2+ regulation of PKC, on the basis of 
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the finding that the kinase activity and phospholipid binding of PKC were known to be 
Ca2+ dependent, whereas the isoform lacking the C2 domain failed to exhibit Ca2+ 
dependent activities (Ono et al., 1989). Subsequent studies have revealed the existence of 
homologous C2 domains in a large number of proteins, which are widely distributed in all 
cell types in eukaryotes. Identification of the C2 domain in synaptotagmin (Perin et al., 
1990) and cytosolic phospholipase A2 (cPLA2) (Clark et al., 1991) found that they both 
bind to phospholipids and natural cell membranes in a Ca2+-dependent manner, which is 
also a shared feature of protein kinase C (Bazzi and Nelsestuen, 1987, 1990; Brose et al., 
1992). These findings led to the belief that the C2 domain was involved in Ca2+-dependent 
membrane binding. Moving forward, a number of C2 domains within different proteins 
have been isolated and structurally characterized. Most of them are involved in signal 
transduction, lipid modification, membrane trafficking, activation of GTPases, and control 
of protein phosphorylation (Zhang and Aravind, 2010), including synaptotagmins 
(Fernandez et al., 2001; Shao et al., 1998), rabphilin-3A (Biadene et al., 2006), cPLA2 
(Perisic et al., 1998a) and so on.  
 
To date, more than 100 structures of C2 domains have been solved by NMR (nuclear 
magnetic resonance) spectroscopy and X-ray crystallography. Characterization of the 
structures has confirmed that the C2 domain is an independently folded module of about 
130 residues, and revealed a common fold that C2 domains share: an eight-stranded 
antiparallel b-sandwich consisting of a pair of four-stranded b-sheets connected by highly 
variable loops (Rizo and Südhof, 1998). Two types of topology are found in C2 domains: 
(i) the synaptotagmin-like variants also referred to as the type I topology and (ii) the PLC-
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like variants, also known as the type II topology. The arrangement of b-strands in C2 
domains of type II topology constitutes a circular permutation of type I C2 domains. Strand 
1 of the type I C2 domains occupies the same position as the eighth strand of the type II 
C2 domains. In Figure 1.3, the N and C termini are at the top of the C2 domain in the type 
I topology but at the bottom of the type II topology. Having one or the other topology does 
not appear to be a determinant for the domain’s function and it is unclear why C2 domains 
occur in two topologies (Corbalan-Garcia and Gómez-Fernández, 2014). 
 
 
1.3 Ca2+ binding properties of C2 domains  
 
The Ca2+-binding sites of canonical C2 domains are composed of three variable loops 
located at one side of the domain (top) (Figure 1.3). Both side chains and the backbones 
of the loop residues are involved in coordination of multiple Ca2+ ions. The Ca2+-binding 
sites are formed primarily by conserved aspartate residues and the carboxylate or carbonyl 
groups of other residues. Up to four Ca2+-binding sites were identified to be possible in a 
C2 domain depending on the residues that are present on the loop (Ubach et al., 1998). In 
most cases, five highly conserved aspartate residues coordinate two or three Ca2+ ions. 
Taking the C2A domain of synaptotagmin as an example, there are five aspartate residues 
(D172, D178, D230, D232 and D238) in loops 1-3 that contribute to the coordination 
spheres of three Ca2+ ions via their carboxylate groups. Four of these residues (D172, D230, 
D232 and D238) simultaneously coordinate more than one Ca2+ ion. Additional residues 
on the loops also provide ligands for Ca2+ coordination, including the side chain of S235 
and main chain oxygen of L171 and F231(Ubach et al., 1998). It is not clear why a C2 











Figure 1. 2 Two topologies of C2 domain. 
Cartoon diagrams of the structure of the type I and type II topology of C2 domains [left: 
synaptotagmin 5 C2A domain, PDB: 5H4Y; right: cytosolic phospholipase A2 (cPLA2) C2 
domain, PDB: 1RLW]. Bound Ca2+ ions are shown as yellow spheres and the localization 
of the three Ca2+ binding loops (Loop 1-3) are marked. Note that due to the circular 
permutation, the β1 strand in topology I overlaps with β8 strand in topology II, leaving the 





advantageous by providing positive cooperativity to facilitate the Ca2+ binding, thereby 
generating a narrower activation threshold as observed for cooperative Ca2+ binding to 
many proteins of the EF-hand class (Linse and Forsén, 1995).  
 
Although C2 domains share a high degree of structural homology and conserved residues 
for Ca2+ coordination (Figure 1.4), the Ca2+ binding mode varies from one C2 domain to 
another, in terms of binding stoichiometry and affinities. First, different numbers of  Ca2+ 
ions have been found to occupy the Ca2+-binding sites in different C2 domains, ranging 
from zero to four. For instance, the C2A domains of otoferlin (Helfmann et al., 2011) is 
unable to bind Ca2+ for having an unconventional loop 1, which is significantly shorter and 
flatter compared to the Ca2+ binding C2 domains. The C2 domain of protein kinase C-delta 
(PKCδ) (Pappa et al., 1998) has also been shown to be Ca2+ insensitive, due to lack of 
conserved aspartate residues necessary for Ca2+ coordination. In contrast, two Ca2+ ions 
bind to the cPLA2 C2 (Perisic et al., 1998a), synaptotagmin-7 C2A (Voleti et al., 2017) and 
myoferlin C2A domains (Harsini et al., 2019) and three Ca2+ ions bind to synaptotagmin 1 
C2B (Cheng et al., 2004) and phospholipase C-δ1 C2 domain (Essen et al., 1997). Four 
Ca2+ ions are observed to bind to the loop regions in the crystal structure of the C2 domain 
of perforin (Yagi et al., 2015) (Figure 1.5). Secondly, Ca2+ exhibits a wide range of binding 
affinities to different binding sites in C2 domains. Taking synaptotagmin 1 C2B domain as 
an example, the dissociation constants (Kd) measured for the three Ca2+ binding sites are 
54 μM, 530 μM and >2 mM by NMR spectroscopy (Fernández-Chacón et al., 2001), and 
119 μM, 465 μM and 1.7 mM by ITC (Radhakrishnan et al., 2009). In comparison, the C2 









Figure 1. 3 Sequence alignments of selected C2 domains.  
(A) Alignment of type I topology C2 domains. (B) Alignment of C2 domains that have 
type II topology. Residues that very highly conserved are highlighted in white with a red 
background. Residues that appear to be partially but still highly conserved are highlighted 
in white with a blue background. Hydrophobic residues are highlighted in yellow. The 












  Figure 1. 4 Comparison of the Ca2+ binding modes of C2 domains. 
(A) Two Ca2+ ions are bound to cPLA2 C2 domain (cyan) (PDB: 1RLW). (B) Three Ca2+ ions bind to 
synaptotagmin 1 C2B domain (blue) (PDB: 1UOV) . (C) Four Ca2+ ions are identified to bind to the loops of 
perforin C2 domain (pink) (PDB: 4Y1T). Bound Ca2+ ions are shown as yellow spheres and Ca2+ binding loops 
(Loop 1-3) are marked. Side chains and main chains of residues involved in Ca2+ coordination, contributing with 




(Zheng et al., 2000). Moreover, C2 domains also demonstrate different Ca2+ dependencies 
for binding to phospholipids and other proteins, even for the same family of C2-containing 
proteins. All of the C2A-domains from the synaptotagmin proteins interact with syntaxin 
1 in a Ca2+ dependent manner but synaptotagmins 1, 2, and 5 require Ca2+ concentrations 
of >0.2 mM, whereas synaptotagmins 3 and 7 bind at <1 μM Ca2+ (Li et al., 1995).  
 
It is also worth mentioning that, it is not totally reliable to predict the Ca2+ binding manner 
of a C2 domain solely based on the sequence analysis. The position of variable loops, which 
provides the proper spatial orientation of residues for Ca2+ binding, is difficult to predict 
due to the high dynamics of the region. Secondly, Ca2+-binding sites cannot simply be 
located from the sequence because the coordination of Ca2+ ions is also dictated by 
backbone carbonyl groups and water molecules. Therefore, direct structural 
characterization of C2 domains is of great significance on defining the Ca2+ binding 
mechanisms at the atomic level. 
 
How does Ca2+ binding modulate the structure and activity of C2 domains? Unlike the 
Ca2+-induced large structural rearrangement in EF-hand proteins (Ikura, 1996), Ca2+ 
binding does not seem to introduce big conformational changes of the C2 domain backbone: 
subtle rotations of some side chains upon Ca2+ coordination were witnessed in a number of 
studies (Grobler et al., 1996; Shao et al., 1996, 1998; Verdaguer et al., 1999). For example, 
as a consequence of  Ca2+ binding to PLC- δ1, the only structural change occurs in the 
carboxylate oxygens of Asp 653 and Asp 708 at the binding sites, which move closer to 
each other by 0.8 Å. Binding of Ca2+ also has been shown to structurally stabilize the 
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secondary structure of C2 domains, and this is characterized by a variety of techniques, 
such as differential scanning calorimetry (DSC), infrared spectroscopy and thermal 
denaturation (García-García et al., 1999; Torrecillas et al., 2003, 2004).  
 
Most importantly, it is broadly considered that the key role of Ca2+ binding to C2 domains 
is the electrostatic switch that changes the electrostatic potential of the loop region for 
favorable interaction with membranes. This model was initially proposed for the C2A 
domain of synaptotagmin 1 (Shao et al., 1997): upon Ca2+ binding, the zwitterionic 
environment of the loop region drastically changes, becoming largely positive, thereby 
triggering synaptic vesicle exocytosis. Later, electrostatic potential calculations of different 
C2 domains showed that Ca2+ markedly changes the potential of the loop regions, thereby 
facilitating the association to negatively charged or zwitterionic membranes (Murray and 
Honig, 2002).  
 
 
1.4 Membrane binding properties of C2 domains  
 
As mentioned above, one major function of proteins that contain C2 domains is targeting 
membrane surfaces as a consequence of Ca2+-binding. A number of studies have 
demonstrated that C2 domains display different phospholipid selectivity. For example, the 
C2 domains of synaptotagmins and protein kinases C (PKC) family bind to acidic 
phospholipids such as phosphatidylserine (PS) and phosphatidylinositol (PI) (Corbalán-
García et al., 1999; Fernandez et al., 2001; Fukuda et al., 1996; Medkova and Cho, 1998), 
whereas the C2 domains of cPLA2α  and plant phospholipase D target neutral 
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phosphatidylcholine (PC) (Nalefski et al., 1998, 2001; Stahelin et al., 2003; Zheng et al., 
2000). Furthermore, C2 domains also exhibit lipid specificity in a Ca2+-dependent manner: 
studies have shown that at a Ca2+ concentration required for transmitter release (~100 μM) , 
the C2B domain of synaptotagmin 1 switches the specificity of binding from 
phosphatidylinositol-3,4,5-trisphosphate to phosphatidylinositol-4,5-bisphosphate 
(Schiavo et al., 1996). This lipid selectivity property may have a direct relation with the 
specific function a C2 domain carries as cell membranes present various and dynamic 
composition of lipids (Tucker et al., 2004). 
 
To further explain these diverse lipid binding features of C2 domains, the binding 
mechanisms have to be elucidated. Effort by extensive studies has established the 
consensus that C2 domain binding to the membrane uses a combination of electrostatic and 
hydrophobic interaction. For a majority of membrane-binding C2 domains, the 
phospholipid binding site is related to the Ca2+-binding region, and the residues on the 
surface of the Ca2+ -binding loops likely determine their lipid-binding manners. First, some 
C2 domains have been shown to bind anionic lipids via the cationic residues present on the 
loop region through non-specific electrostatic interaction irrespective of the presence of 
Ca2+ (Davletov and Sudhof, 1993; Fukuda et al., 1994). In contrast, a number of other C2 
domains bind to their target phospholipids in a Ca2+-dependent manner. As described 
earlier, Ca2+ binding changes the electrostatic potential of the loop region of many C2 
domains and the resulting positively charged surface drives the interaction with anionic 
phospholipids, exemplified by the synaptotagmin C2A domain and PKCb C2 domain 
(Murray and Honig, 2002; Striegel et al., 2012).  
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Structural characterization of the lipid binding sites of C2 domains has provided more 
insights on the binding mechanisms. An early determination of the three-dimensional  
structure of the C2 domain of PKCα in complex with Ca2+ and 1,2-dicaproyl-sn-
phosphatidylserine (DCPS) showed that the phosphoryl group of the phosphoserine 
completes the coordination sphere of  a Ca2+ ion (Verdaguer et al., 1999). In this case, Ca2+ 
acts as a bridge tethering the C2 domain and phospholipid (Figure 1.6 A - B). Additional 
binding sites were identified in the following ternary complex of Ca2+-bound PKCα with 
either 1,2-diacetyl-sn-phosphatidyl-L-serine (DAPS) or 1,2-dicaproyl-sn-phos-phatidic 
acid (DCPA). The glycerol moiety of the phospholipid is hydrogen-bonded with residues 
Arg216 and Arg249 in loop 1; the serine head group interacts with Pro188 and Asn189 in 
loop 1 (Ochoa et al., 2002). This interplay between Ca2+ ions, phospholipid molecules and 
residues in C2 domains was subsequently supported  by  a number of studies on other C2 
domains (Bittova et al., 1999; Hirano et al., 2019; Malmberg et al., 2003). 
 
More recently, the X-ray crystal structure of cytosolic PLA2α (cPLA2α) C2 domain bound 
to 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) was solved in the presence of 
Ca2+ (Hirano et al., 2019). In contrast to the two bound Ca2+ ions reported in the lipid-free 
structure (Dessen et al., 1999; Perisic et al., 1998a), an additional Ca2+ ion was observed to 
coordinate in the PC-bound structural complex by bridging residue N65 and the DHPC 
phosphoryl group. This finding expanded our views on the Ca2+-dependent lipid binding 
mechanism of C2 domains. Indeed, most of the structural characterizations of C2 domains 







Figure 1. 5 Two lipid binding modes of C2 domain. 
(A) Overall structure of the C2 domain of PKCα in complex with Ca2+ and DCPS (PDB: 
1DSY) showing the lipid binding site overlaps with the Ca2+-binding region. Bound Ca2+ 
ions are shown as yellow spheres. (B) Close-up view of the lipid binding site demonstrating 
the phosphoryl group completes the coordination sphere of  a Ca2+ ion (Ca1). (C) The 
rabphilin 3A C2A-PI(4,5)P2 complex (PDB: 4NS0), showing the β sheet groove interacts 
with the phospholipid. (D) Close-up view of the β3–β4 groove, indicating the interactions 
between the C2A domain and the PI(4,5)P2 ligand. The C2 domain contacting residues and 
the corresponding ligands are represented in sticks and explicitly labeled. Bonds are shown 




of extra Ca2+ ions when C2 domains target membranes, which might help explain the 
existence of unoccupied Ca2+-binding sites in many C2 domains.  
 
Moreover, the crystal structures of PKCα with DAPS and DCPA showed the presence of 
a second binding site for phospholipids in the vicinity of the lysine-rich cluster from the b3 
and b4 strands. The concave surface with positive charges suited to interact with the 
anionic lipids (Ochoa et al., 2002). This interaction was further confirmed by the crystal 
structure of PKCα C2 domain in complex with Ca2+ and PtdIns(4,5)P2, where PtdIns(4,5)P2 
binds specifically to the b3-b4 groove, forming direction interactions with four lysines as 
well as two aromatic residues. Mutations of these residues were shown to cause severely 
impaired plasma membrane localization of PKCα. Structure-based sequence alignment has 
revealed high conservation of aromatic and cationic residues in the b3-b4 among many C2 
domains, including synaptotagmins 1, 4, 7 and 13, rapbhilin 3A, PI3K-C2α, piccolo and 
RIM1, 2 (Corbalan-Garcia and Gómez-Fernández, 2014). This model was further 
supported by the crystal structures of the C2A domain of rabphilin 3A and synaptotagmin 
1 in complex with PtdIns(4,5)P2 and IP3, which show that a collection of residues 
surrounding the polybasic cluster are essential to hold the phosphoinositide in order to 
induce Ca2+-dependent vesicle clustering (Guillen et al., 2013) (Figure 1.6 C - D). The 
finding that phospholipids specifically interact with the lysine-rich cluster in addition to 
the Ca2+ binding region, suggests that C2 domain may be regulated by a dual-target 





1.5 Ca2+-mediated membrane repair 
 
Eukaryotic cells are not protected by a hardened and impermeant cell wall like bacterial 
cells. The loss of a cell wall leads to an unprotected lipid bilayer membrane, which is more 
vulnerable to mechanical and chemical stress. Consequently, plasma membrane disruption 
occurs frequently especially in mechanically active tissues, such as skeletal and cardiac 
muscles and skins (Clarke Mark S. F. et al., 1995; McNeil and Ito, 1990; McNeil and 
Khakee, 1992). By using histochemical techniques to detect membrane damage in rat 
muscle fibers, it was shown that membrane wounding occurs far more frequently after 
eccentric exercise than the unexercised rat (McNeil and Khakee, 1992). Fortunately, 
membrane repair mechanisms have evolved in eukaryotic cells to reseal membrane 
breaches. The wounded cell is able to survive when an effective repair response is triggered 
that restores membrane integrity.  
 
In fact, early in the 1920s, studies on the embryonic fate of egg fragments already 
demonstrated that metazoan cells could survive rupture of their surface membranes 
(Wilson, 1925). Several decades later, Chambers & Chambers and Heilbrunn discovered 
that healing of injured cells required the presence of physiological levels of Ca2+ 
(Chambers and Chambers, 1961; Heilbrunn, 2013). They observed that, in the presence of 
Ca2+, cells displayed a rapid (seconds) reaction to a wound. This consisted of the 
disappearance of certain cytoplasmic vesicles at the disruption site and the simultaneous 
appearance there of an enlarged vesicle population. They also inferred that cytoplasm 
would begin and continue to spill out of the wounded cell in the absence of Ca2+. In the 
presence of Ca2+, the wounded cell clearly recovered. The critical role of Ca2+ as an 
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activating trigger for membrane repair has been universally accepted since then and 
evidently supported by a myriad of other studies. 
 
Pioneering studies of cell membrane repair mainly were performed on sea urchin eggs and 
revealed that repair of the disruptions is mediated by Ca2+-regulated exocytosis. Using 
confocal microscopy, researchers visualized Ca2+-dependent exocytosis during membrane 
resealing by a mechanism similar to neurotransmitter release: when a sea urchin egg was 
wounded with a laser beam, rapid and localized exocytosis followed Ca2+ influx at the 
wound site (Bi et al., 1995; Steinhardt et al., 1994).  It was then proposed that exposure of 
cytoplasm to high Ca2+ caused by a puncture of the fibroblast or sea urchin egg surface 
results in massive fusion of internal vesicles with each other and with the plasma membrane. 
These fusion reactions proceed rapidly until a patch of membrane continuous with the 
plasma membrane has formed, preventing further Ca2+ entry (Terasaki et al., 1997). 
Subsequent studies identified lysosomes as the Ca2+-regulated exocytic compartments 
responsible for plasma membrane repair based on the observation of specific markers of 
lysosomes aggregating on the surface of injured epithelial and myoblasts cells (Reddy et 
al., 2001; Rodríguez et al., 1997). Instead of the traditional view that lysosomes are the 
final sites of accumulation of internalized macromolecules, it is believed now that 
lysosomes also behave as secretory vesicles, fusing with the plasma membrane in response 
to Ca2+ entry (Andrews, 2000). Ca2+-dependent lysosomal exocytosis was later shown to 




All these findings together have established a broadly accepted mechanism to explain cell 
membrane repair - the “lipid patch” model. This model proposes that, a disrupted 
membrane causes diffusion of Ca2+ from the extracellular space and creates a zone of high 
Ca2+ around the disruption site. In response to the Ca2+ influx, protein-carrying repair 
vesicles (lysosomes) are targeted to the disruption site, where they accumulate and fuse 
with one another and the plasma membrane. Fusion of the repair vesicles with the plasma 
membrane puts a membrane patch across the membrane disruption, thereby resealing the 
disrupted plasma membrane (Figure 1.7).  
 
Consistent with the critical role of Ca2+ in cell membrane repair, a number of Ca2+-sensor 
proteins have been identified to be involved in resealing in various cell types, including 
SNARE proteins, synaptotagmins, S100A10, annexins, calpains and Ferlins. Most Ca2+ 
sensor proteins contain one or more Ca2+-binding domains, such as a C2 domain or an EF-
hand motif. Taking synaptotagmins for example, as mentioned above, synaptotagmins are 
a group of transmembrane proteins that contain two C2 domains in their cytosolic regions 
(Davletov and Sudhof, 1993). Synaptotagmins 1 and 2  are conventionally known for 
triggering the Ca2+-activated fusion of neurotransmitter-containing vesicles through 
interaction with SNARE machinery in neural synaptic vesicle exocytosis (Bommert et al., 
1993; Brose et al., 1992; Elferink et al., 1993; Schiavo et al., 1997). Later, synaptotagmin 
1 was shown to be  required for membrane repair in severed axons of squid and crayfish 
giant axons (Detrait et al., 2000). In addition, synaptotagmin 7, ubiquitously expressed in 
mammalian cells, was found to be critical for membrane resealing in embryonic fibroblasts 








Figure 1. 6 Schematic diagram of the lipid patch model of plasma membrane repair. 
(A) A disrupted membrane causes diffusion of Ca2+ from the extracellular space and creates 
a zone of Ca2+ calcium around the disruption site. (B) Ca2+ activates repair proteins and 
protein-carrying repair vesicles are targeted to the disruption site, where they accumulate 
and fuse with one another and the plasma membrane in the presence of localized high levels 
of Ca2+. (C) Fusion of the repair vesicles with plasma membrane puts a membrane patch 
across the membrane disruption and thereby reseals the disrupted plasma membrane and 




demonstrated defective lysosomal exocytosis and decreased capacity to reseal their plasma 
membrane, resulting in extensive fibrosis in the skin and skeletal muscle.  
 
Similar to synaptotagmins, a variety of proteins have been shown to be part of the 
membrane repair components, aside from the traditionally recognized functions of theirs, 
such as S100A10, annexins, and MG53 (Cai et al., 2009a; Koerdt and Gerke, 2017; 
Rezvanpour et al., 2011). Are there any proteins that have been identified to be specific 
and exclusive for membrane repair-based fusion events? Dysferlin seems to be the one.  
 
 
1.6 Dysferlin and muscular dystrophy 
 
In 1998, a novel gene was identified in skeletal muscle cell as the cause of two forms of 
inherited muscular dystrophy (Bashir et al., 1998; Liu et al., 1998). This gene shows 
homology to the Caenorhabditis elegans (C. elegans) spermatogenesis factor fer-1. The 
proposed name “dysferlin” combines the role of the gene in producing muscular dystrophy 
with its C. elegans homology. Fer-1 is a spermatogenesis factor that is specifically 
expressed in primary spermatocytes of C. elegans. In spermatids, mutations in fer-1 cause 
infertility by impairing the fusion of large vesicles with the plasma membrane (Achanzar 
and Ward, 1997; Ward et al., 1981). Given the structural and sequence homology between 
dysferlin and fer-1, it was postulated that dysferlin might also be a vesicle-associated 
membrane protein involved in the docking and fusion of vesicles in the skeletal muscle 
cells. Soon after the identification of dysferlin, several new genes showing protein structure 
and sequence similarity to dysferlin were identified, including myoferlin and otoferlin 
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(Britton et al., 2000; Yasunaga et al., 1999). Therefore, a new family of mammalian 
proteins was discovered and named “Ferlin”. All ferlin proteins, including dysferlin, 
contain a variable number of C2 domains, accessory domains and a single C-terminal 
transmembrane spanning helix domain (Peulen et al., 2019). 
 
In 2003, Bansal et al. made the fundamental discovery that dysferlin played an essential 
role in Ca2+-dependent sarcolemma resealing. They showed that dysferlin-null mice 
developed a progressive muscular dystrophy, compared to the normal muscle cells, where 
membrane patches enriched in dysferlin can be detected in response to injuries. Further, 
increased entry of fluorescence dye into the muscle cells after a laser-induced disruption at 
plasma membrane was observed for the wounded muscle in the absence of Ca2+, and 
dysferlin-null muscle, indicating disruptive muscle fibers could not be resealed without 
participation of Ca2+ or dysferlin (Bansal et al., 2003). Subsequently, the role of dysferlin 
in membrane repair was confirmed and extended by several other groups. For example, 
fusion and accumulation of dysferlin-containing vesicles and with lysosomes in response 
to muscle cell wounding was detected by live-cell imaging (McDade and Michele, 2014), 
supporting the “lipid patch” hypothesis for membrane repair mechanism described above.  
 
However, the exact mechanism of dysferlin-mediated membrane repair is still unclear, and 
many steps involved in this process are unknown. One major mystery is the unique domain 
organization of dysferlin. Dysferlin is a 230 kD cytosolic-facing, membrane bound protein, 
which contains seven tandem C2 domains (C2A-C2G), two Fer domains (FerA and FerB) 
and a DysF domain (Sula et al., 2014) (Figure 1.8 A). Regarding the C2 domains of 
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dysferlin, it seems that they have distinct functions. For instance, the C2A domain was 
identified to bind phospholipids in a Ca2+-dependent fashion, whereas other C2 domains 
showed weak and Ca2+-independent binding (Therrien et al., 2009). It has been reported 
that the dysferlin C2A domain mediates the fusion of lysosomes with the plasma membrane 
(Han et al., 2012), and that it is also required for MG53-dependent accumulation of 
dysferlin at damage sites (Matsuda et al., 2012) (Figure 1.8 B). One study demonstrated 
that all seven dysferlin C2 domains interact with Ca2+ with various binding affinities 
ranging from micromolar to millimolar, and with different stoichiometry (Abdullah et al., 
2014). Additionally, the C2B-C2C motif was proposed to mediate dysferlin expression at 
the plasma membrane, as well as its endocytic rate (Evesson et al., 2010). However, only 
the structure of the C2A domain of dysferlin has been reported (Fuson et al., 2014). There 
is very limited data regarding the structure and detailed Ca2+ binding mechanisms of other 
C2 domains. On the other hand, functions of Fer and DysF domains as well as the linker 
regions are also unidentified.  
 
As mentioned, in humans, mutations in dysferlin are linked to two types of muscular 
dystrophy diseases: limb-girdle muscular dystrophy 2B (LGMD2B), a autosomal recessive 
degenerative myopathy, and Miyoshi muscular dystrophy (MM), a late-onset muscular 
dystrophy. Muscular dystrophy is a diverse group of inherited myogenic disorders, 
characterized by progressive loss of skeletal muscle strength and integrity, causing muscle 
weakness and wasting. Clinically, these diseases can present at any age from birth to middle 
years, resulting in severe morbidity and disability (Laval and Bushby, 2004). At the level 







Figure 1. 7 Dysferlin domain organization and dysferlin-mediated membrane repair 
model.  
(A) Domain organization for human dysferlin showing the seven C2 domains, two Fer 
domains, one DysF domain and a C-terminal transmembrane domain (red), connected by 
linker regions (grey). (B) Dysferlin is localized by its C-terminal transmembrane domain 
to cytoplasmic vesicles and the plasma membrane. On injury of the membrane, Ca2+ influx 
(green) raises the intracellular Ca2+ concentration locally, triggering the dysferlin-mediated 
patch repair response by binding to the C2 domains of dysferlin. Dysferlin molecules 
present on repair vesicles and the plasma membrane mediate docking and fusion of the 




fibres, increase in fibre size variation, fibre splitting and centrally located myonuclei. 
Successive rounds of degeneration and regeneration of muscle fibres eventually result in 
necrosis and replacement of muscle with fatty and fibrous tissue (Laval and Bushby, 2004). 
Its most common form in children, Duchenne muscular dystrophy, affects approximately 
1 in every 3,500 to 6,000 male births each year in the United States. To date, there are more 
than 30 forms of clinically distinctive muscular dystrophies, classified by the distribution 
of muscle degeneration, age of onset, rate of progression, severity of symptoms, and family 
history.  
 
LGMD2B and Miyoshi myopathy (MM) are two autosomal recessive muscle diseases. 
LGMD2B is a predominantly proximal muscular dystrophy affecting the voluntary 
muscles, such as the arms, legs, fingers, toes, and facial muscles. The patients show normal 
mobility in childhood with a slowly progressive muscle weakness and wasting (Prelle et 
al., 2003). By contrast, Miyoshi myopathy is a predominantly distal muscular dystrophy 
with early involvement of muscles that are located away from the center of the body, such 
as those in the legs (Flachenecker et al., 1996). 
 
More than 100 pathogenic mutations have been identified throughout the entire dysferlin 
gene including all seven C2 domains (Krahn et al., 2009). Clinical data have reported that 
the pathogenic dysferlin mutations affect the protein expression level in skeletal muscle, 
characterized by severely decreased  or absence of dysferlin expression (Krahn et al., 2009; 
Nguyen et al., 2005). An amount of dysferlin £ 20% has been shown to be  pathogenic and 
always caused by primary dysferlin gene mutations (Cacciottolo et al., 2011). The V67D 
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substitution on the C2A domain was shown to impede the membrane repair process by 
diminishing phospholipid binding (Davis et al., 2002). Another substitution on the C2A 
domain, W52R, leading to Miyoshi myopathy (MM) (De Luna et al., 2007) inhibits the 
association with MG53 (Matsuda et al., 2012). The L344P substitution occurs within the 
linker between dysferlin C2B and C2C domains was demonstrated to change the tertiary 
conformation of C2B-C2C module (Woolger et al., 2017). Nevertheless, how these 
substitutions affect dysferlin expression and activities on the molecular basis still remains 
largely unknown. 
 
Last but not least, in vivo studies (co-immunoprecipitation, pull-down assays, 
immunofluorescence, etc.) have made progress on identifying proteins that cooperate with 
dysferlin to regulate membrane fusion and provided new mechanistic insights into dysferlin 
function. For instance, dysferlin associates with annexins A1 and A2 in a Ca2+-dependent 
and membrane injury dependent manner (Lennon et al., 2003); Caveolin-3 and calpain-3, 
two muscle specific proteins that are responsible for distinct forms of muscular dystrophy, 
have  also  been  found  to  interact  with  dysferlin (Matsuda et al., 2001; Anderson et al., 
2000).  Patients  deficient  in  caveolin-3  have  been  reported  to exhibit  a reduction or 
mislocalization of dysferlin, and patients deficient in dysferlin have reduced levels of 
calpain-3 (Anderson et al., 2000; Capanni et al., 2003). Dysferlin binding to SNAREs was 
identified in myoblast cell, revealing a function for dysferlin as a Ca2+ sensing SNARE-
mediated membrane fusion events (Codding et al., 2016). Futhermore, dysferlin was shown 
to bind to AHNAK, a previously reported marker of enlargeosomes (Cocucci et al., 2004), 
through the C2A domain (Huang et al., 2007). AHNAK has also been reported to 
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participate in a ternary membrane repair complex with S100A10 and annexin A2 (Dempsey 
et al., 2012; Rezvanpour et al., 2011). Dysferlin with MG53 and caveolin-3 were shown to 
made up an essential component of the membrane repair machinery in striated muscle (Cai 
et al., 2009b). Additionally, the C2A domain of dysferlin was identified to be important for 
association with MG53. All these findings combined with multiple proteomic studies have 
suggested a multiprotein complex that includes dysferlin, AHNAK, annexin, S100A10, 
and MG53, and the C2A domain seems to play a critical role in interacting with other 
proteins (Leung et al., 2011; Morrée et al., 2010; Park et al., 2010). Thus, to uncover the 
mechanisms of membrane repair and related disorders, it is important to understand how 
the dysferlin-mediated membrane repair complex is assembled and how Ca2+ may play a 
regulatory role.  
 
 
1.7 Scope of thesis 
 
Dysferlin plays an essential role in muscle cell membrane resealing and abnormality of it 
leads to serious muscular dystrophy diseases. However, lack of information on the 
structures and Ca2+-binding modes of the C2 domains of dysferlin does not allow a full 
understanding of the mechanisms of membrane repair. Although a crystal structure of the 
C2A domain was reported prior to the thesis (Fuson et al., 2014), it is unclear how the 
domain interacts with Ca2+. The Ca2+-binding site of the C2A domain is yet to be unveiled. 
Further, identification of other C2 domains in dysferlin remains ambiguous with respect to 
the domain boundaries and structural characterization. Limited data exists about the 
possible interdomain interaction and the modular topology of dysferlin. In addition, how 
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pathogenic substitutions affect the activities of dysferlin on the molecular basis still 
remains largely unknown.  
 
Consequently, further biochemical and structural studies will be needed to answer the 
above questions. The objectives of this thesis were:  
1) Determine the structure of the dysferlin C2A domain in the Ca2+-free and Ca2+-bound 
state. Assess the dynamics of the protein in the two states. (Chapter 2 – 3) 
2) Investigate how calcium binds and modulates the dysferlin C2A domain in details. 
Compare the calcium binding mode with that of other C2 domain containing proteins. 
(Chapter 3) 
3) Assess how some pathogenic substitutions in dysferlin C2 domains affect the domain 
structure and activity. (Chapter 4) 
4) Characterize other C2 domains in dysferlin such as C2B and C2C domains and 
determine the precise domain boundaries. Explore the possible interdomain 
interactions. (Chapter 5) 
 
To address these goals, a variety of biophysical and thermodynamic techniques were 
undertaken. Nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography 
were used to determine the structures of dysferlin C2A domain. The dynamic properties of 
the C2A domain were probed by  NMR spectroscopy and circular dichroism (CD) 
spectropolarimetry, which revealed the flexibility of the dysferlin C2A domain as its 
unique feature. Isothermal titration calorimetry (ITC) was carried out to measure the 
thermodynamic properties of Ca2+ binding to the C2A domain. Based on the solved 
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structures and established Ca2+ binding properties of the C2A domain, impact of 
pathogenic mutations was then assessed on the molecular basis. Finally, to design and 
generate recombinant dysferlin C2B and C2C domains, a combination of biological and 
computational analyses were used. Together, these studies expand our knowledge of the 
Ca2+ signaling in dysferlin-mediated membrane repair, and pathogenesis of related diseases. 






Abdullah, N., Padmanarayana, M., Marty, N.J., and Johnson, C.P. (2014). Quantitation of 
the Calcium and Membrane Binding Properties of the C2 Domains of Dysferlin. Biophys. 
J. 106, 382–389. 
Achanzar, W.E., and Ward, S. (1997). A nematode gene required for sperm vesicle 
fusion. J. Cell Sci. 110, 1073–1081. 
Anderson, L.V.B., Harrison, R.M., Pogue, R., Vafiadaki, E., Pollitt, C., Davison, K., 
Moss, J.A., Keers, S., Pyle, A., Shaw, P.J., et al. (2000). Secondary reduction in calpain 3 
expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi 
myopathy (primary dysferlinopathies). Neuromuscul. Disord. 10, 553–559. 
Andrews, N.W. (2000). Regulated secretion of conventional lysosomes. Trends Cell Biol. 
10, 316–321. 
Bailey, K. (1942). Myosin and adenosinetriphosphatase. Biochem. J. 36, 121–139. 
Bansal, D., Miyake, K., Vogel, S.S., Groh, S., Chen, C.-C., Williamson, R., McNeil, P.L., 
and Campbell, K.P. (2003). Defective membrane repair in dysferlin-deficient muscular 
dystrophy. Nature 423, 168–172. 
Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., 
Marchand, S., Bourg, N., Argov, Z., et al. (1998). A gene related to Caenorhabditis 
elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 
2B. Nat. Genet. 20, 37–42. 
Bazzi, M.D., and Nelsestuen, G.L. (1987). Association of protein kinase C with 
phospholipid vesicles. Biochemistry 26, 115–122. 
Bazzi, M.D., and Nelsestuen, G.L. (1990). Protein kinase C interaction with calcium: a 
phospholipid-dependent process. Biochemistry 29, 7624–7630. 
Berridge, M.J., Lipp, P., and Bootman, M.D. (2000). The versatility and universality of 
calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21. 
Bi, G.Q., Alderton, J.M., and Steinhardt, R.A. (1995). Calcium-regulated exocytosis is 
required for cell membrane resealing. J. Cell Biol. 131, 1747–1758. 
Biadene, M., Montaville, P., Sheldrick, G.M., and Becker, S. (2006). Structure of the 
C2A domain of rabphilin-3A. Acta Crystallogr. D Biol. Crystallogr. 62, 793–799. 
Bittova, L., Sumandea, M., and Cho, W. (1999). A Structure-Function Study of the C2 
Domain of Cytosolic Phospholipase A2 IDENTIFICATION OF ESSENTIAL 
CALCIUM LIGANDS AND HYDROPHOBIC MEMBRANE BINDING RESIDUES. J. 
Biol. Chem. 274, 9665–9672. 
 
 33 
Bommert, K., Charlton, M.P., DeBello, W.M., Chin, G.J., Betz, H., and Augustine, G.J. 
(1993). Inhibition of neurotransmitter release by C2-domain peptides implicates 
synaptotagmin in exocytosis. Nature 363, 163–165. 
Brini, M., Calì, T., Ottolini, D., and Carafoli, E. (2014). Neuronal calcium signaling: 
function and dysfunction. Cell. Mol. Life Sci. 71, 2787–2814. 
Britton, S., Freeman, T., Vafiadaki, E., Keers, S., Harrison, R., Bushby, K., and Bashir, 
R. (2000). The Third Human FER-1-like Protein Is Highly Similar to Dysferlin. 
Genomics 68, 313–321. 
Brose, N., Petrenko, A.G., Sudhof, T.C., and Jahn, R. (1992). Synaptotagmin: a calcium 
sensor on the synaptic vesicle surface. Science 256, 1021–1025. 
Cacciottolo, M., Numitone, G., Aurino, S., Caserta, I.R., Fanin, M., Politano, L., Minetti, 
C., Ricci, E., Piluso, G., Angelini, C., et al. (2011). Muscular dystrophy with marked 
Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur. J. 
Hum. Genet. 19, 974–980. 
Cai, C., Masumiya, H., Weisleder, N., Matsuda, N., Nishi, M., Hwang, M., Ko, J.-K., 
Lin, P., Thornton, A., Zhao, X., et al. (2009a). MG53 nucleates assembly of cell 
membrane repair machinery. Nat. Cell Biol. 11, 56–64. 
Cai, C., Weisleder, N., Ko, J.-K., Komazaki, S., Sunada, Y., Nishi, M., Takeshima, H., 
and Ma, J. (2009b). Membrane Repair Defects in Muscular Dystrophy Are Linked to 
Altered Interaction between MG53, Caveolin-3, and Dysferlin. J. Biol. Chem. 284, 
15894–15902. 
Capanni, C., Sabatelli, P., Mattioli, E., Ognibene, A., Columbaro, M., Lattanzi, G., 
Merlini, L., Minetti, C., Maraldi, N.M., and Squarzoni, S. (2003). Dysferlin in a 
hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP 
kinase inhibition. Exp. Mol. Med. 35, 538–544. 
Carafoli, E. (2002). Calcium signaling: A tale for all seasons. Proc. Natl. Acad. Sci. 99, 
1115–1122. 
Chakrabarti, S., Kobayashi, K.S., Flavell, R.A., Marks, C.B., Miyake, K., Liston, D.R., 
Fowler, K.T., Gorelick, F.S., and Andrews, N.W. (2003). Impaired membrane resealing 
and autoimmune myositis in synaptotagmin VII–deficient mice. J. Cell Biol. 162, 543–
549. 
Chambers, R., and Chambers, E.L. (1961). Explorations into the Nature of the Living 
Cell. Acad. Med. 36, 966. 
Cheng, Y., Sequeira, S.M., Malinina, L., Tereshko, V., Söllner, T.H., and Patel, D.J. 
(2004). Crystallographic identification of Ca2+ and Sr2+ coordination sites in 
synaptotagmin I C2B domain. Protein Sci. Publ. Protein Soc. 13, 2665–2672. 
 
 34 
Clapham, D.E. (2007). Calcium Signaling. Cell 131, 1047–1058. 
Clark, J.D., Lin, L.-L., Kriz, R.W., Ramesha, C.S., Sultzman, L.A., Lin, A.Y., Milona, 
N., and Knopf, J.L. (1991). A novel arachidonic acid-selective cytosolic PLA2 contains a 
Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65, 1043–
1051. 
Clarke Mark S. F., Caldwell Robert W., Chiao Hsi, Miyake Katsuya, and McNeil Paul L. 
(1995). Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in 
Heart. Circ. Res. 76, 927–934. 
Cocucci, E., Racchetti, G., Podini, P., Rupnik, M., and Meldolesi, J. (2004). 
Enlargeosome, an Exocytic Vesicle Resistant to Nonionic Detergents, Undergoes 
Endocytosis via a Nonacidic Route. Mol. Biol. Cell 15, 5356–5368. 
Codding, S.J., Marty, N., Abdullah, N., and Johnson, C.P. (2016). Dysferlin Binds 
SNAREs (Soluble N -Ethylmaleimide-sensitive Factor (NSF) Attachment Protein 
Receptors) and Stimulates Membrane Fusion in a Calcium-sensitive Manner. J. Biol. 
Chem. 291, 14575–14584. 
Corbalan-Garcia, S., and Gómez-Fernández, J.C. (2014). Signaling through C2 domains: 
More than one lipid target. Biochim. Biophys. Acta BBA - Biomembr. 1838, 1536–1547. 
Corbalán-García, S., Rodríguez-Alfaro, J.A., and Gómez-Fernández, J.C. (1999). 
Determination of the calcium-binding sites of the C2 domain of protein kinase Calpha 
that are critical for its translocation to the plasma membrane. Biochem. J. 337 ( Pt 3), 
513–521. 
Corrotte, M., Almeida, P.E., Tam, C., Castro-Gomes, T., Fernandes, M.C., Millis, B.A., 
Cortez, M., Miller, H., Song, W., Maugel, T.K., et al. (2013). Caveolae internalization 
repairs wounded cells and muscle fibers. ELife 2, e00926. 
Davis, D.B., Doherty, K.R., Delmonte, A.J., and McNally, E.M. (2002). Calcium-
sensitive Phospholipid Binding Properties of Normal and Mutant Ferlin C2 Domains. J. 
Biol. Chem. 277, 22883–22888. 
Davletov, B.A., and Sudhof, T.C. (1993). A single C2 domain from synaptotagmin I is 
sufficient for high affinity Ca2+/phospholipid binding. J. Biol. Chem. 268, 26386–26390. 
De Luna, N., Freixas, A., Gallano, P., Caselles, L., Rojas-García, R., Paradas, C., 
Nogales, G., Dominguez-Perles, R., Gonzalez-Quereda, L., Vílchez, J.J., et al. (2007). 
Dysferlin expression in monocytes: A source of mRNA for mutation analysis. 
Neuromuscul. Disord. 17, 69–76. 
Dempsey, B.R., Rezvanpour, A., Lee, T.-W., Barber, K.R., Junop, M.S., and Shaw, G.S. 
(2012). Structure of an Asymmetric Ternary Protein Complex Provides Insight for 
Membrane Interaction. Structure 20, 1737–1745. 
 
 35 
Dessen, A., Tang, J., Schmidt, H., Stahl, M., Clark, J.D., Seehra, J., and Somers, W.S. 
(1999). Crystal Structure of Human Cytosolic Phospholipase A2 Reveals a Novel 
Topology and Catalytic Mechanism. Cell 97, 349–360. 
Detrait, E., Eddleman, C.S., Yoo, S., Fukuda, M., Nguyen, M.P., Bittner, G.D., and 
Fishman, H.M. (2000). Axolemmal repair requires proteins that mediate synaptic vesicle 
fusion. J. Neurobiol. 44, 382–391. 
Elferink, L.A., Peterson, M.R., and Scheller, R.H. (1993). A role for synaptotagmin (p65) 
in regulated exocytosis. Cell 72, 153–159. 
Essen, L.-O., Perisic, O., Lynch, D.E., Katan, M., and Williams, R.L. (1997). A Ternary 
Metal Binding Site in the C2 Domain of Phosphoinositide-Specific Phospholipase C-δ1 
† , ‡. Biochemistry 36, 2753–2762. 
Evesson, F.J., Peat, R.A., Lek, A., Brilot, F., Lo, H.P., Dale, R.C., Parton, R.G., North, 
K.N., and Cooper, S.T. (2010). Reduced Plasma Membrane Expression of Dysferlin 
Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway. J. 
Biol. Chem. 285, 28529–28539. 
Fernandez, I., Araç, D., Ubach, J., Gerber, S.H., Shin, O., Gao, Y., Anderson, R.G.W., 
Südhof, T.C., and Rizo, J. (2001). Three-Dimensional Structure of the Synaptotagmin 1 
C2B-Domain: Synaptotagmin 1 as a Phospholipid Binding Machine. Neuron 32, 1057–
1069. 
Fernández-Chacón, R., Königstorfer, A., Gerber, S.H., García, J., Matos, M.F., Stevens, 
C.F., Brose, N., Rizo, J., Rosenmund, C., and Südhof, T.C. (2001). Synaptotagmin I 
functions as a calcium regulator of release probability. Nature 410, 41–49. 
Flachenecker, P., Kiefer, R., Naumann, M., Handwerker, M., and Reichmann, H. (1996). 
Distal muscular dystrophy of Miyoshi type. J. Neurol. 244, 23–29. 
Fukuda, M., Aruga, J., Niinobe, M., Aimoto, S., and Mikoshiba, K. (1994). Inositol-
1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II. J. Biol. 
Chem. 269, 29206–29211. 
Fukuda, M., Kojima, T., and Mikoshiba, K. (1996). Phospholipid Composition 
Dependence of Ca-dependent Phospholipid Binding to the C2A Domain of 
Synaptotagmin IV. J. Biol. Chem. 271, 8430–8434. 
Fuson, K., Rice, A., Mahling, R., Snow, A., Nayak, K., Shanbhogue, P., Meyer, A.G., 
Redpath, G.M.I., Hinderliter, A., Cooper, S.T., et al. (2014). Alternate Splicing of 
Dysferlin C2A Confers Ca2+-Dependent and Ca2+-Independent Binding for Membrane 
Repair. Structure 22, 104–115. 
García-García, J., Corbalán-García, S., and Gómez-Fernández, J.C. (1999). Effect of 
Calcium and Phosphatidic Acid Binding on the C2 Domain of PKCα As Studied by 
Fourier Transform Infrared Spectroscopy. Biochemistry 38, 9667–9675. 
 
 36 
Grobler, J.A., Essen, L.-O., Williams, R.L., and Hurley, J.H. (1996). C2 domain 
conformational changes in phospholipase C-δ1. Nat. Struct. Biol. 3, 788–795. 
Guillen, J., Ferrer-Orta, C., Buxaderas, M., Perez-Sanchez, D., Guerrero-Valero, M., 
Luengo-Gil, G., Pous, J., Guerra, P., Gomez-Fernandez, J.C., Verdaguer, N., et al. 
(2013). Structural insights into the Ca2+ and PI(4,5)P2 binding modes of the C2 domains 
of rabphilin 3A and synaptotagmin 1. Proc. Natl. Acad. Sci. 110, 20503–20508. 
Han, W.-Q., Xia, M., Xu, M., Boini, K.M., Ritter, J.K., Li, N.-J., and Li, P.-L. (2012). 
Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in 
coronary arterial endothelial cells. J. Cell Sci. 125, 1225–1234. 
Harsini, F.M., Bui, A.A., Rice, A.M., Chebrolu, S., Fuson, K.L., Turtoi, A., Bradberry, 
M., Chapman, E.R., and Sutton, R.B. (2019). Structural Basis for the Distinct Membrane 
Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin. J. Mol. 
Biol. 431, 2112–2126. 
Heilbrunn, L.V. (1940). The Action of Calcium on Muscle Protoplasm. Physiol. Zool. 13, 
88–94. 
Heilbrunn, L.V. (2013). The Dynamics of Living Protoplasm (Academic Press). 
Helfmann, S., Neumann, P., Tittmann, K., Moser, T., Ficner, R., and Reisinger, E. 
(2011). The Crystal Structure of the C2A Domain of Otoferlin Reveals an 
Unconventional Top Loop Region. J. Mol. Biol. 406, 479–490. 
Hirano, Y., Gao, Y.-G., Stephenson, D.J., Vu, N.T., Malinina, L., Simanshu, D.K., 
Chalfant, C.E., Patel, D.J., and Brown, R.E. (2019). Structural basis of 
phosphatidylcholine recognition by the C2–domain of cytosolic phospholipase A2α. In 
ELife, p. 
Huang, Y., Laval, S.H., van Remoortere, A., Baudier, J., Benaud, C., Anderson, L.V.B., 
Straub, V., Deelder, A., Frants, R.R., den Dunnen, J.T., et al. (2007). AHNAK, a novel 
component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin 
during skeletal muscle regeneration. FASEB J. 21, 732–742. 
Ikura, M. (1996). Calcium binding and conformational response in EF-hand proteins. 
Trends Biochem. Sci. 21, 14–17. 
Katz, A.K., Glusker, J.P., Beebe, S.A., and Bock, C.W. (1996). Calcium Ion 
Coordination: A Comparison with That of Beryllium, Magnesium, and Zinc. J. Am. 
Chem. Soc. 118, 5752–5763. 
Koerdt, S.N., and Gerke, V. (2017). Annexin A2 is involved in Ca2+-dependent plasma 
membrane repair in primary human endothelial cells. Biochim. Biophys. Acta BBA - 
Mol. Cell Res. 1864, 1046–1053. 
 
 37 
Krahn, M., Béroud, C., Labelle, V., Nguyen, K., Bernard, R., Bassez, G., Figarella-
Branger, D., Fernandez, C., Bouvenot, J., Richard, I., et al. (2009). Analysis of the DYSF 
mutational spectrum in a large cohort of patients: DYSF Mutational Spectrum in a Large 
Cohort. Hum. Mutat. 30, E345–E375. 
Laval, S.H., and Bushby, K.M.D. (2004). Limb-girdle muscular dystrophies – from 
genetics to molecular pathology. Neuropathol. Appl. Neurobiol. 30, 91–105. 
Lennon, N.J., Kho, A., Bacskai, B.J., Perlmutter, S.L., Hyman, B.T., and Brown Jr., R.H. 
(2003). Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal 
Wound-healing. J. Biol. Chem. 278, 50466–50473. 
Leung, C., Utokaparch, S., Sharma, A., Yu, C., Abraham, T., Borchers, C., and 
Bernatchez, P. (2011). Proteomic identification of dysferlin-interacting protein complexes 
in human vascular endothelium. Biochem. Biophys. Res. Commun. 415, 263–269. 
Li, C., Ullrich, B., Zhang, J.Z., Anderson, R.G.W., Brose, N., and Südhof, T.C. (1995). 
Ca 2+ -dependent and -independent activities of neural and non-neural synaptotagmins. 
Nature 375, 594–599. 
Linse, S., and Forsén, S. (1995). Determinants that govern high-affinity calcium binding. 
Adv. Second Messenger Phosphoprotein Res. 30, 89–151. 
Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J.A., 
Hentati, F., Hamida, M.B., et al. (1998). Dysferlin, a novel skeletal muscle gene, is 
mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 20, 31–
36. 
Malmberg, N.J., Van Buskirk, D.R., and Falke, J.J. (2003). Membrane-Docking Loops of 
the cPLA2 C2 Domain:  Detailed Structural Analysis of the Protein−Membrane Interface 
via Site-Directed Spin-Labeling. Biochemistry 42, 13227–13240. 
Matsuda, C., Hayashi, Y.K., Ogawa, M., Aoki, M., Murayama, K., Nishino, I., Nonaka, 
I., Arahata, K., and Jr, R.H.B. (2001). The sarcolemmal proteins dysferlin and caveolin-3 
interact in skeletal muscle. Hum. Mol. Genet. 10, 1761–1766. 
Matsuda, C., Miyake, K., Kameyama, K., Keduka, E., Takeshima, H., Imamura, T., 
Araki, N., Nishino, I., and Hayashi, Y. (2012). The C2A domain in dysferlin is important 
for association with MG53 (TRIM72). PLoS Curr. 
McDade, J.R., and Michele, D.E. (2014). Membrane damage-induced vesicle–vesicle 
fusion of dysferlin-containing vesicles in muscle cells requires microtubules and kinesin. 
Hum. Mol. Genet. 23, 1677–1686. 
McNeil, P.L., and Ito, S. (1990). Molecular traffic through plasma membrane disruptions 
of cells in vivo. J. Cell Sci. 96, 549–556. 
 
 38 
McNeil, P.L., and Khakee, R. (1992). Disruptions of muscle fiber plasma membranes. 
Role in exercise-induced damage. Am. J. Pathol. 140, 1097–1109. 
Medkova, M., and Cho, W. (1998). Differential Membrane-Binding and Activation 
Mechanisms of Protein Kinase C-α and -ε. Biochemistry 37, 4892–4900. 
Missiaen, L., Robberecht, W., Bosch, L.V.D., Callewaert, G., Parys, J.B., Wuytack, F., 
Raeymaekers, L., Nilius, B., Eggermont, J., and Smedt, H.D. (2000). Abnormal 
intracellular Ca2+homeostasis and disease. Cell Calcium 28, 1–21. 
Morrée, A. de, Hensbergen, P.J., Haagen, H.H.H.B.M. van, Dragan, I., Deelder, A.M., 
Hoen, P.A.C. ’t, Frants, R.R., and Maarel, S.M. van der (2010). Proteomic Analysis of 
the Dysferlin Protein Complex Unveils Its Importance for Sarcolemmal Maintenance and 
Integrity. PLOS ONE 5, e13854. 
Murray, D., and Honig, B. (2002). Electrostatic Control of the Membrane Targeting of 
C2 Domains. Mol. Cell 9, 145–154. 
Nalefski, E.A., McDonagh, T., Somers, W., Seehra, J., Falke, J.J., and Clark, J.D. (1998). 
Independent Folding and Ligand Specificity of the C2 Calciumdependent Lipid Binding 
Domain of Cytosolic Phospholipase A2. J. Biol. Chem. 273, 1365–1372. 
Nalefski, E.A., Wisner, M.A., Chen, J.Z., Sprang, S.R., Fukuda, M., Mikoshiba, K., and 
Falke, J.J. (2001). C2 Domains from Different Ca2+ Signaling Pathways Display 
Functional and Mechanistic Diversity. Biochemistry 40, 3089–3100. 
Nguyen, K., Bassez, G., Bernard, R., Krahn, M., Labelle, V., Figarella‐Branger, D., 
Pouget, J., Hammouda, E.H., Béroud, C., Urtizberea, A., et al. (2005). Dysferlin 
mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies. Hum. Mutat. 
26, 165–165. 
Ochoa, W.F., Corbalán-Garcia, S., Eritja, R., Rodrı́guez-Alfaro, J.A., Gómez-Fernández, 
J.C., Fita, I., and Verdaguer, N. (2002). Additional Binding Sites for Anionic 
Phospholipids and Calcium Ions in the Crystal Structures of Complexes of the C2 
Domain of Protein Kinase Cα. J. Mol. Biol. 320, 277–291. 
Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa, U., and Nishizuka, Y. 
(1989). Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like 
sequence. Proc. Natl. Acad. Sci. 86, 4868–4871. 
Pappa, H., Murray-Rust, J., Dekker, L.V., Parker, P.J., and McDonald, N.Q. (1998). 
Crystal structure of the C2 domain from protein kinase C-delta. Struct. Lond. Engl. 1993 
6, 885–894. 
Park, E.Y., Kwon, O.-B., Jeong, B.-C., Yi, J.-S., Lee, C.S., Ko, Y.-G., and Song, H.K. 
(2010). Crystal structure of PRY‐SPRY domain of human TRIM72. Proteins Struct. 
Funct. Bioinforma. 3, 790–795. 
 
 39 
Perin, M.S., Fried, V.A., Mignery, G.A., Jahn, R., and Südhof, T.C. (1990). Phospholipid 
binding by a synaptic vesicle protein homologous to the regulatory region of protein 
kinase C. Nature 345, 260–263. 
Perisic, O., Fong, S., Lynch, D.E., Bycroft, M., and Williams, R.L. (1998a). Crystal 
structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J. 
Biol. Chem. 273, 1596–1604. 
Perisic, O., Fong, S., Lynch, D.E., Bycroft, M., and Williams, R.L. (1998b). Crystal 
Structure of a Calcium-Phospholipid Binding Domain from Cytosolic Phospholipase A2. 
J. Biol. Chem. 273, 1596–1604. 
Permyakov, E. (2009). Metalloproteomics (John Wiley & Sons). 
Permyakov, E., and Kretsinger, R.H. (2011). Calcium Binding Proteins (John Wiley & 
Sons). 
Peulen, Rademaker, Anania, Turtoi, Bellahcène, and Castronovo (2019). Ferlin 
Overview: From Membrane to Cancer Biology. Cells 8, 954. 
Prelle, A., Sciacco, M., Tancredi, L., Fagiolari, G., Comi, G.P., Ciscato, P., Serafini, M., 
Fortunato, F., Zecca, C., Gallanti, A., et al. (2003). Clinical, morphological and 
immunological evaluation of six patients with dysferlin deficiency. Acta Neuropathol. 
(Berl.) 105, 537–542. 
Radhakrishnan, A., Stein, A., Jahn, R., and Fasshauer, D. (2009). The Ca2+ Affinity of 
Synaptotagmin 1 Is Markedly Increased by a Specific Interaction of Its C2B Domain with 
Phosphatidylinositol 4,5-Bisphosphate. J. Biol. Chem. 284, 25749–25760. 
Reddy, A., Caler, E.V., and Andrews, N.W. (2001). Plasma Membrane Repair Is 
Mediated by Ca2+-Regulated Exocytosis of Lysosomes. Cell 106, 157–169. 
Rezvanpour, A., Santamaria-Kisiel, L., and Shaw, G.S. (2011). The S100A10-Annexin 
A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair. J. Biol. 
Chem. 286, 40174–40183. 
Ringer, S. (1883). A further Contribution regarding the influence of the different 
Constituents of the Blood on the Contraction of the Heart. J. Physiol. 4, 29–42. 
Rizo, J., and Südhof, T.C. (1998). C 2 -domains, Structure and Function of a Universal Ca 
2+ -binding Domain. J. Biol. Chem. 273, 15879–15882. 
Rodríguez, A., Webster, P., Ortego, J., and Andrews, N.W. (1997). Lysosomes Behave as 




Schiavo, G., Gu, Q.-M., Prestwich, G.D., Söllner, T.H., and Rothman, J.E. (1996). 
Calcium-dependent switching of the specificity of phosphoinositide binding to 
synaptotagmin. Proc. Natl. Acad. Sci. 93, 13327–13332. 
Schiavo, G., Stenbeck, G., Rothman, J.E., and Söllner, T.H. (1997). Binding of the 
synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-
25, can explain docked vesicles at neurotoxin-treated synapses. Proc. Natl. Acad. Sci. 94, 
997–1001. 
Shao, X., Davletov, B.A., Sutton, R.B., Südhof, T.C., and Rizo, J. (1996). Bipartite 
Ca2+-binding motif in C2 domains of synaptotagmin and protein kinase C. Science 273, 
248–251. 
Shao, X., Li, C., Fernandez, I., Zhang, X., Südhof, T.C., and Rizo, J. (1997). 
Synaptotagmin–Syntaxin Interaction: The C2 Domain as a Ca2+-Dependent Electrostatic 
Switch. Neuron 18, 133–142. 
Shao, X., Fernandez, I., Südhof, T.C., and Rizo, J. (1998). Solution Structures of the Ca 
2+ -free and Ca 2+ -bound C 2 A Domain of Synaptotagmin I: Does Ca 2+ Induce a 
Conformational Change? †. Biochemistry 37, 16106–16115. 
Stahelin, R.V., Rafter, J.D., Das, S., and Cho, W. (2003). The Molecular Basis of 
Differential Subcellular Localization of C2 Domains of Protein Kinase C-α and Group 
IVa Cytosolic Phospholipase A2. J. Biol. Chem. 278, 12452–12460. 
Steinhardt, R.A., Bi, G., and Alderton, J.M. (1994). Cell Membrane Resealing by a 
Vesicular Mechanism Similar to Neurotransmitter Release. Science 263, 390–393. 
Stewart, T.A., Yapa, K.T.D.S., and Monteith, G.R. (2015). Altered calcium signaling in 
cancer cells. Biochim. Biophys. Acta BBA - Biomembr. 1848, 2502–2511. 
Striegel, A.R., Biela, L.M., Evans, C.S., Wang, Z., Delehoy, J.B., Sutton, R.B., Chapman, 
E.R., and Reist, N.E. (2012). Calcium Binding by Synaptotagmin’s C2A Domain is an 
Essential Element of the Electrostatic Switch That Triggers Synchronous Synaptic 
Transmission. J. Neurosci. 32, 1253–1260. 
Strynadka, N.C.J., and James, M.N.G. (1989). Crystal structures of the helix-loop-helix 
calcium-binding proteins. Annu. Rev. Biochem. 58, 951–998. 
Sula, A., Cole, A.R., Yeats, C., Orengo, C., and Keep, N.H. (2014). Crystal structures of 
the human Dysferlin inner DysF domain. BMC Struct. Biol. 14, 3. 
Terasaki, M., Miyake, K., and McNeil, P.L. (1997). Large Plasma Membrane Disruptions 




Therrien, C., Di Fulvio, S., Pickles, S., and Sinnreich, M. (2009). Characterization of 
Lipid Binding Specificities of Dysferlin C2 Domains Reveals Novel Interactions with 
Phosphoinositides †. Biochemistry 48, 2377–2384. 
Torrecillas, A., Corbalán-García, S., and Gómez-Fernández, J.C. (2003). Structural Study 
of the C2 Domains of the Classical PKC Isoenzymes Using Infrared Spectroscopy and 
Two-Dimensional Infrared Correlation Spectroscopy. Biochemistry 42, 11669–11681. 
Torrecillas, A., Laynez, J., Menéndez, M., Corbalán-García, S., and Gómez-Fernández, 
J.C. (2004). Calorimetric Study of the Interaction of the C2 Domains of Classical Protein 
Kinase C Isoenzymes with Ca2+ and Phospholipids. Biochemistry 43, 11727–11739. 
Tsien, R.Y. (1981). A non-disruptive technique for loading calcium buffers and indicators 
into cells. Nature 290, 527–528. 
Tucker, W.C., Weber, T., and Chapman, E.R. (2004). Reconstitution of Ca2+-Regulated 
Membrane Fusion by Synaptotagmin and SNAREs. Science 304, 435–438. 
Ubach, J., Zhang, X., Shao, X., Südhof, T.C., and Rizo, J. (1998). Ca2+ binding to 
synaptotagmin: how many Ca2+ ions bind to the tip of a C2-domain? EMBO J. 17, 
3921–3930. 
Verdaguer, N., Corbalan-Garcia, S., Ochoa, W.F., Fita, I., and Gómez-Fernández, J.C. 
(1999). Ca2+ bridges the C2 membrane-binding domain of protein kinase Cα directly to 
phosphatidylserine. EMBO J. 18, 6329–6338. 
Voleti, R., Tomchick, D.R., Südhof, T.C., and Rizo, J. (2017). Exceptionally tight 
membrane-binding may explain the key role of the synaptotagmin-7 C 2 A domain in 
asynchronous neurotransmitter release. Proc. Natl. Acad. Sci. 114, E8518–E8527. 
Ward, S., Argon, Y., and Nelson, G.A. (1981). Sperm morphogenesis in wild-type and 
fertilization-defective mutants of Caenorhabditis elegans. J. Cell Biol. 91, 26–44. 
Wilson, E.B. (1925). The cell in development and heredity. (New York: Macmillan). 
Woolger, N., Bournazos, A., Sophocleous, R.A., Evesson, F.J., Lek, A., Driemer, B., 
Sutton, R.B., and Cooper, S.T. (2017). Limited proteolysis as a tool to probe the tertiary 
conformation of dysferlin and structural consequences of patient missense variant L344P. 
J. Biol. Chem. 292, 18577–18591. 
Yagi, H., Conroy, P.J., Leung, E.W.W., Law, R.H.P., Trapani, J.A., Voskoboinik, I., 
Whisstock, J.C., and Norton, R.S. (2015). Structural Basis for Ca 2+ -mediated Interaction 
of the Perforin C2 Domain with Lipid Membranes. J. Biol. Chem. 290, 25213–25226. 
Yasunaga, S., Grati, M., Cohen-Salmon, M., El-Amraoui, A., Mustapha, M., Salem, N., 
El-Zir, E., Loiselet, J., and Petit, C. (1999). A mutation in OTOF , encoding otoferlin, a 




Zhang, D., and Aravind, L. (2010). Identification of novel families and classification of 
the C2 domain superfamily elucidate the origin and evolution of membrane targeting 
activities in eukaryotes. Gene 469, 18–30. 
Zheng, L., Krishnamoorthi, R., Zolkiewski, M., and Wang, X. (2000). Distinct Ca2+ 
Binding Properties of Novel C2 Domains of Plant Phospholipase Dα and β. J. Biol. 
Chem. 275, 19700–19706. 
Zhou, Y., Frey, T.K., and Yang, J.J. (2009). Viral calciomics: Interplays between Ca2+ 
















Dysferlin is a 230 kD cytosolic-facing, membrane bound protein that is a member of the 
Ferlin family. All Ferlin proteins, including dysferlin, contain a variable number of C2 
domains, accessory domains and a single C-terminal transmembrane spanning helix 
domain (Peulen et al., 2019). For example, dysferlin includes seven C2 domains (C2A-
C2G), three Fer domains (FerA, FerB, and FerI) and two DysF domains (Sula et al., 2014). 
Of these, the N-terminal C2A domain appears to be the most important for membrane 
repair and is also the location of several substitutions that cause limb-girdle muscular 
dystrophy type 2B (LGMD2B) or Miyoshi myopathy (MM) (Krahn et al., 2009). The C2A 
domain demonstrates the strongest interaction with phosphoinositide and 
phosphotidylserine membrane surfaces and is the only C2 domain in dysferlin that does so 
in a calcium-dependent manner (Therrien et al., 2009) . Further, the C2A domain in 
dysferlin has been identified as the main domain responsible for  interaction with other 
proteins (eg. MG53, AHNAK) in response to calcium ion influx to mediate membrane 




The three-dimensional structure of the calcium-free dysferlin C2A was determined by 
NMR spectroscopy by previous members of the Shaw lab (Dr. Liliana Santamaria-Kisiel, 
Dr. Pascal Mercier and Chantal Forristal). The structure displayed an anti-parallel β-
sandwich arrangement connected by loops on the top typical of the C2 domain fold (Figure 
2.1 A). However, the top loops of C2A show remarkably greater flexibility than any other 
C2 domain that have been structurally characterized (Figure 2.1 B). A previously reported 
crystal structure of the dysferlin C2A domain has shown the similar fold with less 
flexibility (Fuson et al., 2014) (Figure 2.1 C). In this crystal structure, only one of the six 
molecules in the asymmetric unit coordinated a single divalent cation that was modeled 
and refined it as a calcium ion. Thus, we consider this structure as apo state. By overlapping 
the six molecules in a asymmetric unit, variations in positions of loop 1 and 3 were 
observed (Figure 2.1 D). This raised our interest in investigating the difference between 
the NMR and crystal structures of the C2A domain by probing its dynamics in solution. 
Although structures of many C2 domains in the apo and calcium bound state have been 
determined, little is known about the dynamics of these proteins. It is also not clear how 
calcium-binding to the dysferlin C2A domain alters the structure of this protein and how 
this might affect its interaction with the inner membrane surface or accessory proteins. In 
this chapter, I pursued a detailed analysis of the backbone flexibility and dynamics of the 
dysferlin C2A domain in the calcium-free and calcium-saturated states and the effect of 
calcium coordination. A combination of methods was applied, including NMR-based 
heteronuclear NOE and T2 relaxation measurements, and thermal unfolding by circular 
dichroism. The work provides novel insights into the flexible properties of the dysferlin 








Figure 2. 1 NMR and crystal structures of the C2A domain in the apo state.  
(A) Ribbon diagrams of the representative structures of apo-C2A domain of dysferlin show 
the eight-strand antiparallel β-sandwich assembly in magenta (β1-β8) and single α-helix in 
cyan. The top loops are shown in gray and labelled by numbers. (B) The superposition of 
the 20 lowest energy structures for the apo-C2A showing the flexibility of the loop region 
(grey). (C) The crystal structure of dysferlin C2A domain (Fuson et al., 2014) (PDB: 4IHB). 
The eight β sheets are shown in blue, α-helix in orange, and loops in grey. (D) The 
superposition of the structures of the six C2A molecules in a asymmetric unit showing the 




2.2 Materials and Methods 
 
 
2.2.1 Expression and purification of dysferlin C2A domain 
The dysferlin C2A construct was cloned by Chantal Forristal prior to this project. The 
construct contained dysferlin (DYSF) residues 1-130 and a seven-residue linker 
(GSGGGGG) at the N-terminus that remained after cleavage of the affinity tag. Unlabeled 
and uniformly 15N, 13C-labeled wild-type C2A domain of human dysferlin (residues 1-130) 
were overexpressed in the BL21-CodonPlus (DE3) Escherichia coli (E. coli ) strain in LB 
or M9 minimal medium supplemented with 30 μg/mL kanamycin and 30 μg/mL 
chloramphenicol. 15NH4Cl (1 g/L) and 13C6-glucose (2 g/L) were used as the sole nitrogen 
and carbon sources in the M9 minimal media. The cultures were grown at 37 ºC until an 
optical density at 600 nm (OD600) of 0.6 was reached at which point cells were cooled to 
16 °C and induced with 0.5 mM IPTG for 16 hours. Cells were harvested by centrifugation 
at 6,000 rpm for 15 min and resuspended in lysis buffer (25mM Tris, 300 mM NaCl, 10 
mM imidazole, pH 7.5). Cells were lysed by EmulsiFlex-C5 homogenizer (Avestin) and 
ultracentrifuged at 38,000 rpm for 90 min. The supernatant was filtered through 0.45 
micron low protein binding syringe filters (Millipore) and subsequently applied to a 5 mL 
HisTrap FF column on an AKTA FPLC (GE Healthcare) pre-equilibrated in lysis buffer. 
The column was washed with lysis buffer plus 50 mM imidazole until the OD280 returned 
to baseline. Bound protein was then eluted with a 250-500 mM imidazole in the elution 
buffer (25mM Tris, 300 mM NaCl, 250-500 mM imidazole, pH 7.5). Fractions containing 
the protein were pooled and TEV protease was added to cleave the His6 tag (~1:50 ratio 
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protease:protein) and dialyzed against cleavage buffer (25 mM Tris, 300 mM NaCl, pH 
7.5) overnight at 4 ºC with gentle agitation. Cleaved protein was purified on a 5 mL 
HisTrap FF column, again in lysis buffer, and flow through was collected containing the 
protein. A final purification step by size exclusion chromatography was performed on a 
HiLoad Superdex75 pre-equilibrated with appropriate buffers. Fractions containing the 
protein were pooled and stored at -80 ºC.  
2.2.2 Analytical ultracentrifugation 
Sedimentation velocity studies were carried out using a Beckman Optima XL-A Analytical 
Ultracentrifuge. Two protein samples at 20 μM each were analyzed: apo-C2A in 25 mM 
MES (pH 7.5), 300 mM NaCl, 3 mM EDTA, and Ca2+-C2A in 25 mM MES (pH 7.5), 300 
mM NaCl, 3 mM Ca2+. Samples and matching buffer blanks were prepared in a double 
sector cell (1.2 cm) with quartz windows. An An60Ti rotor and double-sector cells with 
Epon charcoal centerpieces were used. Centrifugation was carried out at 4 °C. 60 
absorbance measurements at 280 nm were collected at 5-min intervals, in 0.002 cm radial 
steps. A rotor speed of 50,000 rpm was used. Data were analyzed using non-linear 
regression in SEDFIT software and fit to a c(s) distribution (Schuck, 2000), to determine 
sedimentation coefficients corrected to 20 °C in H2O (S20,w). 
2.2.3 NMR spectroscopy 
All NMR experiments were collected at 25 ˚C on a Varian Inova 600 MHz NMR 
spectrometer equipped with a triple resonance cryogenic probe and z-field gradients (the 
Biomolecular NMR Facility, Department of Biochemistry in the Schulich School of 
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Medicine, The University of Western Ontario). All data were processed using NMRPipe 
(Delaglio et al., 1995) and analyzed using NMRViewJ (Johnson and Blevins, 1994). 
 
2.2.4 Backbone Chemical Shift Assignment of apo-C2A 
The apo-C2A sample was prepared at a concentration of 600 μM in 25 mM MES (pH 4.5), 
150 mM NaCl, 1 mM DTT, 5 mM EDTA containing 10% D2O, 200 μM DSS as an internal 
reference, and 200 μM imidazole as an internal pH indicator (Baryshnikova et al., 2008). 
Data for the backbone assignments were obtained from HNCACB (Wittekind and Mueller, 
1993) , CBCA(CO)NH (Grzesiek and Bax, 1992) and 1H-15N HSQC experiments. The 1H 
spectral window was 7000 Hz centered on 4.785 ppm. The 15N spectral window was 1944 
Hz centered on 116.191 ppm and The 13C spectral window was 8443 Hz centered on 46.000 
ppm. 
2.2.5 Heteronuclear NOE measurements of apo- and Ca2+-C2A 
Heteronuclear NOE experiments (Farrow et al., 1994a) were performed for both apo- and 
Ca2+-C2A. The 15N-labelled apo-C2A sample was prepared at 700 μM in 25 mM MES (pH 
4.5), 150 mM NaCl, 1 mM DTT, 5 mM EDTA and the 15N-labelled Ca2+-C2A was also 
700 μM  in 25 mM HEPES (pH 7.0), 150 mM NaCl, 250 μM TECP, 10 mM CaCl2. To 
avoid protein precipitation over time, identical fresh sample was used for each experiment. 
Spectra were collected first with a recovery delay of 6-s (non-saturated spectrum) and 
second with a recovery delay of 3-s of proton saturation (saturated spectrum). The 1H-15N 
NOE value for each residue was calculated as the ratio of the cross-peak intensity 
(saturated/non-saturated), and error was estimated from the baseline noise in the two 
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spectra. Both saturated and non-saturated experiments were conducted in duplicate with 
fresh protein samples. 
 
2.2.6 T2 relaxation experiment of apo-C2A 
T2 relaxation (Bloembergen et al., 1948) data for 15N-labelled apo-C2A (pH 4.5) was 
collected at a concentration of 170 μM using a 3-s delay. Two dimensional 1H-15N HSQC 
spectra were recorded with seven different relaxation times: relaxT = 0.01-s, 0.03-s, 0.05-
s, 0.07-s, 0.09-s, 0.11-s and 0.15-s. T2 values were determined by fitting the measured peak 
heights to a two-parameter single-exponential decay function of the form: 
 
!(#) = 	 !!exp	(− "#!)                       (Equation 1) 
 
where I(t) is the intensity after a delay of time t and I0 is the intensity at time t = 0. 
 
2.2.7 Circular dichroism 
Folding and stability of all proteins was monitored by circular dichroism 
spectropolarimetry using a Jasco J-810 instrument (Biomolecular Interactions and 
Conformations Facility, The University of Western Ontario). All proteins were extensively 
dialyzed in the CD buffer for at least one day with stirring. Samples comprised 20 μM 
protein in 10 mM MOPS (pH 7.5), 50 mM NaCl, 1 mM EDTA for apo-C2A and 20 mM 
CaCl2 for Ca2+-C2A. For each protein, 15 scans from 250-200 nm (80 nm/min with 
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increment of 1 nm) were recorded using a 1 mm path-length cell at 20 °C, averaged and 
the buffer background was subtracted.  
 
Thermal denaturation studies were performed by exposing the protein to different 
temperatures within the range of 5-95 °C (1 °C/min with increments of 0.5 °C) by 
monitoring changes in the ellipticity at 215 nm. A 1 mM path length cuvette was used. The 
ellipticity was normalized between 0-1 using the function: 
                                        
Y'= (Y-Ymax)/(Ymax-Ymin)              (Equation 2) 
 
where Y is the observed CD signal at 215 nm, Ymax is the signal for the folded protein 





2.3.1 Optimized purification of the dysferlin C2A domain 
In order to obtain His6-tagged recombinant C2A protein, the supernatant containing the 
protein was loaded onto a Ni2+-charged IMAC (HisTrap FF column) following bacterial 
overexpression and cell lysis. A concentration of 10 mM imidazole was added to both 
binding and wash buffers to interfere with the weak binding of other proteins. The C2A 
protein was then eluted with a higher concentration of imidazole. A Coomassie-stained 









Figure 2. 2 Purification of the dysferlin C2A domain. 
(A) Purification of His6-tagged C2A by HisTrap FF chromatography monitored by SDS-
PAGE stained with Coomassie blue. Cell lysate was obtained following cell lysis and 
ultracentrifugation and loaded onto HisTrap FF column. His6-tagged C2A was then eluted 
by increasing the level of imidazole in the elution buffer (black arrow). (B) Purification of 
cleaved C2A by HisTrap FF chromatography. The eluted His6-tagged C2A was cleaved by 
TEV protease and loaded onto HisTrap FF column again. Cleaved C2A was eluted in the 
flow-through fractions (black arrow). (C) Mass spectrum confirming the molecular weight 




C2A protein was successfully purified from the cell lysate. After the first purification step 
and His6 tag cleavage by TEV protease, a previous method of C2A purification in the lab 
utilized ion exchange chromatography. This required lower pH conditions (~5.5) and led 
to significant precipitation of the protein. To solve this issue, nickel affinity purification 
using a HisTrap FF column was applied again in the second step after cleavage of the His6 
tag so that the pH was kept at 7.5 to avoid precipitation. This was followed by gel filtration 
chromatography. No significant precipitation was observed during this step and the protein 
yield was greatly increased. The protein was produced at levels of 25-50 mg per liter 
medium. Figure 2.2 B shows successful TEV cleavage and elution of C2A protein from 
the second HisTrap FF. A sample from one of the fractions was sent for electrospray 
ionization mass spectrometry (ESI-MS). The mass spectrum clearly shows one main 
species corresponding to the mass of C2A of 14.8 kDa (Figure 2.2 C).  
 
To identify the dimerization/oligomerization state of C2A, analytical ultracentrifugation 
was used to study its overall shape in solution. Both apo- and Ca2+-C2A samples were 
analyzed and results showed that, in the absence (+EDTA) and presence of calcium, C2A 
sediments as a monodisperse sample, fitting well to a single species/peak, corresponding 
to molecular weights of ~14 kDa and sedimentation coefficients of 1.5 S20,w (Figure 2.3). 
This confirms that C2A is monomeric in both apo- and Ca2+-state with homogeneous 


















Figure 2. 3 Sedimentation velocity studies of the C2A domain. 
Sedimentation velocity experiments of apo-C2A (red) and Ca2+-C2A (black). All data were 
analyzed using the Lamm equation and fit to a c(s) distribution. Sedimentation coefficients, 
corrected to 20 °C and in H2O (S20,w), were determined to be 1.472 S for apo-C2A, and 
1.493 S for Ca2+-C2A. Fitted molecular weights were calculated to be 14.0 kDa for apo-





2.3.2 Assignment of the NMR spectrum of apo-C2A 
Previous work on dysferlin C2A in the lab has solved the solution NMR structure of its 
calcium free state at pH 7.5. Figure 2.1 B shows the superposition of 20 structures with the 
lowest combined NOE and dihedral energies as representative of the calculation. The 
backbone assignment of apo-C2A was also performed by NMR under pH 7.5. However, 
due to the amide exchange with the bulk H2O solvent, a large number of amide resonances 
from the loop regions of the protein were missing. For example, under pH 7.5, many amide 
resonances from loops L1 (E10, N11, V12, H13, T14, D18, S20, D21, A22, Y23, C24), L2 
(T35, K36, V37, S41, V42), L3 (D71, H72, E73, T74, M75, R77, R79) were absent in the 
1H-15N HSQC spectra, which became an obstacle for further investigation of the protein 
properties. 
It was reported previously that the amide hydrogen exchange in proteins is pH-dependent: 
at pH 4.5, amide hydrogen exchange rate is slowed by ~1000 fold compared to pH 7.5 
(Matthew and Richards, 1983). Thus, the 1H-15N HSQC spectrum of apo-C2A at pH 4.5 
was obtained and compared with that at pH 7.5. Many more peaks were observed at lower 
pH while all the peaks remained well-dispersed, indicating the protein is still properly 
folded and the amide exchange was significantly slowed (Figure 2.4). The backbone 
assignment (1H, 15N, and 13C) of the apo-C2A was further completed at pH 4.5 using 
standard heteronuclear multiple dimensional NMR spectroscopy including 1H-15N HSQC, 
HNCACB (Wittekind and Mueller, 1993) and CBCA(CO)NH (Grzesiek and Bax, 1992) 
(Figure 2.5 and Table 2.1). Figure 2.6 shows the 1H-15N HSQC spectrum of apo-C2A (pH 














Figure 2. 4 Overlaid 1H-15N HSQC spectra of apo-C2A at pH 4.5 and 7.5. 
600 MHz 1H-15N HSQC spectra for the dysferlin C2A in the apo-state at pH 4.5 (red) and 



















Figure 2. 5 Selected region of sequential backbone assignment of apo-C2A. 
The spectra illustrate 15N planes for sequential assignment of residues E51-L54 of the apo-
C2A at pH 4.5. For each pair of planes, the CBCA(CO)NH is shown on the left and the 
HNCACB on the right where the x-axis is the amide proton chemical shift and the y-axis 
is the 13C plane of the three-dimensional experiments. The Cα and Cβ for the intraresidues 
(indicated as i) are shown on the HNCACB spectra and the corresponding Cα and Cβ for 














Figure 2. 6 Backbone amide assignments of apo-C2A (pH 4.5). 
1H-15N HSQC spectrum of 600 μM uniformly 15N, 13C-labelled apo-C2A in 25 mM MES 
(pH 4.5), 150 mM NaCl, 1 mM DTT, 5 mM EDTA containing 10% D2O. The spectrum 
was acquired on a Varian INOVA 600 MHz spectrometer. Assigned backbone amide cross 
peaks are indicated with their one letter amino acid code and number. Pairs of resonances 





Under pH 4.5, some new signals appeared and were assigned including several in loops 
L1-L3: E10, N11, V12 and T14 in loop L1, T35, K36, V37, S41 and V42 in loop L2, and 
T74, M75, R77 in loop L3. This indicates that residues in these loops are exposed to solvent, 
do not participate in any hydrogen bonding interactions and are subject to amide exchange 
with the bulk H2O solvent. It is also worth mentioning that several other residues including 
A9, H13, D21 and A22 in loop L1, G49 in loop L2, and R79, F80, L81 and G82 in loop 
L3 were still absent from the 1H-15N HSQC at pH 4.5, suggesting these regions of the apo-
C2A structure may undergo conformational exchange. 
2.3.3 pH-dependent dynamics of apo-C2A  
The structure of the dysferlin C2A domain in the calcium-free (apo-C2A) state was 
determined using NMR by previous students. The apo-C2A structure shows anti-parallel 
β-sandwich arrangement that contains a single short α-helix typical of the C2 domain fold 
in a classic type II C2 topology. Notably, the loops that connect the β-sheets show very 
poor definition with large variations in the positions, suggesting that loops L1-L3 are 
flexible in solution in the absence of calcium (Figure 2.1 B). To verify this, various 
methods were used and the results are stated as follows.  
 
As mentioned above, amide hydrogen exchange in proteins is pH-dependent and the 1H-
15N HSQC spectra of apo-C2A at pH 4.5 and 7.5 showed large differences in the number 
and position of the peaks. Theoretically, amide protons that undergo faster exchange with 
the solvent give rise to weaker or unobservable signals from the NMR spectra. Thus, the 
peak intensities were measured for both pH’s and the peak intensity ratios of each residue 





Figure 2. 7 pH-dependent dynamics of apo-C2A.  
(A) The residues that were absent in the 1H-15N HSQC spectrum at pH 7.5 but present at 
pH 4.5 are shown on the cartoon structure of the apo-C2A structure (red). (B) Plot of 1H-
15N HSQC peak intensities (top) and their ratio (bottom). 1H-15N HSQC peak intensities of 
each residue of apo-C2A at pH 4.5 (red bars) and pH 7.5 (black bars), and ratio of peak 
intensities at pH 7.5 and pH 4.5 (I7.5/I4.5). A linear schematic of apo-C2A secondary 
structure is indicated on the top of the figure. 
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different regions of the protein showed striking differences in peak intensity ratios. Some 
residues on loops L1 and L2 had the greatest changes including D16, T17, I19, I38, K39, 
as indicated by the smaller peak intensity ratios at pH 7.5 and pH 4.5 (I7.5/I4.5). Some other 
residues on loop L1-L3 were absent at pH 7.5 (N11, V12, T14, Y23, C24, T35, K36, V37, 
S41, V42, T74, M75, G76 and R77), shown by blank I7.5/I4.5. By contrast, peak intensity 
within the β-sheet regions showed no major changes with larger I7.5/I4.5 values (~1) (Figure 
2.7 B). These observations indicate that residues on the loop L1-L3 undergo fast amide 
solvent exchange at physiological pH (7.5), which results in the dramatic flexibility of this 
region that can be reduced by lowering the pH. 
2.3.4 Dynamic properties of C2A monitored by heteronuclear NOE and T2 
relaxation 
The amide assignments of the apo-C2A at pH 4.5 were used to measure 1H-15N 
heteronuclear NOE for each residue, which provide valuable information on flexibility and 
dynamics of the protein backbone (Farrow et al., 1994b). In these experiments, two 1H-
15N-correlated spectra are collected where one experiment contains a 3 second proton 
saturation period prior to the pulse sequence and the other spectrum contains a delay of 
equivalent length. Amides that undergo fast timescale motions (ps - ns) show decreased 
signal intensity in the proton-saturated spectrum. In this experiment, the heteronuclear 
NOE values were measured across the backbone of apo-C2A (pH 4.5) and Ca2+-C2A (pH 
7.5). As shown in Figure 2.8, in these cases the average observed NOE values were near 
0.8, close to that expected for a 15 kDa protein with little flexibility. Close examination 



















Figure 2. 8 Dynamic properties of C2A measured by heteronuclear NOE. 
Heteronuclear NOE analysis of apo-C2A (black) and Ca2+-C2A (red). The values plotted 
are an average of two independent experiments at 600 MHz. Only assigned resonances in 
the 1H-15N HSQC spectra were selected for analysis. The secondary structure domains are 
indicated on the top of the figure. Resonances that showed decreased NOE values in the 




and the bottom loops that connect β4 - β5, β6 - β7 showed decreased NOE intensities than 
the rest parts of the protein, indicative of greater flexibility in these regions. Upon calcium 
addition, little difference for the β-sheet regions for β1-β5 and β7-β8 exists in apo- and 
Ca2+-C2A domains suggesting the structures and motions of these regions of the protein 
are similar. In contrast, several residues in loops L1-L3 (D16, T17, D18, I19, S20, V37, 
S41, K70, T74, M75, R77) and β6 (E83) had smaller NOE values in apo-C2A compared 
to Ca2+-C2A suggesting these regions in apo-C2A are more flexible than in the calcium-
bound state. It is worth mentioning that to measure the NOEs for apo-C2A, pH 4.5 was 
chosen where the largest number of signals can be observed on the spectra, although some 
signals are still missing (shown by the gaps between data points in Figure 2.8). Based on 
the previous finding that the protein’s motion is restricted at lower pH, it can be predicted 
that apo-C2A under higher pH would show more significant change in flexibility compared 
to the calcium-bound state.   
 
In the T2 relaxation experiments, a series of 1H-15N HSQC spectra of apo-C2A were 
recorded using seven relaxation periods: 0.01-s, 0.03-s, 0.05-s, 0.07-s, 0.09-s, 0.11-s and 
0.15-s. As expected, the overall resonance intensity showed a progressive decrease when 
T2 relaxation time was increased, resulting in broadened spectra (Figure 2.9 A) The 
corresponding peak intensities of each resonance were fit with a two-parameter exponential 
function to obtain the T2 values. Shown in Figure 2.8 B, data for most residues could be 
well fit with small SD error and showed an average T2 value of around 0.086-s. Notably, 
E10, S20, L92 and several C-terminal residues exhibited significantly larger T2 values than 









Figure 2. 9 T2 measurements of apo-C2A.  
1H-15N NMR T2 relaxation data of 170 μM apo-C2A. (A) 1H-15N HSQC spectra recorded 
with relaxation delay of 0.01-s, 0.07-s and 0.15-s, showing the decrease in signal intensities. 
(B) Plot of peak intensities of I38, H66 and K70 as a function of relaxation delays. The 
curves represent the non-linear fits of the data using an exponential decay function. T2 data 
for all the resonances were fitted using the same method. (C) Fitted values of T2 as a 
function of residue number are shown. Residues that were calculated to have larger T2 
values are indicated by one-letter residue code and number. The standard deviation error 




Table 2. 1 Summary of chemical shifts, 15N T2 relaxation times, heteronuclear NOE 
values of the backbone amides in apo-C2A. 
 
Residue 1H (ppm) 15N (ppm) NOE600  T2 (s) 
M1 8.61 120.1 0.865 ± 0.062 0.0698 ± 0.027 
L2 9.03 127.3 0.851 ± 0.026 0.0822 ± 0.0052 
R3 9.39 127.4 0.885 ± 0.025 0.0819 ± 0.0029 
V4 8.98 123.6 0.874 ± 0.006 0.0869 ± 0.0038 
F5 9.71 129.8 0.927 ± 0.054 0.0753 ± 0.004 
I6 8.98 127.8 0.909 ± 0.032 0.0666 ± 0.0023 
L7 8.29 128.1 0.911 ± 0.045 0.0817 ± 0.0045 
Y8 7.24 112.2 0.902 ± 0.029 0.0565 ± 0.0025 
E10 8.76 115.9  0.4295 ± 0.0482 
N11 8.71 118.2 0.905 ± 0.003 0.078 ± 0.0038 
V12 9.06 118.2 0.854 ± 0.049 0.0774 ± 0.0035 
T14 8.52 117 0.879 ± 0.007 0.0906 ± 0.0043 
D16 8.38 115.7 0.83 ± 0.042 0.0639 ± 0.0019 
T17 7.86 112.4 0.867 ± 0.047 0.0706 ± 0.0007 
D18 8.33 120.9 0.833 ± 0.044 0.0775 ± 0.005 
I19 7.92 119.2 0.812 ± 0.024 0.0607 ± 0.0021 
S20 8.13 120 0.736 ± 0.011 0.2112 ± 0.0363 
Y23 9.13 117.1 0.959 ± 0.105 0.0729 ± 0.007 
C24 8.13 116.7 0.857 ± 0.117 0.0618 ± 0.0047 
S25 9.25 119.5 0.882 ± 0.059 0.0608 ± 0.0044 
A26 9.18 127.3 0.878 ± 0.041 0.0724 ± 0.003 
V27 8.92 120.9 0.878 ± 0.013 0.0838 ± 0.0035 
F28 7.9 127.1 0.929 ± 0.052 0.0838 ± 0.0045 
A29 8.16 129.8 0.867 ± 0.042 0.0793 ± 0.0039 
G30 8.24 134.5 0.871 ± 0.021 0.0881 ± 0.0056 
V31 8.21 123.5 0.858 ± 0.015 0.0829 ± 0.0034 
K32 8.91 131.5 0.912 ± 0.006 0.0732 ± 0.0033 
K33 9.15 125.9 0.82 ± 0.057 0.0919 ± 0.0034 
R34 8.26 117.9 0.835 ± 0.04 0.0817 ± 0.0013 
T35 8.55 111.6 0.976 ± 0.004 0.0637 ± 0.0047 
K36 9.6 119  0.0497 ± 0.0046 
V37 8.25 120.1 0.775 ± 0.015 0.0645 ± 0.0028 
I38 9.51 130 0.941 ± 0.025 0.0831 ± 0.0044 
K39 8.54 126.9 0.902 ± 0.03 0.0669 ± 0.0056 
S41 8.29 113.5 0.807 ± 0.031 0.0601 ± 0.0028 
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V42 8.31 121.3 0.89 ± 0.064 0.0583 ± 0.0034 
N43 7.84 117.7 0.903 ± 0.02 0.076 ± 0.0033 
V45 7.25 120.2 0.927 ± 0.007 0.059 ± 0.0019 
W46 8.38 124.6 0.949 ± 0.082 0.0864 ± 0.003 
N47 9.09 120.4 0.965 ± 0.075 0.074 ± 0.0048 
E48 7.98 117.9 0.902 ± 0.012 0.0708 ± 0.0016 
F50 8.87 118.6 0.934 ± 0.008 0.0827 ± 0.0051 
E51 8.35 119.3 0.907 ± 0.087 0.0809 ± 0.0025 
W52 10.02 128.9 0.843 ± 0.001 0.1044 ± 0.0063 
D53 8.65 123.5 0.866 ± 0.052 0.0893 ± 0.0054 
L54 8.5 126.3 0.839 ± 0.039 0.0885 ± 0.0061 
K55 8.84 119.7 0.817 ± 0.004 0.0622 ± 0.0029 
G56 8.93 108.8 0.776 ± 0.019 0.0639 ± 0.0025 
I57 7.77 122.8 0.824 ± 0.008 0.0878 ± 0.0035 
L59 7.34 121 0.764 ± 0.033 0.0807 ± 0.0055 
D60 8.6 121.6 0.853 ± 0.002 0.0513 ± 0.0025 
Q61 8.59 118.9 0.82 ± 0.022 0.0748 ± 0.0026 
G62 8.8 107.8 0.834 ± 0.047 0.075 ± 0.0032 
S63 7.73 117.4 0.892 ± 0.023 0.0789 ± 0.0024 
E64 8.88 122.6 0.891 ± 0.017 0.0926 ± 0.0025 
L65 8.42 123.1 0.896 ± 0.017 0.0902 ± 0.0035 
H66 8.53 125.3 0.928 ± 0.011 0.0867 ± 0.0047 
D67 9.06 122.9 0.897 ± 0.01 0.0734 ± 0.0038 
V68 9 125.2 0.896 ± 0.002 0.0746 ± 0.0021 
K70 8.1 117.3 0.78 ± 0.06 0.0797 ± 0.0035 
T74 8.07 112.5 0.786 ± 0.123 0.0527 ± 0.0081 
M75 8.5 117.9 0.726 ± 0.084 0.0373 ± 0.0115 
G76 8.37 108.1 0.907 ± 0.004 0.0794 ± 0.0037 
R77 7.51 120.6 0.77 ± 0.087 0.0829 ± 0.003 
E83 9.54 119.3 0.819 ± 0.074 0.031 ± 0.0172 
A84 9.3 124.3 0.94 ± 0.018 0.0649 ± 0.0049 
K85 8.73 121.3 0.882 ± 0.035 0.0864 ± 0.005 
V86 8.82 124.7 0.846 ± 0.009 0.0906 ± 0.0081 
L88 8.08 124.3 0.87 ± 0.01 0.0592 ± 0.0043 
R89 8.73 120.2 0.85 ± 0.013 0.0706 ± 0.0036 
V91 7.49 117.7 0.864 ± 0.021 0.0846 ± 0.0076 
L92 7.25 116.1  0.1941 ± 0.0221 
A93 7.2 118.3 0.852 ± 0.038 0.072 ± 0.0028 
T94 7.4 111.5 0.852 ± 0.015 0.1068 ± 0.007 
S96 7.95 109.9 0.817 ± 0.045 0.0635 ± 0.0015 
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L97 8.27 121.2 0.885 ± 0.001 0.0706 ± 0.0019 
S98 7.58 110.3 0.975 ± 0.013 0.0148 
A99 9.07 125.3 0.892 ± 0.006 0.0653 ± 0.004 
S100 8.2 115.5 0.89 ± 0.012 0.0905 ± 0.0044 
F101 9.16 120.9 0.919 ± 0.021 0.0775 ± 0.0038 
N102 8.63 122.4 0.827 ± 0.031 0.0834 ± 0.0042 
A103 9.31 128.4 0.886 ± 0.045 0.0931 ± 0.0029 
L105 8.09 121.2 0.937 ± 0.003 0.0727 ± 0.0043 
L106 9.58 124.9 1.012 ± 0.035 0.0718 ± 0.0081 
D107 8.97 119.3 0.91 ± 0.032 0.0681 ± 0.0035 
T108 8.12 109.1 0.866 ± 0.03 0.0731 ± 0.0023 
K109 8.29 122.2 0.847 ± 0.076 0.083 ± 0.0037 
K110 8.19 113.2 0.882 ± 0.03 0.0815 ± 0.0061 
Q111 8.64 119.4 0.868 ± 0.019 0.0782 ± 0.0036 
T113 8.5 113.9 1.021 ± 0.091 0.0747 ± 0.0038 
G114 9.06 112.2 0.97 ± 0.009 0.0737 ± 0.0045 
A115 8.02 124.5 0.989 ± 0.045 0.0772 ± 0.0054 
S116 8.52 115.4 0.894 ± 0.012 0.085 ± 0.0056 
V118 8.88 127.5 0.964 ± 0.034 0.0791 ± 0.0025 
L119 8.74 123.7 0.884 ± 0.078 0.079 ± 0.0025 
Q120 9.35 121.1 0.87 ± 0.087 0.0754 ± 0.0041 
V121 9.22 124.6 0.846 ± 0.027 0.0732 ± 0.0045 
S122 9.47 119.9 0.852 ± 0.059 0.0702 ± 0.0031 
Y123 8.91 125.2 0.821 ± 0.015 0.0844 ± 0.0035 
T124 8.7 124.7 0.911 ± 0.066 0.0768 ± 0.0052 
L126 8.15 121.9 0.798 ± 0.02 0.0912 ± 0.0044 
G128 8.45 110 0.61 ± 0.006 0.1222 ± 0.0047 
A129 7.98 123.6 0.071 ± 0.004 0.2341 ± 0.0089 
V130 8.18 120.2  0.2539 ± 0.0107 




E10 and S20 are located in loop 1, and L92 in the bottom loop between β6 and β7 
suggesting increased flexibilities and faster dynamics occur within these regions. Moreover, 
the C-terminus of the protein, which is a short random coil, also showed greater flexibility.  
 
The heteronuclear NOE and T2 relaxation data of the apo-C2A showed some agreement: 
the loop 1 region and bottom loop that connects β6 and β7 of the protein exhibit greater 
flexibilities in both experiments. However, the NOE data also showed the similar increased 
dynamics in loop 2 and 3 and the bottom loop between β4 and β5, whereas in T2 relaxation 
experiment these regions showed little deviation from the average.  
2.3.5 Thermal stability study of C2A by circular dichroism 
Next, the secondary structure and thermal stability of apo- and Ca2+-C2A were studied by 
circular dichroism (CD). Far-UV CD spectra from 200-250 nm for C2A in the two states 
showed they both had a similar spectral signature with a minimum observed around 215 
nm, characteristic of a typical β-sheet structure (Figure 2.10 A). The spectra between 200-
205 nm became noisy and turbulent due to the high tension voltage beyond 600 V. The 
thermal unfolding experiment was performed over a temperature range of 20-95 °C at a 
wavelength of 215 nm. It can be clearly observed that Ca2+-C2A had a higher melting 
temperature than apo-C2A with an almost 10 °C difference, suggesting the addition of 











Figure 2. 10 Change in stability of C2A monitored by circular dichroism. 
(A) Circular dichroism spectra of apo-C2A (black) and Ca-C2A (red) from 250 – 200 nm. 
The measurements were taken at 25 °C. The buffer background was subtracted. (B) 
Thermal denaturation apo-C2A (black) and Ca-C2A (red) monitored by circular dichroism 
within the range of 40 – 90°C in 0.5 °C increments. The unfolding profile as a function of 






2.4.1 Flexibility as a novel feature of the dysferlin C2A domain 
The structure of dysferlin C2A domain was previously reported with a single Ca2+ 
coordinated to one of the six molecules in the asymmetric unit determined by X-ray 
crystallography (Fuson et al., 2014) (Figure 2.11 B). It is ambiguous from the structure 
whether the protein is apo or Ca2+-bound. Our work in this chapter focused on the C2A 
domain in the calcium free state by adding abundant EDTA into the sample solution to 
completely remove the calcium. Unexpectedly, many resonances corresponding to the 
residues within the loop region were missing in the 1H-15N HSQC spectra due to fast 
exchange of hydrogens between backbone amides and the solvent. Upon solving this 
solution structure,  apo-C2A exhibited shorter β-sheets and more flexible loops compared 
to the crystal structure (Figure 2.11 A). Similar findings were also reported in studies by 
NMR spectroscopy on the C2 domain of MFG-E (Ye et al., 2013)  and synaptotagmin I 
(Shao et al., 1998). In these cases, several amide resonances of residues in the loop region 
were missing in the 1H-15N HSQC spectrum, and a considerable number of long-range 
NOEs between protons in loop region that were observed for the Ca2+-bound form had 
substantially smaller intensities or were absent in the data obtained for the Ca2+-free C2A 
domain. All these data combined with ours suggest a state of Ca2+-free C2 domain with 
greater flexibility and dynamics in the loops that NMR is competent to probe over X-ray 
crystallography. This advantage of NMR has also been indicated in studies on other 
proteins. For instance, the difference between the crystal and solution NMR structures of 
Ca2+-calmodulin indicates considerable backbone plasticity within the domains of 
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calmodulin, which is critical to their ability to bind a wide range of targets (Chou et al., 
2001). 
 
Our work also applied a combination of useful tools to comprehensively examine the 
protein dynamic behavior including pH titration, heteronuclear NOE, T2 relaxation and 
thermal denaturation experiments. These experiments confirmed the increased dynamics 
of Ca2+-free C2A loop region that can be stabilized and rigidified upon calcium binding. 
Several studies have suggested the similar idea for other C2 domains by using alternative 
methods including hydrogen/deuterium exchange by mass spectrometry (Hsu et al., 2008), 
molecular dynamics simulations (Banci et al., 2002) and Carr-Purcell-Meiboom-Gill 
(CPMG) NMR experiment (Morales et al., 2016). For example, the C2 domain protein 
kinase Cα showed a similar magnitude of difference with our data in heteronuclear NOE 
values in response to calcium binding within the loop region (Morales et al., 2016).  
 
However, compared to all the Ca2+-free C2 domains solved by NMR and X-ray 
crystallography, none of them shows the same level of flexibility as dysferlin C2A domain 
does. For example, one of the few NMR structures of Ca2+-free C2 domains, piccolo C2A 
domain, was shown to have a much more rigid structure with longer β-sheets and more 
refined loops compared to dysferlin C2A (Garcia et al., 2004) (Figure 2.11 C). The 
difference can also be observed from the structure of synaptotagmin I C2A domain in Ca2+-
free state (Shao et al., 1998) (Figure 2.11 D). Furthermore, the high number of missing 
amide resonances in the NMR spectra also seems to be an exclusive feature of dysferlin 




















Figure 2. 11 Comparison of C2 domain structures in the calcium free state. 
(A) The solution NMR structure of dysferlin C2A domain (solved by Dr. Liliana 
Santamaria-Kisiel, Dr. Pascal Mercier and Chantal Forristal). (B) The crystal structure of 
dysferlin C2A domain (Fuson et al., 2014) (PDB: 4IHB). (C) The solution NMR structure 
of calcium free piccolo C2A domain (Garcia et al., 2004) (PDB: 1RH8). (D) The solution 
NMR structure of calcium free synaptotagmin I C2A domain. (PDB data missing, figure 




domain (Ubach et al., 2001) and perforin C2 domain (Yagi et al., 2015). Taken together, 
our work reveals the flexibility of dysferlin C2A domain in the apo-state as a distinctive 
characteristic over other C2 domains. 
2.4.2 Significance of the flexibility of C2A in calcium and membrane binding 
One major function of C2 domains is targeting membrane surfaces as a consequence of 
calcium binding and specific C2 domains have different phospholipid selectivity. For 
example, the C2 domains of protein kinase C-α and -ε and synaptotagmins bind to the 
anionic head group of phosphatidylserine (Corbalán-García et al., 1999; Davletov and 
Sudhof, 1993; Fukuda et al., 1996; Medkova and Cho, 1998) while the C2 domain of 
cPLA2 binds to neutral phosphatidylcholine (Nalefski et al., 1998, 2001). It is widely 
believed that the lipid binding sites of C2 domains are located in the top loops. The 
dysferlin C2A domain has been identified to bind specifically to phosphoinositide and 
phosphotidylserine in a calcium-dependent fashione (Therrien et al., 2009). With a low 
intracellular concentration of [Ca2+] (100 nM) in the resting state of a cell, the dysferlin 
C2A domain can be considered largely in the apo-state. The high flexible property of C2A 
may help it avoid the binding to the lipid membrane. Since our work suggests the role of 
calcium to stabilize the structure of dysferlin C2A, we hypothesize that upon the influx of 
calcium from the extracellular space due to membrane disruption, the C2A domain adapts 
a more ordered and rigid conformation, triggering membrane repair through lipid binding. 
This can also explain why dysferlin-mediated membrane repair is calcium-dependent 
(Bansal et al., 2003; Han and Campbell, 2007). However, studies of dysferlin’s interactions 
with other proteins indicate a more complicated picture. C2A was shown to associate with 
MG53 dimers in a Ca2+-dependent manner (Matsuda et al., 2012) but also have calcium-
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independent interaction with AHNAK (Huang et al., 2007). It is not clear whether these 
interactions are linked with the flexibility and dynamics of the protein, which would be an 
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Dissecting the Calcium Binding Mechanisms of the 




As a calcium binding module, it has been shown that many activities of the dysferlin C2A 
domain are regulated by calcium. Most importantly, the dysferlin C2A domain targets 
several phospholipids in a calcium-dependent manner, which is consistent with its role in 
skeletal muscle membrane repair (Bansal et al., 2003; Han and Campbell, 2007; Therrien 
et al., 2009). Dysferlin rapidly responds to plasma membrane injury by sensing Ca2+ influx 
at the site of damage, and then facilitates Ca2+-dependent patch repair (Davenport et al., 
2016). How calcium binds to dysferlin to alter its structure and regulate this process is not 
known.  
 
To date, more than 100 unique structures of C2 domains have been solved by NMR 
spectroscopy and X-ray crystallography. The variable loops at the top of the domains are 
involved in the coordination of Ca2+ ions. The Ca2+-binding sites are formed primarily by 
conserved aspartate residues and the carboxylate or carbonyl group of other residues. Up 
to four Ca2+-binding sites are possible in a C2 domain depending on the residues that are 
present on the loops. Although C2 domains share a high degree of structural similarity, the 
Ca2+ binding modes differ significantly, and it is not clear how Ca2+ binding affects protein 




Earlier, we solved the crystal structure of the Ca2+-C2A domain which shows two bound 
calcium ions (Ca1, Ca2) coordinating to residues in loops L1, L2 and L3. One calcium ion 
(Ca1) is coordinated by side chain oxygen atoms of residues D18, D21 (bidentate) and N40, 
the backbone carbonyl of I19 and two water molecules. The second ion (Ca2) uses D18, 
D21, D71 (bidentate) and E73 side chains, the backbone carbonyl from H72 and a single 
water molecule. Residues D18 and D21 bisect the positions of the two calcium ions and 
use side chain oxygen atoms to ligate both Ca1 and Ca2 simultaneously (Figure 3.1).  
 
In this chapter, we characterized the binding order and affinities of the two Ca2+ ions, and 
investigated the detailed binding mode of dysferlin C2A by using a combination of 
methods including NMR spectroscopy, ITC, site-directed mutagenesis and circular 
dichroism spectropolarimetry. The models we proposed provide useful understanding for 




3.2 Materials and Methods 
 
3.2.1 Site-directed mutagenesis of the dysferlin C2A domain  
QuikChange site-directed mutagenesis (Wang and Malcolm, 1999) was performed to 
introduce the following mutations on the dysferlin C2A plasmid: C2AD16K, C2AD18N, 








Figure 3. 1 Ca2+-bound and apo Structure of dysferlin C2A domain and the calcium 
binding site. 
(A) Cartoon of the crystal structure of Ca2+-bound C2A. Bound two Ca2+ ions are shown 
as orange spheres. (B) The solution NMR structure of apo-C2A. β-sheets are depicted in 
light blue and loops in gray, labelled by numbers. (C) Close-up view of the calcium binding 
site showing the binding residues D18, I19, D21, N40, D71, H72 and E73. Oxygen atoms 




the mutations are shown in Table 3.1. The wild-type C2A plasmid was isolated from 
harvested BL21 E. coli cells using a Bio Basic Inc. EZ-10 spin column miniprep kit. Base 
pair mutations were incorporated into DNA using the QuikChange Site-Directed 
Mutagenesis protocol (Agilent) and polymerase chain reaction (PCR). Methylated parental 
strands that remained in the PCR reaction were digested by Dpn1 overnight at 37°C. The 
following day, plasmid DNA was purified using a PCR clean-up kit (BioBasic Inc). All 
PCR products were transformed into competent MM294 cells and incubated on antibiotic-
treated LB-agar plates overnight at 37 °C. Multiple colonies were picked and grown in LB. 
Plasmids were isolated from harvested cells using a Bio Basic Inc. EZ-10 spin column 
miniprep kit and were sequenced (London Regional Genomics Centre, Canada) to verify 
that the correct mutations were incorporated. All the substituted proteins were expressed 
and purified using the same protocol described in Chapter 2.2.1. 
 
3.2.2 Ca2+ and La3+ titrations monitored by NMR Spectroscopy 
All NMR experiments were collected at 25˚C on a Varian Inova 600 MHz NMR 
spectrometer equipped with a triple resonance cryogenic probe and z-field gradients. All 
data were processed using NMRPipe (Delaglio et al., 1995) and analyzed using 
NMRViewJ (Johnson and Blevins, 1994). NMR titration experiments were conducted in 
25 mM HEPES, 150 mM NaCl, 250 μM TCEP, pH 7.5 with 10% D2O, 200 μM DSS as an 
internal reference, and 200 μM imidazole as an internal pH indicator. Uniformly 15N-
labeled C2A protein and substituted proteins were incubated with Chelex-100 (Bio-Rad) 
for 1h to remove residual Ca2+ ions before acquiring initial 1H-15N HSQC spectra by the 







Table 3. 1 Primers used for dysferlin C2A mutagenesis. 
 
Construct Primer Sequence 
 
D16N Forward: 5’- CCACACACCCAACACCGACATCAG -3’ 
Reverse: 5’- CTGATGTCGGTGTTGGGTGTGTGG-3’ 
 
D16K Forward: 5’- CCACACACCCAAAACCGACATCAG -3’ 
Reverse: 5’- CTGATGTCGGTTTTGGGTGTGTGG -3’ 
 
D18N Forward: 5’- CACACCCGACACCAACATCAGCG -3’ 
Reverse: 5’- CGCTGATGTTGGTGTCGGGTGTG -3’ 
 
D18K Forward: 5’- CACACCCGACACCAAAATCAGCG -3’ 
Reverse: 5’- CGCTGATTTTGGTGTCGGGTGTG -3’ 
 
D21N Forward: 5’- CACCGACATCAGCAACGCCTACTGCTCCGC -3’ 
Reverse: 5’- GCGGAGCAGTAGGCGTTGCTGATGTCGGTG -3’ 
 
D21K Forward: 5’- CACCGACATCAGCAAAGCCTACTGCTCCGC -3’ 
Reverse: 5’- GCGGAGCAGTAGGCTTTGCTGATGTCGGTG -3’ 
 
N40A Forward: 5’- CATCAAGGCCAGCGTGAAC -3’ 
Reverse: 5’- GTTCACGCTGGCCTTGATG -3’ 
 
D71N Forward: 5’- GGTGGTCAAAAACCATGAGACG -3’ 
Reverse: 5’- CGTCTCATGGTTTTTGACCACC -3’ 
 
D71K Forward: 5’- GGTGGTCAAAAAACATGAGACG -3’ 





analysis (Amino Acid Analysis Facility, Hospital for Sick Children, Toronto). The stock 
solution of CaCl2 was analyzed by deductively coupled plasma - mass spectrometry (ICP-
MS) to obtain the accurate concentration (Biotron, Western University). 1-2 μL CaCl2 
solution of desired concentration, diluted from the stock CaCl2 solution, was added to the 
NMR sample at each titration point by a 10 μL Hamilton syringe followed and 1H-15N 
HSQC spectrum were recorded following each addition at different [Ca2+]. Table 3.2 
shows a list of the calcium additions made for the Ca2+ titration experiment of the C2A 
domain. A La3+ titration was performed under the same conditions. The stock La3+ solution 
was made by dissolving lanthanum(III) chloride heptahydrate (LaCl3 · 7H2O) (Sigma-
Aldrich) with the NMR buffer. The Ca2+ titration was also performed by monitoring the 
1H-13C HSQC spectra of C2A using uniformly 15N, 13C -labeled protein under the same 
conditions. A total number of 19 titration points were added to 15N, 13C-labeled apo-C2A 
at a concentration of 675 μM. The final concentration of Ca2+ added was 22 mM. 
 
The chemical shift change (∆δ) or intensity change	(∆I) of selected peaks were measured 
in the 1H dimension at each titration point. The dissociation constant was obtained by fitting 
the data in GraphPad Prism according to the following equation: 
 
∆δ	(∆I) = N (%"&	("&)#)	+,(%"&	("&-#)!+.%"("/%" 							(Equation 1) 
 
where P0  is the total C2A concentration, L0  is the total Ca2+ concentration at a given 




Table 3. 2 A quantitative demonstration of the NMR titration experiment. 
2 μL Ca2+ from six different concentrations of stock solutions was added at each titration 
point to a 600 μL solution containing 432 μM C2A. The titration was completed with the 












































































































































































































































































change	(∆δ)  or peak intensity change (∆I) that would occur upon saturation of C2A by 
Ca2+.  
 
3.2.3 Line-shape simulation 
The 1H cross-section of selected peaks from the 1H, 15N-HSQC calcium titration spectra 
were processed for line shape analysis. The 1H dimension traces through peaks at each 
titration point were extracted using NMRPipe and plotted as the experimental data. The 
LineShapeKin program was then applied for line-shape simulation 
(http://lineshapekin.net/index.htm).  B model (two site binding to one receptor molecule) 
was chosen for the simulation. In this model, binding involves two steps with one ligand 
molecule binding at a time. The conventional description of this model is as follows: 
 






5⎯⎯6	PL/                              (Equation 2) 
 
where P is the C2A concentration, L is the Ca2+ concentration at a given titration point. The 
association constants (K) and off-rate constants (k) are macroscopic constants. The two-
site-binding model can also be interpreted at the molecular-level with a more detailed 





Also, the binding of a second L molecule may have lower or higher affinity due to negative 
or positive cooperativity between the two binding sites, allowing direct evaluation of 
allosteric effects between the sites. The microscopic model was used in the LineShapeKin 
program. Relationships between the micro- and macroscopic association constants (K) in 
these two schemes are as follows: 






	                      (Equation 5) 
 
The off-rate constants (k) are also related below: 
 
	k$%! =	 	#!&$	&"!&$'	#!&%	&"!&%	#!&			                      (Equation 6) 
	k/2/ =	 	k/2/4 + 	k/2/5                                  (Equation 7) 
 
The simulation was performed in MATLAB Version 9.5. The chemical shifts of peaks, 
line-widths, LP ratios, rate constants and relaxation rates were adjusted iteratively to 
achieve consistency with the experimental data and simulated simultaneously for selected 
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peaks. The yielded microscopic association constants and off-rates were then converted to 
macroscopic constants using Equation 3 – 6. The dissociation constants (Kd) can be 
obtained using its relationship with association constants (Ka) as follows: 
	K( = !#'                                        (Equation 8) 
 
3.2.4 Isothermal titration calorimetry 
All calorimetry experiments were performed using a NanoITC (TA Instruments) at 25°C. 
All experiments were completed 2–3 times using freshly prepared proteins extensively 
dialyzed in 25 mM HEPES, 150 mM NaCl, 250 μM TECP, pH 7.5 and pretreated with 
Chelex-100 (Bio-Rad) to remove residual Ca2+ ions for one hour. The optimal 
concentrations of protein in the experiments were determined to be: 4.75 mM Ca2+ titrated 
into 155 μM wild-type C2A, 35 mM Ca2+ titrated into 350 μM C2AD16N, 8 mM Ca2+ titrated 
into 87 μM C2AD16K, 70 mM Ca2+ titrated into 350 μM C2AD18N, 20 mM Ca2+ titrated into 
142 μM C2AD18K, 10 mM Ca2+ titrated into 346 μM C2AD21K, 35 mM Ca2+ titrated into 525 
μM C2AD21N, 20 mM Ca2+ titrated into 182 μM C2AN40A, 60 mM Ca2+ titrated into 635 μM 
C2AD71N, 35 mM Ca2+ titrated into 400 μM C2AD71K. Proteins and Ca2+ solutions were 
degassed under vacuum prior to each titration. Titrations consisted of 25 injections of 2 μL 
Ca2+ solution into a 146 μL cell containing the proteins with constant stirring. Heats of 
dilution were measured in a separate experiment in which Ca2+ solution was injected into 
the buffer alone. Ca2+ titration to wild-type C2A and C2AD16N were analysed using 
sequential-two-binding-site model in NanoAnalyze v3.1.2 (TA instruments) to determine 
best fit values for KA, ΔH and N. ΔS was calculated according to Equation 9. 
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ΔG = –RTlnKA = ΔH – TΔS 
                                                      ΔS = RlnKA + (ΔH/T)                                (Equation 9) 
 
3.2.5 Circular dichroism  
Folding of all proteins were monitored by circular dichroism spectropolarimetry using a 
Jasco J-810 instrument (Biomolecular Interactions and Conformations Facility, University 
of Western Ontario). All proteins were extensively dialyzed in the CD buffer for at least 
one day with stirring. For proteins in the calcium-free state, samples comprised 20 μM 
protein were prepared in 20 mM KH2PO4 (pH 7.5) in the presence of 1mM EDTA. For 
Ca2+-bound samples, buffer containing 10 mM MOPS (pH 7.5) and 20 mM CaCl2 was used 
to avoid precipitation of calcium phosphate. For each sample, 15 scans from 250 –200 nm 
(80 nm/min with increment of 1 nm) were recorded using a 1 mm path-length cell at 20 °C, 
averaged, and the buffer background was subtracted. Thermal denaturation studies were 
performed by exposing the protein to different temperatures within the range of 5 – 95 °C 
(1 °C/min with increments of 0.5°C) by monitoring changes in the ellipticity at 215 nm. A 
1 mM path length cuvette was used. The ellipticity was normalized between 0-1 using the 
function: 










3.3.1 Dysferlin C2A contains two classes of calcium-binding sites 
3.3.1.1 Crystal structure of Ca2+-C2A 
 
Purified dysferlin C2A protein (5 mg/ml) was crystalized in the presence of 20 mM calcium 
by my colleague Dr. Roya Tadayon and the structure of the C2A domain in the calcium-
bound (Ca2+-C2A) state was determined using X-ray crystallography. The structure of the 
Ca2+-bound dysferlin C2A domain was solved to 2.0 Å resolution and contained four 
molecules in the asymmetric unit with near identical conformations. The Ca2+-C2A 
structures shows an anti-parallel β-sandwich arrangement that contains a single short α-
helix (Figure 3.1 A), similar with the apo-C2A structure. The eight β-strands (β1-β8) are 
connected by four loops emerging at the top of the structures (L1-L4) where calcium is 
coordinated (Figure 3.1 A). A short α-helix containing residues L88 and V91 packs tightly 
against residues in the β7 (A99, F101) and β8 (V121) strands. There are significant 
differences in the lengths of the β-sheets between the apo-C2A and Ca2+-C2A structure, 
although the arrangement of the β-sheets remains nearly identical. Specifically, the β-sheets 
for the apo-C2A domain are all 3-5 residues shorter than observed in the Ca2+-C2A 
structure. In all cases, the loss of β-sheet structure in the apo-C2A domain occurs at the 
ends of the sheets closest to the calcium-binding loops (Figure 3.1 A - B). The loops have 
very poor definition in apo-C2A structure, as described in Chapter 2, whereas the loops in 
the Ca2+-C2A structure are well-ordered. These observations indicate that calcium 
rigidifies the Ca2+-C2A structure and stabilizes the β-sheet regions compared to the apo-




The C2A domain in the presence of calcium showed electron density for two calcium ions 
per molecule for all molecules in the asymmetric unit. Inspection of the structures shows 
that both calcium ions exhibit classic pentagonal bipyramidal coordination and regular Ca-
O distances (2.2-2.7 Å). One calcium ion (Ca1) is coordinated by side chain oxygen atoms 
of residues D18, D21 (bidentate) and N40, the backbone carbonyl of I19 and two water 
molecules. The second ion (Ca2) uses D18, D21, D71 (bidentate) and E73 side chains, the 
backbone carbonyl from H72 and a single water molecule. Residues D18 and D21 bisect 
the positions of the two calcium ions (Ca1-Ca2 distance 4.3 Å) and use side chain oxygen 
atoms to ligate both Ca1 and Ca2 simultaneously.  
 
3.3.1.2 Ca2+ titration to the C2A domain by ITC 
 
To further characterize the detailed calcium-binding properties, a combination of calcium 
titration experiments was used by isothermal titration calorimetry (ITC) and NMR 
spectroscopy. The calcium titration experiment by ITC showed a hook shaped curve with 
endothermic reaction in the beginning at lower [Ca2+]/[C2A] ratio with positive entropy 
change (102 J/mol°K) and exothermic at high [Ca2+]/[C2A] ratio with small negative 
entropy change (-8.6 J/mol°K), indicative of two distinct modes of Ca2+ binding (Figure 
3.2). Data was fitted using a sequential-two-binding-site model which yielded two 
dissociation constants (Kd) of 32 and 300 μM. The positive entropy change (ΔS) in the 
initial step signifies binding of first calcium ion is driven by an increase in disorder in the  
system, which may result from release of water molecules that surround calcium ions and 
rearrangement of the loops upon coordinating to C2A (Jelesarov and Bosshard, 1999). 













Figure 3. 2 Ca2+ titration to dysferlin C2A by ITC. 
(A) ITC analysis of calcium binding to the wild-type C2A domain. The data was fit with a 
sequential two-site binding model that yielded Kd values of 32 μM and 300 μM. Data was 
collected at 25 °C with 25 mM HEPES, 150 mM NaCl, 250 μM TCEP, pH 7.5 buffer 
conditions. (B) Bar graph showing the thermodynamic properties for the calcium binding 
to C2A. The data show the first binding is driven by entropy changes (ΔS), indicative of a 
Ca2+-induced conformational change, while the second binding step gave rise to a small 




overall structural change in the C2A structure. This loss in entropy can be attributed to the 
increased Ca2+-induced conformational rigidity of the loops. Together, the ITC data 
suggests that the C2A domain contains one tight and one weak calcium-binding site with 
about 10 times difference in binding affinity. The first binding event has a bigger impact 
on the reaction system likely through bond breaking and conformational change, whereas 
the global structure of C2A may remain largely unchanged upon binding to the second 
calcium. 
 
Some earlier studies have reported the Kd values for the calcium binding sites of the 
dysferlin C2A measured by ITC (Abdullah et al., 2014; Fuson et al., 2014; Harsini et al., 
2019) (Table 3.3), which showed similarities but also significant variations compared to 
our results. All three ITC data sets demonstrated a two-stage profile containing 
endothermic and exothermic reaction with a transition point. The transition point in our 
data agrees with one of studies at a [Ca2+]/[C2A] ratio of 2 (Fuson et al., 2014), whereas 
the other study shows the transition happened earlier when [Ca2+]/[C2A] ratio is less than 
one(Abdullah et al., 2014). The thermodynamic parameters (Kd, ΔH, and ΔS) yielded also 
differ from one to another. For example, the Kd1 and Kd2 values measured in our study are 
larger than those in the other two studies. Our Kd1 value is about 10 and 5000 times larger 
than the other two studies respectively, and the Kd2 is a little closer which is 4 and 6 times 
bigger. These differences may result from different models used to fit the data. One study 
used a multiple-site model which predicted 5 binding sites (Fuson et al., 2014), whereas 
we chose a sequential-two-binding-site model based on the two calcium ions observed in 
our crystal structure.  
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3.3.1.3 Ca2+ titration to the C2A domain monitored by 1H-15N HSQC  
 
In the calcium titration experiment by NMR spectroscopy monitored by 1H-15N HSQC, a 
total number of 19 titration points were conducted until no further chemical shift changes 
were observed in the spectra. As noted in Figure 3.3, many resonances for calcium-
coordinating residues in the loop regions L1-L3 were absent in spectra of the apo-C2A 
domain and could not be followed during calcium titrations. Nevertheless, the addition of 
calcium to the apo-C2A domain resulted in many changes in the 1H-15N HSQC spectra, 
including the appearance of all L1-L3 signals absent in apo-C2A spectra including E10, 
N11, D16, Y23, T35, S41, R77, D71, H72, A115, etc. (Figure 3.3 B). Further, the NMR 
titration data showed calcium-induced chemical shift changes that occurred in both the 
slow and fast chemical shift exchange regimes. Several signals including those for loop 
residues T17, I19, I38 and V45 showed the largest changes and exhibited slow exchange 
behavior while other residues (L7, F28, W52, A103, T113) showed faster exchange 
(Figure 3.3 A).  
 
Due to the complexity of changes in the 1H-15N HSQC spectra, multiple methods were 
applied to further understand the detailed binding properties. For peaks that underwent 
slow exchange (T17, I19, I38 and V45), the peak intensities of both free and bound peaks 
throughout the process of titration were plotted. As shown in Figure 3.4 A, the peaks 
corresponding to T17 and V45 of Ca2+-free state gradually decreased in intensities with the 
addition of Ca2+ (black panels), and meanwhile a separate signal for Ca2+-bound state 
appeared and intensified (purple panels). The free-state peaks completely disappeared 





Figure 3. 3 Ca2+ titration to dysferlin C2A monitored by 1H-15N HSQC NMR. 
(A) Overlay of 1H-15N HSQC spectra of 432 μM 15N-labeled C2A recorded with increasing 
[Ca2+]. Slow exchange and fast intermediate exchange were observed during titration and 
are labeled with black and red arrows respectively. The appearance of new peaks is shown 
by the grey dashed boxes. (B) The residues that showed the largest calcium-induced 
chemical shifts (blue) and those that appear upon Ca2+ binding (magenta) are shown on the 
cartoon structure of the Ca2+-bound dysferlin C2A structure. Most residues reside in loop 





Figure 3. 4 Data analysis from Ca2+ titration to dysferlin C2A by NMR. 
(A) Track record of the free and Ca2+-bound peaks for T17 and V45 along the titration 
process. (B) Plot of intensities of free peaks corresponding to residues T17, I19, K39 and 
V45 on 1H dimension at each titration point as a function of [Ca2+]/[C2A] ratio. The curves 
represent the fits of the data to 2:1 binding model. (C) Plot of intensities of Ca2+-bound 
peaks corresponding to residues T17, I19, K39 and V45. The curves represent the fits of 
the data to Hill function. (D) Plot of chemical shift change of W52 peak showing 
unsuccessful fitting with Equation 1. (E) Plot of intensities of four new peaks that 
appeared upon Ca2+ addition. Intensities of peaks of D16 and S41 increased within the 




saturated at this point. Interestingly, with the addition of more Ca2+, intensities of the 
bound-state peaks continued increasing and reached a plateau when [Ca2+]/[C2A] ≈ 10. 
The plotting showed a hyperbolic binding curve (Figure 3.4 C), indicating a second Ca2+ 
ion binds to the protein during this stage, and it has largely rigidified the structure of the 
C2A domain because the final intensities of the bound-state peaks were remarkably higher 
than the starting free-state peaks. The data set of the free-state peak intensities were fitted 
with two-site binding model (Equation 1) considering the influence of the second binding 
(Figure 2B) and a Kd of 46 μM was obtained, which is close to the Kd measured by ITC. 
Unfortunately, it was difficult to measure the Kd of the second binding site from the bound-
peak data due to the complexity of the data and lack of suitable model. Another attempt 
was to obtain Kd from peaks that showed faster exchange by measuring the chemical shift 
change during the titration. The W52 cross peak was chosen but the data was also difficult 
to fit using Equation 1 (Figure 3.4 D) likely because W52 exhibited a combination of fast 
and intermediate exchange regime. Indeed, all the above results may not be reliable because 
the model chosen is best used for pure slow/fast exchange, whereas the NMR signals from 
our experiments showed significant broadening during the calcium titration and in some 
cases signals appeared to contain both slow and fast exchange components.  
 
The NMR titration also provides valuable information on the binding order of two calcium 
ions. During the titration, many resonances that were missing in the apo-C2A spectrum 
appeared upon the Ca2+ addition due to the restriction of amide exchange with the H2O 
solvent. By plotting the intensities of the new peaks, we found that residues in loop 1 and 
2 (D16, S41) showed a faster increase in intensities than residues in loop 3 (D71, H72) 
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(Figure 3.4 E), suggesting the Ca2+ ion that only binds to residues in loop 1 and 2 may be 
the first binding Ca2+ with a higher binding affinity. In fact, D71 and H72 did not show 
obvious resonances in the spectra until more than 2 equivalents of calcium was titrated, 
suggesting that they were not affected by the first Ca2+ ion. Thus, the other Ca2+ ion in the 
crystal structure that coordinates D71 and E73 in loop 3 may be the second binding Ca2+ 
with a lower affinity. 
 
3.3.1.4 Line shape analysis 
 
To further obtain more accurate information of the calcium binding mode, we applied an 
on-line program called “LineShapeKin” (http://lineshapekin.net/index.htm) which 
performs simulation of NMR line shapes for multi-site exchange models. A kinetic model 
describing a two-site binding mechanism was used (Equation 1). Two examples of this 
are shown for F28 in β-sheet β2 that shows fast intermediate exchange (Figure 3.5 A, B) 
and N40 in loop L2 that shows slow intermediate exchange (Figure 3.5 D, E). The 
chemical shifts of peaks, line-widths, LP ratios, rate constants and relaxation rates were 
adjusted iteratively to achieve consistency with the experimental data and simulated 
simultaneously for the F28 and N40 peak. The final simulated data were shown in Figure 
3.5 C, F and four association constants (KA) were yielded from the program: KA1a = 
2.00*104 M-1, KA1b = 1.00*104 M-1, KA2a = 3.00*103 M-1, KA2b = 6.00*103 M-1. Using 
Equation 3, 4 and 7, the disassociation constants (Kd) were calculated (Kd1 = 33 μM, Kd2 
= 500 μM), which showed very good agreement with results from our ITC data (Kd1 = 32 
μM, Kd2 = 300 μM) confirming the presence of a tight and a weak binding site. The 















Figure 3. 5 Line-shape simulation of F28 and N40 peaks. 
(A, D) Overlays of regions of the 1H-15N HSQC spectra from the Ca2+ titration into C2A. 
In (A), Phe28 undergoes fast intermediate exchange change, where the peak changes in 
chemical shift during the titration and broadens without completely disappearing. In (D), 
Asn40 is an example of slow intermediate exchange, where the peak broadens during the 
titration and reappears in a new position. In both cases the arrow indicates the direction of 
peak movement at increasing Ca2+ concentration. (B, E) Experimental data showing one-
dimensional 1H traces through the Phe28 and Asn40 peaks at each titration point. (C, F) 
Line-shape simulation using a two-site binding model with LineShapeKin software for F28 




= 4 s-1, k2A2b = 4 s-1, which could be then converted to macroscopic constants using 
Equation 5, 6. This gave rise to koff,1 = 4 s-1, koff,2 = 8 s-1 for the two calcium binding event. 
The small koff observed for both sites rationalizes the lack of pure fast exchange changes 
in the NMR spectra which would only be observed for minute chemical shift changes (ie. 
<< 4 Hz) upon calcium binding and the more apparent slow exchange component for 
signals that undergo larger changes (i.e. F28, N40 in Figure 3.5).  
 
3.3.1.5 Ca2+ titration to the C2A domain monitored by 1H-13C HSQC  
 
Calcium titration experiments were also conducted using NMR spectroscopy monitored by 
1H-13C HSQC. Using the same method as 1H-15N HSQC, a total number of 19 titration 
points were added to 15N, 13C-labeled apo-C2A at a concentration of 675 μM. The titration 
data showed similar calcium-induced chemical shift changes as 1H-15N HSQC. Both slow 
and fast chemical shift exchange regimes were observed during the titration (Figure 3.6 
A). Expectedly, no new peaks appeared in the 13C-HSQC titration because aliphatic protons 
are not affected by amide exchange with the H2O solvent. As shown in Figure 3.6 A, the 
cross peaks corresponding to the γ and δ carbon of residue I19 (I19.CG and I19. CD) 
exhibited slow exchange, and the intensities their free and bound peaks were plotted against 
the [Ca2+]/[C2A] ratio shown in Figure 3.6 B - C. The trends of the plotted data highly 
resemble the features of the plots for residues undergoing slow exchange in the 1H-15N 
HSQC titration data (Figure 3.4 B, C), where the free-state peaks completely disappeared 
when [Ca2+]/[C2A] ≈ 2,while intensities of the bound-state peaks continued increasing and 
reached a plateau when [Ca2+]/[C2A] ≈ 10. Thus, our 1H-13C HSQC titration data showed 













Figure 3. 6 Ca2+ titration to dysferlin C2A monitored by 1H-13C HSQC NMR. 
(A) Overlay of region of 1H-13C HSQC spectra of 675 μM 13C-labeled C2A recorded with 
increasing [Ca2+]. Slow exchange of the cross peaks corresponding to the γ and δ carbon 
of residue I19 (I19.CG and I19. CD) are labelled. (B) Plot of intensities of free peaks of 
I19.CG and I19. CD on 1H dimension at each titration point as a function of [Ca2+]/[C2A] 
ratio. (C) Plot of intensities of Ca2+-bound peaks of I19.CG and I19. CD on 1H dimension 






3.3.1.6 La3+ titration to the C2A domain  
 
Lanthanide ions have ionic radii close to that of Ca2+ and are widely used as surrogate of 
Ca2+ as they bind to Ca2+-binding sites in proteins (Dudev et al., 2005). To further probe 
the Ca2+-binding sites in C2A, La3+ titration experiment was performed by NMR 
spectroscopy. The exchange rate between La3+-free and bound state of the resonances were 
found generally faster compared to those in Ca2+ titration. Some of the peaks that showed 
slow exchange in the Ca2+ titration exhibited fast exchange in the La3+ titration, including 
Y8, K39, V45, K110 and T113 (Figure 3.7 A). By superimposing the final La3+- and Ca2+-
bound spectrum, the peaks were largely overlapped, which suggests that La3+ binding 
brings very similar conformational change as the results from Ca2+ binding to the same 
sites. Notably, movement of some resonances (K39, V45) produced nonlinear curves with 
a transition point at 742 μM [La3+] (orange peaks in Figure 3.7 B, C). This is a sign of two-
state binding interaction, as the secondary interaction has a different effect on the chemical 
shifts than the primary interaction. This finding further verified the conclusion in the Ca2+ 
titration experiment that the C2A domain contains two classes of Ca2+-binding sites. The 
fact that nonlinear chemical shift changes only appeared in La3+ titration may ascribe to the 
different binding affinities of La3+ compared to Ca2+.  
 
Taken together, by combining a variety of methods including X-ray crystallography, ITC, 
NMR spectroscopy, and line-shape simulation, we characterized two classes of calcium-
binding sites in the dysferlin C2A domain and determined the binding affinities with Kds 









Figure 3. 7 La3+ titration to dysferlin C2A by NMR spectroscopy. 
(A) Superimposed 1H-15N HSQC spectra of 487 μM 15N-labeled C2A titrated with La3+. 
Peaks that showed remarkable chemical shift are labeled on the spectra. (B, C) Close-up 
views of the spectra showing the nonlinear movement of the peaks corresponding to 




3.3.1.7 The C2A domain does not bind to Mg2+ 
 
Some Ca2+-binding proteins are shown to bind to Mg2+, such as parvalbumin (Cates et al., 
2002). We queried whether the dysferlin C2A domain also binds to Mg2+ by monitoring 
1H-15N HSQC spectra of apo-C2A and the same sample added with MgCl2 of 66 times the 
protein concentration. The two 1H-15N HSQC spectra perfectly superimpose (Figure 3.8). 
This indicates that under the conditions used, C2A domain of dysferlin does not interact 
with the Mg2+. 
 
3.3.2 Calcium binding to dysferlin C2A domain is tightly coupled 
In order to further explore the detailed binding mode, site-directed mutagenesis was 
conducted to the calcium-coordinating residues in the calcium-binding loops L1 (D18,  
D21), L2 (N40) and L3 (D71). First, substitution to asparagine was made for D18, D21 and 
D71 (C2AD18N, C2AD21N, and C2AD71N), predicting that the Ca2+ binding could still be 
maintained but weakened. There are multiple other C2 domain structures from cPLA2, 
perforin and myoferlin (PDB: 1RLW (Perisic et al., 1998), 4Y1T (Yagi et al., 2015), 6EEL 
(Harsini et al., 2019)) which show that asparagine is an effective residue to coordinate 
calcium. We repeated the calcium titration experiments by NMR and ITC for the 
substituted proteins, and in all cases 1H-15N HSQC spectra showed the proteins were 
properly folded with little perturbation of the calcium-free structures. Calcium titration 
experiments followed by NMR spectroscopy or ITC both showed that calcium binding was 
completely eliminated for the C2AD18N, C2AD21N and C2AD71N substitutions (Figure 3.9 - 
3.10). In the calcium-bound structure of the C2A domain, D18 and D21 provide ligands 













Figure 3. 8 Mg2+ titration to dysferlin C2A by NMR spectroscopy. 
Superimposed 1H-15N HSQC spectra of  300 μM 15N-labeled apo-C2A (black) and C2A 
mixed with 20 mM Mg2+ (orange). No chemical shift change was observed. Data was 













Figure 3. 9 Calcium binding to two sites in the C2A domain is tightly coupled.  
Overlay of a portion of 1H-15N HSQC spectra of 15N-labeled C2A, C2AD18N, C2AD21N, 
C2AN40A and C2AD71N recorded with increasing [Ca2+] showing resonances of residues Y8 
and V45. Resonances of residues Y8 and V45 exhibited slow exchange in the titration of 
wild-type C2A (shown as black arrows), but very little or no chemical shift in C2AD18N, 










Figure 3. 10 ITC data of Ca2+ binding to C2A mutants.  
Isotherm graphs of calcium binding to the mutants C2A domain including D18N, D18K, 
N40A, D21N, D21K, and D71N. All of them showed strongly disrupted Ca2+ binding. Data 





an  asparagine in either D18 or D21 eliminated  all calcium  binding. In the  NMR titration 
data, compared to the wild-type C2A where peaks Y8 and V45 exhibited slow chemical 
shift exchange upon calcium addition, the same peaks barely showed any chemical shift 
changes in the case of C2AD18N, C2AD21N (Figure 3.9). The ITC data agreed with the NMR 
results, shown by the minute heat change upon titration of large amount of calcium (Figure 
3.10). To further validate our findings, we substituted the D18 and D21 positions with 
lysine. The resulting proteins (C2AD18K, C2AD21K) showed negligible calcium binding 
(Figure 3.10).  These observations suggest that binding of each calcium ion by the dysferlin 
C2A domain is dependent on the binding of its partner calcium ion.  
 
To test this idea we examined substitutions at N40 and D71 (C2AN40A, C2AD71N). Unlike 
D18 and D21, these two residues each contribute to the binding of a single calcium ion. 
N40 in L2 contributes an oxygen ligand to Ca1, while D71 in L3 contributes two oxygen 
ligands to Ca12 (Figure 3.1 C). N40 was substituted to alanine (C2AN40A) and D71 was 
mutated to asparagine (C2AD71N). Again, substitution of either of these positions completed 
abolished calcium binding at both sites, shown by the undetectable chemical shift change 
in NMR and negligible heat change in ITC (Figure 3.9 – 3.10). These results support the 
idea that binding of two Ca2+ ions to C2A domain is tightly coupled, and loss of Ca2+ 
binding to one site causes concomitant disruption of the second Ca2+ binding site.  
3.3.3 Calcium binding is affected by multiple factors 
Prior to our crystal structure, it was reported that substitution of residue D16 (C2AD16A) in 
the L1 loop impairs calcium binding (Abdullah et al., 2014). Yet this residue does not 
coordinate either of the Ca2+ ions in the crystal structure, and the oxygens of its side chain 
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are 7.6 Å away from the Ca2+ ions, beyond the maximum 
possible distance between ligand oxygen atoms and the calcium ion (~3.5 Å) (Figure 3.11 
D). Thus, we intended to discover how the calcium binding to C2A protein is affected by 
residue D16. First, substitution to an asparagine (C2AD16N) was made followed by titration 
experiments by ITC and NMR. The ITC experiments show that C2AD16N maintained the 
calcium binding property with a similar ITC profile (Figure 3.11 B) as the wild-type C2A 
(Figure 3.2 A) indicating two classes of binding sites. Surprisingly, fitting the data using 
sequential-two-binding-site model yielded two dissociation constants (Kd) of 550 μM and 
4.3 mM, suggesting that the binding affinities are about 10 times weaker than the wild type 
C2A domain. This result was validated from NMR-based calcium titration experiments 
that showed some resonances that underwent slow exchange binding kinetics for wild-type 
C2A converted to fast or fast-intermediate exchange kinetics for C2AD16N, as exemplified 
by Y8 and V45 (Figure 3.11 C). D16 was then substituted to a positively charged lysine 
(C2AD16K) and the isotherm showed no evidence of binding (Figure 3.11 A). This indicates 
that replacement of a non-calcium coordinating residue in the loop regions of the C2A 
domain alters its ability to bind calcium, which agreed with an earlier study that showed 
the same result with the mutation of C2AD16A (Abdullah et al., 2014). This unexpected 
finding suggests that Ca2+ binding to the C2A domain is not determined solely by the 
ligands that bind Ca2+ ions, but is also affected by non-coordinating residues. We 
hypothesized that the overall electrostatic potential of the loop regions in the C2A domain 
plays an important role to recruit calcium ions prior to coordination by specific residues. 
In the apo-state the overall negative charge is dispersed by the flexibility of the loops as 










Figure 3. 11 D16 mediates Ca2+ binding to dysferlin C2A.  
(A) Cartoon of crystal structure of Ca2+-C2A showing the position of D16 and the distance 
between side chain oxygens and the two calcium ions. (B, C) ITC analysis of Ca2+ binding 
to C2AD16K and C2AD16N mutants. Titration to C2AD16K shows abolished Ca2+ binding 
while C2AD16N shows a similar binding curve as wild-type C2A but with binding affinities 
~10 times lower (0.55 mM and 4.32 mM). (D) Overlay of a portion of 1H-15N HSQC 
spectra of 15N-labeled C2AD16N with increasing [Ca2+] showing resonances of residues Y8 
and V45 which exhibited fast intermediate exchange during the titration. (E) The 
electrostatic surface potential representation of apo-C2A loop region generated by  the 
APBS electrostatic function in PyMOL. (F) The electrostatic surface potential 
representation of C2AD16K loop region showing an electrostatic-switch from negative to 

























C2A (ITC) 32 4.661 102.3 300 -44.15 -8.58 
C2A (Line shape analysis) 33 - - 500 - - 
C2A (ITC) (Abdullah et al., 2014)  3.7 0.67 104.25 80 -7.53 52.75 
C2A (ITC) (Fuson et al., 2014)* 0.006 -1.8 36.09 53.2 -19.25 3.54 
C2AD16N (ITC) 553 10.13 9.634 4328 -47.79 -115 
 





residues (E73) repel each other. Our model suggests that loss of negative charge of any 
aspartate in the loops will change the electrostatic potential, making calcium recruitment 
and coordination less favorable. This idea was also proposed in a study of synaptotagmin 
C2A Domain, where electrostatic repulsion in the Ca2+ binding pocket was shown to be 
important for preventing interactions between the C2 domain and the negatively charged 
membrane (Striegel et al., 2012). To illustrate this, the electrostatic potential surface of 
wide-type apo-C2A and C2AD16K was calculated and the loop regions were displayed in 
Figure 3.11 E – F. It is shown that substitution of D16K causes visually dramatic effect 
on the electrostatic  potential of the loops, resulting in a switch from a negative to positive 
potential, which is a similar effect caused by calcium binding suggested by many studies  
(Murray and Honig, 2002; Ubach et al., 1998). 
 
Another interesting finding when we examined the 1H-15N HSQC spectra of calcium-free 
C2AD71N was that it revealed significant differences in the positions and number of 
resonances compared to the wild-type protein under identical experimental conditions. 
There were a few new peaks showing up as well as chemical shift changes of some peaks 
in the spectrum of C2AD71N (Figure 3.12 A). Substitution of D71 to a positively charged 
lysine (C2AD71K) gave rise to similar changes shown in Figure 3.12 B. The spectrum of 
the calcium-free C2AD71N and C2AD71K contained many new resonances that could mostly 
be attributed to residues in the loops that are missing in spectra of the wild-type protein 
based on our observation in Chapter 2. This increased number of resonances in 1H-15N 
HSQC spectra can be caused by decreased flexibility of the protein structure, so we 




Figure 3. 12 NMR spectra of C2AD71N and C2AD71K compared to wild-type C2A. 
Overlaid 1H-15N HSQC spectrum of C2AD71N (red) and apo-C2A (black) (A), C2AD71K 
(orange) and apo-C2A (black) (B). New peaks that appeared in the spectra of C2AD71N and 




neutral residue might stabilize the loop region through neutralizing one of the calcium sites 
in the same manner as the calcium does. To test this, we further studied the C2AD71K 
substituted protein as D71 coordinates a single calcium ion (Ca2) using its carboxyl group. 
As expected, calcium binding to the C2AD71K protein was abolished based on the ITC data 
(Figure 3.13 A). Further, examination of the calcium-free C2AD71K spectrum showed that 
many of the new signals were located very close to signals in the calcium-bound C2A 
spectrum. (Figure 3.13 B), indicating C2AD71K and calcium-bound C2A may share 
structural similarities. To examine this possibility, we measured the thermal stability of 
apo- and Ca2+-C2A domains and compared these to C2AD71K using circular dichroism 
(Figure 3.13 C).  
  
As expected, calcium binding to the apo-C2A domain increased the thermal melting 
midpoint by about 10˚C, which confirms the stabilizing effect of calcium binding. In 
comparison, the calcium-free C2AD71K domain had a melting temperature that was very 
similar to Ca2+-C2A. This observation is consistent with a significant stabilizing effect of 
the D71K substitution that is similar to calcium binding. 
 
Next, we were curious if mutations of other aspartate residues in the loops would have the 
same effect as D71K. We examined the 1H-15N HSQC spectra and thermal stability of 
C2AD18K, C2AD21K, and C2AD16K. As mentioned above, calcium binding is abolished for 
all these three mutants. Comparisons of the 1H-15N HSQC spectra to the wild-type apo-
C2A showed that there were several new resonances appearing in the spectra of C2AD18K 








Figure 3. 13 D71K disrupts Ca2+ binding to dysferlin C2A.  
(A) ITC analysis of Ca2+ binding to C2AD71K mutant showed no binding. (B) Selected 
region of overlaid 1H-15N HSQC spectrum of C2AD71K (blue) and Ca-C2A (red). Peaks of 
D71K and Ca-C2A in close positions are labelled in dashed boxes and residue numbers. 
(C) Thermal denaturation of C2AD71K (blue), apo-C2A (black), Ca-C2A (red) monitored 




(Figure 3.14). The thermal denaturation experiments showed that only the C2AD18K 
increased the thermal melting midpoint by about 5˚C compared to the apo-C2A, while 
C2AD21K and C2AD16K had a melting temperature that was almost the same as apo-C2A 
(Figure 3.14). The above observations indicate that C2AD18K likely has an effect of 
stabilizing the protein in the same manner as C2AD71K does. 
 
We attribute this observation to the ability of the K71/K18 side chain to occupy a similar 
position as a calcium ion observed in the crystal structure putting the ε-NH3+ group near 
the negatively charged side chains for calcium-binding residues. In the case of C2AD71K, 
the ε-NH3+ group of K71 interacts closely with the side chains of D18, D21 and E73, and 
for C2AD18k, K18 is positioned near D21, D71 and E73 (Figure 3.15). This proposal 
indicates that C2AD71K /C2AD18k may mimic the calcium-bound state (at least for Ca2) and 
have increased stability compared to the wild-type C2A domain and disruption of the 
flexibility in the loops disables the recruitment and coordination of calcium. Taken together,  
by examining the impact of substitutions of D16, D18 and D71 on the structure, calcium 
binding and stability of the C2A protein, we propose that the calcium binding is not solely 
determined by the coordinating ligands, it can also be affected by other factors including 








Figure 3. 14 Effects of D18K, D21K and D16K mutations on C2A. 
Left panel, 1H-15N HSQC spectrum of C2AD18N (orange) (A), C2AD21N (green) (B), 
C2AD16N (blue) (C) superimposed with apo-C2A (black). Right panel, thermal denaturation 
results of C2AD18N, C2AD21N and C2AD16N compared to apo-C2A (black) and Ca-C2A (red) 
















Figure 3. 15 Proposed model of the loop region for C2AD71k and C2AD18k. 
3D model of C2AD71k (A) and C2AD18k (B)  showing both K71 and K18 side chain occupies 
a similar position as a calcium ion (Ca2) putting the ε-NH3+ group near the negatively 
charged side chains for calcium-binding residues (D18, D21 and E73 for C2AD71k; D21, 





3.4.1 Calcium binding sites in dysferlin C2A  
In this chapter, determination of the structure of dysferlin C2A domain in Ca2+-bound state 
revealed the β-strands arrangement referred as type II topology that many other C2 domains 
comprise such as PLC δ1 C2 domain (Essen et al., 1997). More importantly, the Ca2+ 
binding sites are clearly identified from the crystal structure, which are formed primarily 
by aspartate side chains that serve as bidentate ligands for two Ca2+ ions. As previously 
proposed, a C2 domain has a total of four potential Ca2+ binding sites and the occupation 
of Ca2+ ions depends on the side chains present in loops L1-L3 (Rizo and Südhof, 1998). 
In dysferlin C2A domain, we identified three aspartates coordinating two Ca2+ ions in a 
cooperative manner, as well as four other residues binding via side chain or main chain. 
Figure 3.16 shows a structure and sequence comparison of dysferlin C2A with two C2 
domains, PLC-δ1 C2 (PDB: 1DJI) and synaptotagmin I C2B (PDB:1UOV), both of which 
contain two Ca2+ ions occupying in the same positions as that in dysferlin C2A. The 
structure alignment of PLC-δ1 C2 and dysferlin C2A shows the binding residues in each 
protein are almost identical in positions, except that dysferlin C2A provides one more 
aspartate (D18) in loop 1. The positions of loop L1-L3 are also very similar, resulting in 
the same Ca2+ occupation manner for the two proteins (Figure 3.16 A). The comparison 
between dysferlin C2A and synaptotagmin I C2B, on the other hand, also shows similar 
binding sites for the two overlapped Ca2+ ions. However, synaptotagmin I C2B provides 
ligands for an additional Ca2+ ion using the side chain of D365 in loop 3 and main chain of 
M302 in loop 1 (Figure 3.16 B). A close examination of the sequence alignment reveals 











Figure 3. 16 Structure and sequence alignments of C2A with PLC-δ1 C2 and 
synaptotagmin I C2B.  
 
(A) Structural alignment of Ca2+-bound dysferlin C2A (green) and PLC-δ1 C2 (orange) 
showing the Ca2+ binding residues in loop region. (B) Structural alignment of Ca2+-bound 
dysferlin C2A (green) and synaptotagmin I C2B (magenta). The spheres correspond to the 
bound Ca2+ ions found in the crystal structures. The residue numbers of dysferlin C2A are 
labeled near each residue and the residue numbers of PLC-δ1 C2 and synaptotagmin I C2B 
are in brackets. (C) Sequence alignment of dysferlin C2A versus PLC-δ1 C2 and 
synaptotagmin I C2B. The arrows above the sequence correspond to residues that possess 
β strand secondary structure, whereas the lines correspond to the loop region. The Ca2+ 





compared to synaptotagmin I C2B (Figure 3.15 C). As a result, the first half part of loop  
1 in dysferlin C2A projects away from the calcium binding center, whereas that of 
synaptotagmin I C2B is in closer contact with other loops thus forming an additional Ca2+ 
binding site. The same difference can also be seen between synaptotagmin I C2B and PLC-
δ1 C2. The above observations indicate Ca2+ occupation in C2 domains is not only 
determined by the ligands present in loops, subtle difference in the position of loops can 
also contribute to the different binding manners.  
 
3.4.2 Comparison of calcium binding affinity and binding mode with other 
C2 domains 
Traditional methods such as NMR spectroscopy, ITC, and fluorescence assays are 
normally used to determine the intrinsic affinity of the Ca2+ binding sites for C2 domains. 
However, accurate measurement has been challenging for researchers due to the natural 
difficulty in obtaining Kds from multiple binding-site data. For example, fitting the ITC 
data for synaptotagmin-7 C2B domain yielded results that are ambiguous or even 
contradictive with the crystal structure, and reliable Kds cannot be obtained because the 
values are depended strongly on the position chosen for the zero baseline (Voleti et al., 
2017). Measurements of binding affinity by NMR spectroscopy for synaptotagmin-7 C2A 
also only gave an approximate estimate of the affinities (Maximov et al., 2008). Indeed, 
we experienced the similar obstacle on the analysis of NMR titration data that were mainly 
composed of intermediate chemical exchange, in which conventional analysis methods 
have trouble fitting. That is why a combination of other methods were applied in our study 
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including ITC and line shape simulation, which gave us more reliable results compared to 
studies that use a single method.  
 
Further, C2-containing proteins bind to calcium with different dissociation constants 
ranging from nanomolar (nM) to millimolar (mM). In this study, we find dysferlin C2A 
domain contains two Ca2+ binding sites with “middle range” affinities (Kd1 = 32 μM, Kd2 
= 300 μM). Unlike many other C2 domains that have Ca2+ binding sites with quite low 
affinity such as the weakest site of perforin C2 Domain (Kd > 5 mM) (Yagi et al., 2015) 
and synaptotagmin 1 C2A (Kd  > 20 mM) (Fernández-Chacón et al., 2001),  dysferlin C2A 
domain does not seem to contain such a weak binding site based on our results. However, 
why these C2 domains exhibit different intrinsic Ca2+ affinities is not well understood.  
 
Another interesting finding in our work is the coupled binding mode of the two Ca2+ 
binding sites where residue D18 and D21 coordinate both Ca2+ ions simultaneously. This 
sharing of ligating residues in the dysferlin C2A domain is similar to that observed in 
structures of rabphilin-3A C2B domain (Montaville et al., 2007), cytosolic phospholipase 
A2 (cPLA2) C2 domain (Perisic et al., 1998) and synaptotagmin-7 C2B domain (Voleti et 
al., 2017). Mutagenesis of important ligating residues revealed that binding of each calcium 
ion by the dysferlin C2A domain is dependent on the binding of its partner calcium ion. 
Similar finding has also been shown in several studies on other C2 domains. For example, 
a positive cooperativity binding mode was proposed for cPLA2 C2 domain that the first 
calcium ion binds to site I, which preorders the side chains of coordinating Asp residues, 
and partially or fully deprotonates them (Malmberg et al., 2004). The initial binding event 
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prepares the conformation and protonation state of the remaining site for calcium binding, 
enabling the second calcium ion to bind with higher affinity than the first as required for 
positive cooperativity (Malmberg et al., 2004). Also, a study on synaptotagmin 1 C2B 
domain showed that mutating an Asp residue that coordinates a single calcium ion results 
in concomitant disruption of the other binding site, suggesting calcium binding to the first 
site stabilizes the structure of the domain, facilitating calcium binding to the other site 
(Fernandez et al., 2001). This aligns with the observation of the D71 and N40 mutations in 
our study.    
 
Our work has also assessed the importance of a non-coordinating residue, D16, on the 
calcium binding of the C2A protein, which may have been omitted by prior studies. This 
novel finding suggests the calcium binding of C2A is affected by multiple factors other 
than the ligands present in the loops. Disruption of the negative electrostatic environment 
and flexibility of the loops can have a significant influence on its calcium or membrane 
binding properties. The similar idea has also been proposed in several studies on 
synaptotagmin C2A domain, where electrostatic repulsion in the loops was shown to be 
crucial for Ca2+ binding and D/N substitutions that disrupt Ca2+ binding restored membrane 
fusion in a manner that the mutations partially mimicked Ca2+ binding by decreasing the 
negative charge of the pocket (Stevens and Sullivan, 2003; Striegel et al., 2012; Yoshihara 
et al., 2010). Indeed, this idea was further validated by our observation that C2AD71K shares 
structural similarities with wild-type Ca2+-C2A judging by their NMR spectra and the 
model we proposed (Figure 3.14).  It would be interesting to probe the lipid binding 
properties of wild-type C2A in both apo and Ca2+-bound state as well as C2AD71K, as we 
 
 122 
predict that C2AD71K would be able to bind negatively charged phospholipids in a similar 
manner as Ca2+-C2A. 
 
3.4.3 Hypothesis of the membrane binding mechanisms 
One important function of C2 domains is targeting membrane, as a result of calcium 
binding. A number of studies have demonstrated that C2 domains bind to the target 
membranes by using a combination of electrostatic and hydrophobic interactions, and they 
display different phospholipid selectivity. The dysferlin C2A domain has been shown to 
selectively bind to phosphatidylserine (PS) and phosphatidylcholine (PC) in the presence 
of Ca2+ (Therrien et al., 2009). Our work has also suggested that, the switch in electrostatic 
potential of the top loops from negative to positive upon calcium binding may facilitate the 
interaction with the phospholipids. A detailed mechanism was proposed in the structural 
characterization of the C2 domain of PKCα in complex with Ca2+ and 1,2-dicaproyl-sn-
phosphatidylserine (DCPS) that the phosphoryl group of the phosphoserine completes the 
coordination sphere of  a calcium ion (Verdaguer et al., 1999). In the crystal structure of 
Ca2+-bound dysferlin C2A, the coordination sphere for both calcium ions are incomplete 
as one calcium ion (Ca1) binds to two water molecules and the second ion (Ca2) 
coordinates one water molecule. Thus, we hypothesize that Ca2+ acts as a bridge connecting 
the C2A protein and the phospholipids in the membrane, as the phospholipids fill the 
incomplete coordination sphere of the Ca2+ bound to the domain by replacing the water 




Recently, the X-ray crystal structure of cytosolic PLA2α (cPLA2α) C2 domain bound to 
1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) was solved (Hirano et al., 2019). In 
contrast to the two bound Ca2+ ions reported in the lipid-free structure (Dessen et al., 1999; 
Perisic et al., 1998), an additional Ca2+ ion was observed to coordinate in the PC-bound 
structural complex by bridging residue N65 and the DHPC phosphoryl group. This finding 
provides novel insights for the possible lipid binding mode of dysferlin C2A as two Ca2+ 
ions occupy in the same positions of the two proteins using many conserved residues as 
their ligands. Specifically, residue N65 in cPLA2α C2 corresponds to N40 in dysferlin C2A, 
which may recruit an additional Ca2+ ion when binding to phospholipids in the similar 
manner. We hypothesize that there may be participation of extra Ca2+ ions when dysferlin 
C2A targets phospholipids, possibly by providing bridging interactions between the C2A 
domain and the phosphate group, which also interacts directly with N40 or other residues 
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Impacts of Muscular Dystrophy Causing Mutations on 





Muscular dystrophy is a degenerative genetic disorder that results in increasing weakness 
and gradual wasting of skeletal muscles. This muscle wasting occurs because the skeletal 
muscle cells have weakened plasma or sarcolemma membranes. Muscular dystrophy 
encompasses a large number of disorders that can be divided into two classes: those caused 
by defective membrane structure, and those resulting from impaired membrane repair 
(Rahimov and Kunkel, 2013). Here, emphasis will be placed on the proteins involved in 
membrane repair deficient muscular dystrophies. Mutations in the dysferlin gene are linked 
to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B 
(LGMD2B) and Miyoshi myopathy (MM), but the mechanism that leads to muscle 
degeneration is unknown (Bashir et al., 1998; Liu et al., 1998). The C2A domain is the 
major portion of the dysferlin protein responsible for responding to calcium ion influx upon 
membrane damage and the activation of dysferlin (Matsuda et al., 2012; Therrien et al., 
2009). The importance of the C2A domain in dysferlin has been emphasized from a clinical 




One mutation, resulting in the substitution of valine for aspartic acid at residue number 67 
(V67D) in the C2A domain, has been correlated with two forms of muscular dystrophy 
(Illarioshkin et al., 2000). The first type, limb-girdle muscular dystrophy type 2B 
(LGMD2B), affects proximal skeletal muscles, while the second type, Miyoshi myopathy 
(MM), affects distal skeletal muscles. The dysferlin V67D substitution impedes the 
membrane repair process because it diminishes calcium-dependent phospholipid binding 
(Davis et al., 2002). Furthermore, wild-type dysferlin usually binds to and stabilizes 
AHNAK, a large protein also implicated in membrane repair, but the V67D mutation 
prevents this interaction (Huang et al., 2007). Another substitution on the C2A domain, 
W52R, leads to Miyoshi myopathy (MM) (De Luna et al., 2007) and also inhibits the 
association with MG53 (Matsuda et al., 2012). Furthermore, pathogenic mutations have 
been identified throughout the dysferlin gene including all the other C2 domains (Krahn et 
al., 2009). For example, seven mutations (G234E, R253W, L266P, I284T, G299R, S340R, 
L344P) have been characterized on the C2B domain leading to muscular dystrophy 
diseases. Therefore, an understanding of the effects of these substitutions on the structure 
of the C2 domain may provide insight into how and why these mutations disrupt the protein 
activities and ultimately inhibit membrane repair. In this chapter the impacts of several 
pathogenic substitution on the structure, stability and calcium binding ability of the C2A 
domain were investigated. The work provides important evidence that explains the 






4.2 Materials and Methods 
4.2.1 Site-directed mutagenesis of the dysferlin C2A domain  
QuikChange site-directed mutagenesis (Wang and Malcolm, 1999) was performed to 
introduce the following mutations on the dysferlin C2A plasmid: C2AW52R, C2AW52A, 
C2AW52M, C2AW52T, C2AK36W and C2AK36A. The primers used for making the mutations 
are shown in Table 4.1.  The mutagenesis was performed using the same protocol describe 
in Chapter 3.2.1. The mutagenesis of C2AV67D, C2AV67A, C2AV67T, and C2AV67N was made 
by previous students. 
4.2.2 Test expression of the pathogenic mutants of C2A 
Small-scale test expression experiments were performed for the following C2A mutants: 
C2AV67D, C2AV67A, C2AV67T, C2AV67N, C2AW52R, C2AW52A, C2AW52M, C2AW52T C2AK36W 
and C2AK36A. Plasmids containing the mutant DNA were transformed BL21-CodonPlus 
(DE3) E. coli strain. Isolated colonies were picked and grown in 5 mL LB overnight as 
starters. The following day 250 μL starters were inoculated into 25 ml LB with 30 μg/mL 
kanamycin and 30 μg/mL chloramphenicol. The cultures were grown at 37 ºC until an 
OD600 of 0.6 was reached at which point cells were cooled to 16 °C and induced with 0.5 
mM IPTG for 16 hours. Cells were harvested by centrifugation at 4,000 rpm for 20 min 
and resuspended in lysis buffer (25mM Tris, 300 mM NaCl, pH 7.5). Cells were lysed by 
EmulsiFlex-C5 homogenizer (Avestin). Gel sample was taken at this point as total protein 
(i.e. 30 μL + 15 μL 3 × SDS loading buffer). Then 1 mL cell lysate was centrifuged for 10 
- 15 minutes at 14,000 rpm in tabletop centrifuge. The supernatant was taken as gel sample 







Table 4. 1 Primers used for dysferlin C2A mutagenesis. 
 
Construct Primer Sequence 
 
K36W Forward: 5’- GTGAAGAAGAGAACCTGGGTCATCAAGAAC -3’ 
Reverse: 5’- GTTCTTGATGACCCAGGTTCTCTTCTTCAC -3’ 
 
K36A Forward: 5’- GTGAAGAAGAGAACCGCAGTCATCAAGAAC -3’ 
Reverse: 5’- GTTCTTGATGACTGCGGTTCTCTTCTTCAC -3’ 
 
W52R Forward: 5’- GGATTTGAACGTGACCTCAAGG -3’ 
Reverse: 5’- CCTTGAGGTCACGTTCAAATCC -3’ 
 
W52A Forward: 5’- GAGGGATTTGAAGCGGACCTCAAGGGC -3’ 
Reverse: 5’- GCCCTTGAGGTCCGCTTCAAATCCCTC -3’ 
 
W52M Forward: 5’- GAGGGATTTGAAATGGACCTCAAGGGC -3’ 
Reverse: 5’- GCCCTTGAGGTCCATTTCAAATCCCTC -3’ 
 
W52T Forward: 5’- GAGGGATTTGAAACCGACCTCAAGGGC -3’ 






as gel sample (insoluble fraction). The total protein, soluble and insoluble fractions were 
checked by SDS-PAGE. All the mutant proteins were expressed and purified using the 
same protocol described in Chapter 2.2.1. 
 
4.2.3 Circular dichroism 
Folding of all proteins were monitored by circular dichroism spectropolarimetry using a 
Jasco J-810 instrument (Biomolecular Interactions and Conformations Facility, University 
of Western Ontario). All proteins were extensively dialyzed in the CD buffer for at least 
one day with stirring. For proteins in the calcium-free state, samples comprised 20 μM 
protein were prepared in 20 mM KH2PO4 (pH 7.5) in the presence of 1mM EDTA. For 
Ca2+-bound samples, buffer containing 10 mM MOPS (pH 7.5) and 20 mM CaCl2 was used 
to avoid precipitation of calcium phosphate. For each sample, 15 scans from 250 –200 nm 
(80 nm/min with increment of 1 nm) were recorded using a 1 mm path-length cell at 20 °C, 
averaged and the buffer background was subtracted. 
 
Thermal denaturation studies were performed by exposing the protein to different 
temperatures within the range of 5 – 95 °C (1 °C/min with increments of 0.5°C) by 
monitoring changes in the ellipticity at 215 nm. A 1 mM path length cuvette was used. The 
ellipticity was normalized between 0 - 1 using the function: 
 




where Y is the observed CD signal at 215 nm, Ymax is the signal for the folded protein and 
Ymin is the signal for the unfolded protein. A two-state unfolding curve was used to fit the 
data as a function of temperature and fitting for the melting point transition (Tm) and the 
enthalpy (ΔHm) according to Equation 2. During the fitting process a heat capacity (ΔCp) 
of 0 kJ/(mol K) was used. 
 
∆9 = ∆:6 ;1 − ##)= + ∆>7(? − ?6) − ?@A ;
#
#)
=    (Equation 2) 
 
The differences in stability (ΔΔG) between substituted dysferlin proteins and the wild-type 
protein were calculated using ΔHm(wt), Tm(wt), and the differences in melting temperatures 
(ΔTm) between the wild type and the appropriate substituted proteins according to 
Equation 3: 
 
∆∆9 = ∆?6 ;∆9)(:")#)(:") =																		(Equation 3) 
4.2.4 Isothermal titration calorimetry 
All calorimetry experiments were performed using a NanoITC (TA Instruments) at 25°C. 
All experiments were completed 2–3 times using freshly prepared proteins extensively 
dialyzed in 25 mM HEPES, 150 mM NaCl, 250 μM TECP, pH 7.5 and pretreated with 
Chelex-100 (Bio-Rad) to remove residual Ca2+ ions for one hour. The optimal 
concentrations of protein in the experiments were determined to be: 5 mM Ca2+ titrated into 
85 μM C2AV67A, 3 mM Ca2+ titrated into 52 μM C2AW52M, 3 mM Ca2+ titrated into 77 μM 
C2AK36W . Proteins and Ca2+ solutions were degassed under vacuum prior to each titration. 
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Titrations consisted of 25 injections of 2 μL Ca2+ solution into a 146 μL cell containing the 
proteins with constant stirring. Heats of dilution were measured in a separate experiment 
in which Ca2+ solution was injected into the buffer alone. The titration data were analysed 
using sequential-two-binding-site model in NanoAnalyze v3.1.2 (TA instruments) to 
determine best fit values for KA, ΔH and N. ΔS was calculated according to Equation 4. 
ΔG = –RTlnKA = ΔH – TΔS 
                                                      ΔS = RlnKA + (ΔH/T)                                (Equation 4) 
4.2.5 NMR spectroscopy 
All NMR experiments were collected at 25˚C on a Varian Inova 600 MHz NMR 
spectrometer equipped with a triple resonance cryogenic probe and z-field gradients. All 
data were processed using NMRPipe (Delaglio et al., 1995) and analyzed using 
NMRViewJ (Johnson and Blevins, 1994). The 1H, 15N-HSQC NMR experiments were 
conducted in 25 mM HEPES, 150 mM NaCl, 250 μM TECP, pH 7.5 with 10% D2O, 200 
μM DSS as an internal reference, and 200 μM imidazole as an internal pH indicator. A 
sample of 200 μM uniformly 15N-labeled C2AV67A protein was incubated with Chelex-100 
(Bio-Rad) for one hour to remove residual Ca2+ ions before acquiring the 1H-15N HSQC 
spectra by the NMR spectrometer. Subsequently, 2 μL CaCl2 solution was added to the 
sample to make a final [Ca2+] of 20 mM and 1H15N-HSQC spectrum was recorded again 
using the same method. The stock solution of CaCl2 was analyzed by Inductively Coupled 
Plasma - Mass Spectrometry (ICP-MS) to obtain the precise concentration (Biotron, 






4.3.1 Mapping pathogenic mutations in the C2A domain 
The point substitutions C2AV67D and C2AW52R in the dysferlin C2A domain are associated 
with the development of Limb Girdle muscular dystrophy 2B (LGMD2B) and Miyoshi 
myopathy (MM) (Krahn et al., 2009).  In the structure of the C2A domain V67 lies on sheet 
β5 tucked between two alanine residues (A26, A84) on β2 and β6 and across from a series 
of hydrophobic residues on β1 (V4, I6) and β8 (L117, L119). The W52 residue is located 
on sheet β4, the side chain of which is buried inside the β sheet sandwich, projecting 
towards  β2 and β3 (Figure 4.1). Sequence comparison of other C2A domain proteins show 
that despite the fact that V67 and W52 are not well-conserved residues there is a strong 
preference for hydrophobic amino acids at these two positions. 
 
Since the seven C2 domains of dysferlin are expected to share similar β -sandwich 
structures, pathogenic substitutions on other C2 domains can be theoretically mapped to 
the C2A domain through structural and sequence alignments. For example, the C2B 
domain carries a more extensive distribution of substitutions, with seven substitutions 
(G234E, R253W, L266P, I284T, G299R, S340R, L344P) identified and located on five 
different β sheets and two loops. By substituting the corresponding residues in the C2A 
domain, it will be possible to characterize how those substitutions might affect the 
conformation and activity of the other C2 domains. This will help understand how 
pathogenic mechanisms of substitutions that cause dysferlinopathy. Since the C2AV67D and 










Figure 4. 1 Pathogenic mutations in dysferlin C2A and C2B domain. 
(A) Sequence alignment of dysferlin C2A and C2B domain. The arrows above the sequence 
correspond to residues that possess β strand secondary structure, whereas the lines 
corresponds to the loop region. Pathogenic mutated residue V67 and W52 in C2A and R253 
in C2B are highlighted in red and the corresponding conserved residue in the other C2 are 
highlighted in yellow. (B) Cartoon of the crystal structure of Ca2+-bound C2A showing the 
location of mutated residue V67, W52 and K36. Residue V67 and W52 both lie on β sheet 




attempted to investigate a pathogenic substitution in the loop region. Based on the sequence 
alignment of the C2A and C2B domains, we found the substitution at R253 in C2B could 
be mapped to K36 in C2A as the two basic residues in loop 2 are highly conserved between 
two hydrophobic residues (Figure 4.1 A). Making a substitution at K36 in C2A will mimic 
the effect of R253W in C2B, hence we will be able to assess the impact of this substitution 
on the structure and function of the C2 domain.      
 
4.3.2 Impact of pathogenic mutations on the expression and solubility  
The mutations of C2AV67D, C2AW52R and C2AK36W were initially generated to assess the 
impact of substitutions on protein folding and stability. In the test expression experiments, 
E. coli cells containing C2AV67D, C2AW52R and C2AK36W plasmids were grown and induced 
in the same conditions used for the wild type C2A. However, unlike wild type C2A domain 
that was found mostly in the soluble fraction on the gel, C2AV67D and C2AW52R were almost 
completely located in inclusion bodies, and a majority of C2AK36W protein was in the 
precipitate as well (Figure 4.2). Repeated attempts to refold the proteins were unsuccessful 
indicating that these substitutions in the dysferlin C2A domain cause instability or 
misfolding in the domain leading to aggregation. Examining the position of each residue 
in the structure of C2A has helped us understand how the aggregation happened. The 
central location of V67 puts it in a hydrophobic environment at the core of the protein. The 
region surrounding the V67 residue is composed entirely of hydrophobic residues. On the 
same β-sheet, the highly conserved residues, L65 and V69, are also pointed inward 
enhancing the hydrophobic environment at the core of the protein. Additionally, two 








Figure 4. 2 Test expression of C2A mutants. 
Wild-type C2A, C2AV67D, C2AV67A, C2AV67T, C2AV67N, C2AW52R, C2AW52A, C2AW52M, 
C2AW52T C2AK36W and C2AK36A were expressed in E. coli cells and the total protein (W), 




















Figure 4. 3 Close-up views of the location of residue V67, W52 and K36 in the C2A 
structure. 
Residue V67 (A), W52 (B),  and K36 (C) as well as their neighbouring residues are shown 




Once again the neighbouring residues are all hydrophobic, which suggests that 
hydrophobic interactions may play a role in the structure’s stability in this region and that 
maintenance of hydrophobicity at residue number 67 could be crucial for protein stability. 
The introduction of a charged acidic residue in this position is a energetically costly event 
and likely disrupts the hydrophobic interactions forming the core of the protein. A similar 
structural environment can be seen for W52, as it directs inward at the core of the β-sheet 
sandwich likewise, together with two neighbouring hydrophobic residues, F50 on the same 
β-sheet and L2 on adjacent β-sheet. Further, a basic residue K33 on the opposite side is 
also within close distance, pointing inward between the side chains of W52 and F50 
(Figure 4.3 B). Substitution of W52 to an arginine would likely trigger a charge-charge 
repelling effect with K33, resulting in the disruption of the protein conformation. For K36, 
which is located at one end of loop 2, we found it points towards β4, bonding with E48 on 
β4 via electrostatic interaction (Figure 4.3 C). This interaction may be important for 
bringing the two sides of the protein together, thus substitution to a hydrophobic residue 
causes a destabilization effect.  
 
In an attempt to better characterize the mechanism of this instability we incorporated 
several other substitutions at V67, W52 and K36. For V67, we introduced two less 
hydrophobic substitutions (C2AV67A, C2AV67T) and a less acidic one (C2AV67N). In the test 
expression, C2AV67N was found completely in inclusion bodies. Although a large amount 
of C2AV67A and C2AV67T were still located in the insoluble fraction, some protein was found 
in the soluble fractions. For W52, two less hydrophobic substitutions (C2AW52A, C2AW52M), 
and a polar one with a methyl group (C2AW52T) were generated. However, all of them 
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showed serious aggregation on the test expression gel so we chose C2AW52M as the subject 
for the following studies. For K36, we incorporated a less hydrophobic substitution 
(C2AK36A) and C2AK36A showed increased level of solubility than C2AK36W (Figure 4.2). 
In general, the levels of protein expression and solubility for all these proteins were much 
lower compared to wild type dysferlin C2A. However, sufficient amounts of C2AV67A, 
C2AV67T, C2AW52M and C2AK36A proteins were obtained to compare their stabilities to the 
wild-type protein. 
 
4.3.3 Protein purification 
Using the same protocol described in Chapter 2.2.1, the C2AV67A, C2AV67T, C2AW52M , 
C2AK36W and C2AK36A mutant proteins were purified using nickel-charged HisTrap FF 
column followed by gel filtration chromatography. Coomassie-stained SDS-PAGE gels of 
the fractions for each protein are presented in Figure 4.4 and show the expected band of 
molecular weight around 14 kDa for the C2AV67A, C2AV67T, C2AK36W and C2AK36A 
proteins following His6-tagged cleavage by TEV protease. For the C2AW52M protein, in 
particular, the His6-tagged was kept due to the serious precipitation of the protein. The 
SDS-PAGE gel of C2AW52M shows bands of around 19 kDa, corresponding to the 
calculated molecular weight of the His6-C2AW52M protein. 15N-labelled C2AV67A used for 


















Figure 4. 4 Purification of the C2AV67A, C2AV67T, C2AW52M , C2AK36A and C2AK36W 
mutant proteins. 
Purification of C2A mutants by HisTrap FF chromatography monitored by SDS-PAGE 
stained with Coomassie blue. Cleaved C2AV67A and C2AV67T (A),  C2AK36A and C2AK36W 





4.3.4 Pathogenic substitutions cause loss of stability for the C2A domain 
The secondary structure and thermal stability of each substituted protein was studied by 
circular dichroism (CD) as a comparison to the wild-type C2A. First, the secondary 
structure for each protein was examined without attempts to control the levels of calcium. 
That being said, the proteins used were obtained directly from the purification of E.coli 
cells with no manipulation of Ca2+ ions. As mentioned in Chapter 2.3.4, the CD spectrum 
of the dysferlin C2A domain at 25 ˚C had a negative band near 215 nm consistent with the 
well-defined antiparallel β-sheet structure of the protein. As presented in Figure 4.5 A, 4.6 
A, and 4.7 A, the CD spectra of C2AV67A, C2AV67T C2AW52M, C2AK36W, and C2AK36A all 
showed a similar profile, indicating that most of the β-sheet structure is preserved with 
these substitutions. However, the spectra of the substituted proteins (especially C2AW52M) 
were fairly noisy between 200 – 210 nm due to the high tension voltage beyond 600 V. 
This might be a consequence of the  protein aggregation at 25 ˚C although very low 
concentration (20 μM) was used. 
 
Thermal denaturation experiments measured by CD spectropolarimetry examined changes  
in molar ellipticity at 215 nm as a function of temperature (5 - 95 ˚C). The melting curve 
for native C2A in apo and Ca2+-bound state both showed a smooth sigmoidal transition 
between folded and unfolded species that follows a two-state unfolding pathway (Freire, 
1995), with a melting temperate (Tm) at 61 ˚C and 73 ˚C, and enthalpy change (ΔHm) of 










Figure 4. 5 Folding and thermal stability of C2AV67A and C2AV67T monitored by 
circular dichroism. 
(A) Circular dichroism spectra of wild type C2A (black), C2AV67A (red) and C2AV67T (blue) 
from 250 – 195 nm. The measurements were taken at 25 °C. The buffer background was 
subtracted. (B) (C) Thermal denaturation of C2A (black), C2AV67A (red) and C2AV67T (blue) 
in apo- and Ca2+-bound state within the range of 5 – 95°C in 0.5 °C increments. The 
unfolding profile as a function of temperature is shown by CD ellipticity at 215 nm. The 
relative change in ellipticity at 215 nm was plotted as a fraction unfolded and fitted 





For C2AV67A and C2AV67T, the unfolding curves shifted to lower transition temperatures in 
apo and Ca2+-bound state. The unfolding profiles of C2AV67A and C2AV67T almost 
completely overlapped, indicating two proteins underwent similar unfolding process. The 
melting temperate (Tm) for apo-C2AV67A (49.67 ˚C) and apo-C2AV67T (48.2 ˚C)  was over 
10˚C lower than the native apo-C2A. Also Ca2+-C2AV67A and Ca2+-C2AV67T had a Tm that 
is 7˚C lower than the wild-type Ca2+-C2A (Figure 4.5 B – C, Table 4.2). Notably, C2AV67A 
and C2AV67T showed a further gradual transition following melting perhaps indicative of a 
less cooperative unfolding process or the presence of aggregated species in solution. 
Further, denaturation of both C2AV67A and  C2AV67T yielded smaller enthalpy change (ΔHm) 
compared to the wild-type, which resulted from decreased thermal stabilities. These results 
suggest that substitution of V67 causes large instabilities in the C2A domain and that the 
V67D substitution likely causes its unfolding and aggregation. 
 
Fitting of the unfolding data of apo-C2AW52M yielded a higher melting temperate (Tm) 
(79˚C) than the wild-type apo-C2A (Table 4.2). however, the slope of the plot of apo-
C2AW52M was remarkably decreased compared to that of the native C2A, resulting in an 
exceptionally smaller enthalpy change (ΔHm) (Figure 4. 6 B, Table 4.2). The unfolding 
profile of apo-C2AW52M showed a non-cooperative unfolding manner, indicative of 
significant accumulation of intermediates likely due to the protein aggregation. In the case 
of Ca2+-C2AW52M, the unfolding curves showed a melting temperature almost 18˚C lower 
than the native Ca2+-C2A, accompanied with a decreased slope and smaller enthalpy 
change (ΔHm) (Figure 4.6 C, Table 4.2). All these observations suggest that substitution 














Figure 4. 6 Folding and thermal stability of C2AW52M monitored by circular dichroism. 
(A) Circular dichroism spectra of wild type C2A (black) and C2AW52M (green) from 250 – 
195 nm. The measurements were taken at 25 °C. The buffer background was subtracted. 
(B) (C) Thermal denaturation of C2A (black) and C2AW52M (green)  in apo- and Ca2+-
bound state within the range of 5 – 95°C in 0.5 °C increments. The unfolding profile as a 
function of temperature is shown by CD ellipticity at 215 nm. The relative change in 
ellipticity at 215 nm was plotted as a fraction unfolded and fitted according to Equation 








Figure 4. 7 Folding and thermal stability of C2AK36A and C2AK36W monitored by 
circular dichroism. 
(A) Circular dichroism spectra of wild type C2A (black), C2AK36A (pink) and C2AK36W 
(orange) from 250 – 195 nm. The measurements were taken at 25 °C. The buffer 
background was subtracted. (B) (C) Thermal denaturation of C2A (black), C2AK36A (pink) 
and C2AK36W (orange) within the range of 5 – 95°C in 0.5 °C increments. The unfolding 
profile as a function of temperature is shown by CD ellipticity at 215 nm. The relative 
change in ellipticity at 215 nm was plotted as a fraction unfolded and fitted according to 









Table 4. 2 Summary of parameters calculated for the thermal unfolding of the C2A 
domain and its substitutions. 
 
 
Protein Tm (°C) ΔHm (KJ/mol) 
apo-C2A 61.31 147 
Ca2+-C2A 73.08 236.1 
apo-V67A 49.67 72.86 
Ca2+-V67A 66.03 78.18 
apo-V67T 48.2 66.95 
Ca2+-V67T 66.04 57.6 
apo-W52M 79.09 18 
Ca2+-W52M 54.73 28.79 
K36W 56.37 56.2 




Furthermore, the C2AK36A mutant showed almost the same unfolding profile as wild-type 
C2A with similar Tm and ΔHm, while C2AK36W had a melting temperature about 5 ˚C  lower 
with a slightly reduced slope and much lower Tm (Figure 4.7 B – C, Table 4.2). These 
results indicate that substitution of K36 with an alanine does not seem to affect the folding 
and stability of the protein, whereas a tryptophan causes destabilization likely due to its 
hydrophobic exposure effect. 
 
Taken together, although V67D and W52R proteins were unobtainable, we were able to 
assess the importance and function of residue V67 and W52 by introducing other 
substitutions at these positions. We found disruption of hydrophobic properties at these 
positions causes severe instabilities to the overall structure of C2A domain leading to 
aggregation. Substitution of K36W causes similar destabilization effect, but possibly 
through introducing hydrophobic residue to the loop region where is more exposed to the 
solvent, resulting in misfolding of the domain. 
4.3.5 Impact of pathogenic mutations on the calcium binding 
Next,  calcium titration experiments by ITC were conducted to probe the calcium binding 
properties of each protein. As shown in Figure 4.8, the ITC data of C2AV67A, C2AW52M, 
and C2AK36W all demonstrated endothermic reactions in the beginning and exothermic 
binding after the mole ratio of [Ca2+]/[C2A] reached 2, indicative of two distinct Ca2+ 
binding modes. This two-stage titration profile resembles that of wild-type C2A observed 
in Chapter 3.3.1 (Figure 3.2), indicating the Ca2+ binding property of C2A domain is 





        
Figure 4. 8 ITC data of Ca2+ binding to C2AV67A, C2AW52M, and C2AK36W. 
Isotherm graphs of calcium binding to the mutants C2AV67A, C2AW52M, and C2AK36W. Data were collected at 25 °C with 
25 mM HEPES, 150 mM NaCl, 250 μM TCEP, pH 7.5 buffer conditions. The data were all fitted with a sequential two-








Table 4. 3 Summary of Ca2+ binding parameters for the C2A domain and its 















C2A  32 4.661 102.3 300 -44.15 -8.58 
C2AV67A  19 10.78 126.7 342 -35.58 -5.30 
C2AW52M 5.4 0.664 103.1 1082 -41.68 -8.30 





thermodynamic parameters yielded are shown in Table 4.3. Firstly, the Kd values for the 
two binding sites of C2AV67A and C2AK36W are within the same order of magnitude as those 
for the wild-type C2A. The Kd2 values, particularly, are all about 300 μM, suggesting these 
substitutions barely affect the Ca2+ binding affinities of the domain. The C2AW52M protein 
showed a little divergent Ca2+ binding affinities with a smaller KD1 and larger KD2 compared 
to the others. However, it is difficult to assess the accuracy of the ITC data for a large 
amount of precipitate was observed during the titration which might affect the result. 
Secondly, by examining the ΔH and ΔS values, all of them show large positive entropy 
change in the initial step (ΔS1) and a fairly small entropy change (ΔS2) for the second 
binding step, indicating binding of the first calcium ion results in larger overall structural 
change of the domain than the second calcium ion. Taken together, the ITC titrations for 
the C2AV67A, C2AW52M, and C2AK36W proteins demonstrate that substitutions at position 
V67, W52 and K36 do not affect the Ca2+ binding property of the C2A domain.  
 
4.3.6 NMR studies  
To further examine the impact of the substitutions on protein folding, NMR spectroscopy 
was used. Due to severe precipitation of the mutant protein, only adequate C2AV67A protein 
was obtained to for NMR studies. The 1H-15N-HSQC spectra of apo-C2AV67A compared to 
wild-type apo-C2A showed apo-C2AV67A displayed a population of well-dispersed peaks 
and the two spectra demonstrated significant overlap (Figure 4.9 A), indicating the V67A 
substitution does not change the fold and the secondary structure of C2A domain in the 
apo-state. Subsequently, a large amount of Ca2+ was added into the sample and 1H-15N-
HSQC spectra was recorded using the identical parameters. However, the spectrum of 
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C2AV67A protein in Ca2+-bound state showed large variations in peak number and positions 
compared to the wild-type Ca2+-C2A (Figure 4.9 B). It can be observed from the 
superposition of the two spectra that there was an increased number of signals in the 
C2AV67A domain, including a series of signals between 8.0 – 9.0 ppm in 1H dimension and 
115 – 120 ppm in 15N dimension. This might result from proteolysis and degradation of the 
protein. Further, the two spectra do not show high level of overlap regarding peak positions, 
indicating the Ca2+-C2AV67A takes on a conformation different than the wild-type. In 
addition, based on the fact that the signals of Ca2+-C2AV67A are significantly weaker than 
the apo-C2A and large amount of precipitate was observed in the final sample, we conclude 
that protein aggregation occurred during spectral acquisition at room temperature. It is 
difficult to confirm whether this aggregation resulted from Ca2+ binding or the long period 
of time (more than 8 hours) near room temperature. According to the ITC result that 
C2AV67A has very similar Ca2+ binding properties to the wild-type C2A, it is speculated that 
the different spectrum of Ca2+-C2AV67A is likely a consequence of protein proteolysis and 
aggregation, suggesting V67 substitution impairs the long term stability of the C2A domain 








Figure 4. 9 NMR spectra of C2AV67A overlapped with wild-type C2A. 
Overlaid 1H-15N HSQC spectrum of apo-C2AV67A (red) and apo-C2A (black) (A), Ca2+-







In dysferlin, about half of the missense mutations leading to muscular dystrophy are found 
within the C2 or the DysF domains. Most of the C2 domain substitutions are found within 
the predicted β sheet structures and only rarely in the intervening loops. Missense 
mutations often affect those structures as well as residues that were highly conserved in the 
C2 domains (Therrien et al., 2006). This can also be seen from the sequence alignment of 
C2A and C2B domain, where W52 and V67 on C2A and K36 on C2B are all highly 
conserved residues (Figure 4.1 A). We were able to investigate the impact of a pathogenic 
mutation in the loop region through mapping it from C2B (R253) to C2A (K36) domain 
based on the sequence homology. This method can be useful to predict the possible 
consequences of affected residues in different regions of other C2 domains might have on 
the structure or function of the dysferlin protein. 
 
Clinical data have reported that the pathogenic dysferlin mutations affect the protein 
expression level in skeletal muscle, characterized by severely decreased  or absence of 
dysferlin expression (Krahn et al., 2009; Nguyen et al., 2005). An amount of dysferlin £ 
20% has been shown to be  pathogenic and always caused by primary dysferlin gene 
mutations (Cacciottolo et al., 2011). Further characterization of dysferlin on a molecular 
level is needed to better understand the structure and the function of this protein in normal 
and pathological conditions. Our work investigated three pathogenic mutations on C2A 
domain that cause limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi 
myopathy (MM) and show all three substitutions significantly decrease the stability of the 
C2A domain. In the previous chapter we have shown that wild-type dysferlin C2A domain 
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takes on an eight β-sheet structure, with multiple calcium- and phospholipid-binding sites. 
Maintenance of this structure is essential for dysferlin to function in the membrane repair 
process and V67, W52 and K36 are identified to be structurally important. Unfolding or 
improper folding of the C2A domain of dysferlin encompassing the V67D, W52R and 
K36W substitutions is predicted to be responsible for impaired dysferlin function in the 
membrane repair process, and consequently the wasting of skeletal muscles in muscular 
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Dysferlin is a large protein containing 2080 amino acids with a short C-terminal 
transmembrane domain. Within the cytosolic region of dysferlin, it possess a rare feature 
consisting of seven tandem C2 domains (C2A – C2G) separated by linkers, together with 
two Fer domains and one DysF domain. The tertiary structure of dysferlin has not been 
characterized, only DysF domains has been solved by crystallography (Sula et al., 2014), 
and the C2A domain has been comprehensively investigated in the previous chapters of 
this thesis. Dysferlinopathy is characterized by absence or marked reduction of dysferlin 
protein, with 43% of reported pathogenic variants being missense mutations that span the 
length of the dysferlin protein including all the C2 domains (Cacciottolo et al., 2011; Krahn 
et al., 2009). This suggests that all seven C2 domains are structurally or functionally 
important for maintaining dysferlin’s activities. Although it was previously predicted that 
the C2A, C2B, and C2E domains adopted the type II topology, whereas the remainder of 
the C2 domains were expected to adopt the type I topology (Therrien et al., 2006), it is still 
unclear what the specific structure and role of each C2 domain is and the interplay between 




A limited number of studies have focused on the C2 domains of dysferlin individually. By 
using isolated proteins, one study demonstrated that all seven dysferlin C2 domains interact 
with Ca2+ with various binding affinities ranging from micromolar (C2A and C2C) to 
millimolar (C2D), as well as with different stoichiometry (Abdullah et al., 2014). A lipid 
binding assay showed that the C2A domains of dysferlin exhibited binding to 
phosphatidylserine (PS) and several phosphoinositides in a Ca2+-dependent manner, 
whereas all of the other dysferlin C2 domains exhibited weaker and Ca2+-independent 
binding to PS and no detectable binding to phosphoinositides. Although these studies laid 
some ground for investigations into dysferlin C2 domains, some issues are implicit in them. 
Firstly, different studies have used constructs of C2 domains that include different regions 
of the protein, which vary considerably in some cases: the domain boundaries have not 
been defined clearly yet. Secondly, the secondary structure of each C2 domain was almost 
never analyzed to confirm the proper folding of the domains, which could be problematic 
when drawing conclusions regarding any features of the C2 domains. To address the above 
issue, I pursued my studies on characterizing the C2B and C2C domains of dysferlin. The 
work in this chapter aimed to define the accurate domain boundaries of the two domains 
and to investigate the structural properties of them. 
 
5.2 Materials and Methods 
 
5.2.1 Restriction-free (RF) cloning of the dysferlin C2B and C2C domain  
All the dysferlin C2B and C2C constructs were cloned using restriction-free cloning 
technique (van den Ent and Löwe, 2006). Plasmid encoding the full length human dysferlin 
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gene (DYSF) was purchased from Addgene plasmid repository (#60216). DNA fragments 
encoding C2B and C2C domains from the full length DYSF gene were inserted into the 
following vectors containing different affinity tags: pET28a (His6 tag), pET-SUMO (His-
SUMO tag), pGEX (GST tag). Primers were designed using the online program 
(https://www.rf-cloning.org) and are shown in Table 5.1. The DYSF plasmid was isolated 
from harvested MM294 E. coli cells using the Bio Basic Inc. EZ-10 spin column miniprep 
kit. The restriction-free cloning was conducted using Polymerase chain reaction (PCR). 
Methylated parental strands that remained in the PCR reaction were digested by Dpn1 
overnight at 37°C. The following day, plasmid DNA was purified using a PCR clean-up 
kit (BioBasic Inc). All PCR products were transformed into competent MM294 cells and 
incubated on antibiotic-treated LB-agar plates overnight at 37 °C. Multiple colonies were 
picked and grown in LB. Plasmids were isolated from harvested cells using the Bio Basic 
Inc. EZ-10 spin column miniprep kit and were sequenced (London Regional Genomics 
Centre, Canada) to verify that the correct mutations were incorporated. 
 
5.2.2 Test expression and solubility test  
Small-scale test expression experiment was performed for the following constructs: His-
C2B, His-SUMO-C2B, GST-C2B, His-C2C, His-SUMO-C2C, GST-C2C, His-C2BC, 
His-SUMO-C2BC, GST-C2BC, His-C2BC-DysF, His-SUMO-C2BC-DysF, GST-C2BC-
DysF (also shown in Figure 5.3 B). Plasmids containing the DNA were transformed BL21-
CodonPlus (DE3) E. coli strain. Isolated colonies were picked and grown in 5 mL LB/DYT 
overnight as starters. The following day 250 μL starters were inoculated into 25 ml 





Table 5. 1 Primers used for restriction-free cloning for generating dysferlin C2B and 
C2C constructs. 
 
Construct Primer Sequence 
 
His-C2B Forward: 5’- AGGATCCGGCGGCGGCGGCGGCAAACCGCAGGATTTCCAGA -3’ 
Reverse: 5’- AGTGGTGGTGGTGGTGGTGCTAGTCCCCAGGCCCCAGCAC -3’ 
 
His-SUMO-C2B Forward: 5’- GGCTCACAGAGAACAGATTGGTGGTAAACCGCAGGATTTCCAGATCA -3’ 
Reverse: 5’- CGCCGAATAAATACCTAAGCTTGTCTCTAGTCCCCAGGCCCCAGCAC -3’ 
 
GST-C2B Forward: 5’- GTTCCAGGGGCCCCTGGGATCCAAACCGCAGGATTTCCAGA -3’ 
Reverse: 5’- CACGATGCGGCCGCTCGAGTCAGTCCCCAGGCCCCAGCAC -3’ 
 
His-C2C Forward: 5’- AGGATCCGGCGGCGGCGGCGGCGGAGCCCACTTCTGCCTGAAGG -3’ 
Reverse: 5’- CAGTGGTGGTGGTGGTGGTGCTAACTGCCATAGAGGTTGATGTAGC -3’ 
 
His-SUMO-C2C Forward: 5’- GGCTCACAGAGAACAGATTGGTGGTGGAGCCCACTTCTGCCTGAAG -3’ 
Reverse: 5’- CGAATAAATACCTAAGCTTGTCTCTAACTGCCATAGAGGTTGATGTAGC -3’ 
 
GST-C2C Forward: 5’- GTTCCAGGGGCCCCTGGGATCCGGAGCCCACTTCTGCCTGAAG -3’ 
Reverse: 5’- CACGATGCGGCCGCTCGAGTCAACTGCCATAGAGGTTGATGTAGC -3’ 
 
His-C2BC Forward: 5’- CAAGGATCCGGCGGCGGCGGCGGCAAACCGCAGGATTTCCAGATC -3’ 
Reverse: 5’- GTGGTGGTGGTGGTGGTGCTAACTGCCATAGAGGTTGATGTAGC -3’ 
 
His-SUMO-C2BC Forward: 5’- GGCTCACAGAGAACAGATTGGTGGTAAACCGCAGGATTTCCAGATC -3’ 
Reverse: 5’- CGAATAAATACCTAAGCTTGTCTCTAACTGCCATAGAGGTTGATGTAGC -3’ 
 
GST-C2BC Forward: 5’- GTTCCAGGGGCCCCTGGGATCCAAACCGCAGGATTTCCAGATC -3’ 
Reverse: 5’- CACGATGCGGCCGCTCGAGTCAACTGCCATAGAGGTTGATGTAGC -3’ 
 
His-C2BC-DysF Forward: 5’- CAAGGATCCGGCGGCGGCGGCGGCAAACCGCAGGATTTCCAGATC -3’ 




Forward: 5’- CCTCCCCACTTTTGGGCCCTGCACTAAGTTGGCCCTTGTTGG -3’ 
Reverse: 5’- GTGGTGGTGGTGGTGGTGCTACTCGCCCTCCGCCTCCGCCTGC -3’ 
 
GST-C2BC-DysF Forward: 5’- GTTCCAGGGGCCCCTGGGATCCAAACCGCAGGATTTCCAGATC -3’ 







0.6 was reached and were induced with 0.05 – 0.5 mM IPTG, followed by continued 
growth at 37 ˚C for 5 hours or at 16 ˚C for 20 hours. Cells were harvested by centrifugation 
at 4,000 rpm for 20 min and resuspended in various lysis buffers. Cells were lysed by 
EmulsiFlex-C5 homogenizer (Avestin). Gel sample was taken at this point as total protein 
(i.e. 30 μL + 15 μL 3 × SDS loading buffer). Then 1 mL cell lysate was centrifuged for 10 
- 15 minutes at 14,000 rpm in tabletop centrifuge. The supernatant was taken as gel sample 
(soluble fraction). Cell pellet was resuspended in 1 ml of 2% SDS with vortexing and taken 
as gel sample (insoluble fraction). The total protein (W), soluble (S) and insoluble fractions 
(P) were checked by SDS-PAGE along with the relevant negative and positive controls. 
5.2.3 Expression and purification of His-SUMO-C2B and His-SUMO 
The dysferlin C2B domain (residues 216-348) that was inserted into a pET SUMO 
expression system vector (Invitrogen) is referred to as His-SUMO-C2B. Unlabeled or 
uniformly 15N-labeled His-SUMO-C2B were overexpressed in the BL21-CodonPlus (DE3) 
E. coli strain in LB or M9 minimal medium supplemented with 30 μg/mL kanamycin and 
30 μg/mL chloramphenicol. 15NH4Cl (1 g/L) and 13C6-glucose (2 g/L) were used as the sole 
nitrogen and carbon sources in the M9 minimal media. The cultures were grown at 37 ºC 
until an OD600 of 0.6 was reached at which point cells were cooled to 16 °C and induced 
with 0.5 mM IPTG for 20 hours. Cells were harvested by centrifugation at 6,000 rpm for 
15 min and resuspended in lysis buffer (50 mM Tris, 300 mM NaCl, 10 mM imidazole, 
0.1 % Triton X-100, 5% glycerol, pH 9.5). Cells were lysed by EmulsiFlex-C5 
homogenizer (Avestin) and centrifuged at 20,000 g for 40 min. The supernatant was filtered 
through 0.45 micron low protein binding Millipore syringe filters and subsequently applied 
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to a 5 mL HisTrap FF column on an AKTA FPLC (GE Healthcare) pre-equilibrated in 
binding buffer (50 mM Tris, 300 mM NaCl, 10 mM imidazole, 0.1 % Triton X-100, 5% 
glycerol, pH 7.5). The column was washed with the binding buffer with 50 mM imidazole 
until the OD280 returned to baseline. Bound protein was then eluted with a 250-500 mM 
imidazole in the elution buffer (50 mM Tris, 300 mM NaCl, 250-500 mM imidazole, 0.1 % 
Triton X-100, 5% glycerol, pH 7.5). A final purification step by gel filtration was 
performed on a HiLoad Superdex75 pre-equilibrated with appropriate buffers. Fractions 
containing the protein were pooled and stored at -80 ºC.  
 
Uniformly 15N-labeled His-SUMO (Invitrogen) was overexpressed in the BL21-CodonPlus 
(DE3) E. coli strain in M9 minimal medium supplemented with 30 μg/mL kanamycin. The 
cultures were grown at 37 ºC until an OD600 of 0.6 was reached at which point cells were 
cooled to 16 °C and induced with 0.5 mM IPTG for 20 hours. Cells were harvested by 
centrifugation at 6,000 rpm for 15 min and resuspended in lysis buffer (25 mM Tris, 300 
mM NaCl, 10 mM imidazole, pH 7.5). Cells were lysed by EmulsiFlex-C5 homogenizer 
(Avestin) and centrifuged at 38,000 rpm for 90 min. The supernatant was filtered through 
0.45 micron low protein binding Millipore syringe filters and subsequently applied to a 5 
mL HisTrap FF column on an AKTA FPLC (GE Healthcare) pre-equilibrated in lysis 
buffer. The column was washed with the binding buffer with 50 mM imidazole until the 
OD280 returned to baseline. Bound protein was then eluted with a 250-500 mM imidazole 
in the elution buffer (25 mM Tris, 300 mM NaCl, 250-500 mM imidazole, pH 7.5). 




5.2.3 Expression and purification of GST-C2BC-DysF 
The dysferlin C2BC domain (216-521) and DysF domain (886-1067) were linked together 
by cloning and incorporated into the pGEX (GST tag) expression vector (referred to as 
GST-C2BC-DysF). Unlabeled GST-C2BC-DysF was over-expressed in the BL21 (DE3) 
Codon Plus E. coli strain. The cultures were grown at 37 ºC in the presence of ampicillin 
(50 μg/mL) to a density of (A600) 0.6 AU, then induced by adding 0.5 mM IPTG. Induction 
continued for another 20 h with constant shaking at 16 ºC. Cells were harvested by 
centrifugation at 6,000 rpm for 15 min and resuspended in PBS buffer (140 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3). Cells were lysed by EmulsiFlex-
C5 homogenizer (Avestin) and centrifuged at 30,000 rpm for 90 min. All fractionation 
steps were performed at 4 °C. The supernatant was applied to a 5 mL glutathione-linked 
sepharose column (GSTrap FF) on an AKTA FPLC (GE Healthcare) pre-equilibrated in 
PBS buffer. The column was then washed with the PBS buffer until the OD280 returned 
to baseline. The bound GST-C2BC-DysF protein was eluted in elution buffer (50 mM Tris-
HCl, 20 mM reduced glutathione, , pH 8.0). Fractions containing the GST-C2BC-DysF 
protein were verified by SDS-PAGE. 
 
5.2.4 NMR spectroscopy 
All NMR experiments were collected at 25˚C on a Varian Inova 600 MHz NMR 
spectrometer equipped with a triple resonance cryogenic probe and z-field gradients. All 
data were processed using NMRPipe (Delaglio et al., 1995) and analyzed using 
NMRViewJ (Johnson and Blevins, 1994). The 1H-15N HSQC NMR experiments were 
conducted in 25 mM HEPES, 150 mM NaCl, 250 μM TECP, pH 7.5 with 10% D2O, 200 
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μM DSS as an internal reference, and 200 μM imidazole as an internal pH indicator. The 
1H-15N HSQC NMR spectra was collected using a sample of 200 μM uniformly 15N-labeled 
His-SUMO, and a sample of 150 μM 15N-labeled His-SUMO-C2B. Spectral windows were 
7000.0 Hz centered on 4.773 ppm for 1H and 1944.3 Hz centered on 121.2 ppm for 15N.  
For the interaction study of dysferlin C2A and C2B domain, the apo and Ca2+-bound 15N-
labeled C2A samples were prepared as described in Chapter 3.3.2, with a concentration 
of 200 μM. A 1H-15N HSQC NMR spectrum was recorded for each. Then 100 μM 
unlabeled His-SUMO-C2B was added into the sample followed by collection of another 
1H-15N HSQC spectrum. 
5.2.5 Circular dichroism 
Folding of all proteins were monitored by circular dichroism spectropolarimetry using a 
Jasco J-810 instrument (Biomolecular Interactions and Conformations Facility, University 
of Western Ontario). Proteins were extensively dialyzed in the CD buffer (20 mM KH2PO4, 
pH 7.5) for at least one day with stirring. For each sample, 15 scans from 250 –200 nm (80 
nm/min with increment of 1 nm) were recorded using a 1 mm path-length cell at 20 °C and 
95 °C, averaged and the buffer background was subtracted.  
5.2.6 Isothermal titration calorimetry 
All calorimetry experiments were performed using a NanoITC (TA Instruments) at 25°C. 
All experiments were completed 2–3 times using freshly prepared proteins extensively 
dialyzed in 25 mM HEPES, 150 mM NaCl, 250 μM TECP, pH 7.5 and pretreated with 
Chelex-100 (Bio-Rad) to remove residual Ca2+ ions for one hour. The optimal 
concentrations of protein and Ca2+ in the experiments were determined to be: 1.5 mM Ca2+ 
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titrated into 57 μM His-SUMO-C2B. Protein and Ca2+ solution were degassed under 
vacuum prior to each titration. Titrations consisted of 25 injections of 2 μL Ca2+ solution 
into a 146 μL cell containing the proteins with constant stirring. Heats of dilution were 






5.3.1 Design of the dysferlin C2B and C2C constructs  
As mentioned earlier, dysferlin has been identified to possess a unique structure consisting 
of seven tandem cytosolic C2 domains (C2A – C2G) separated by linkers, together with 
two Fer domains and one DysF domain in the middle of the protein (Figure 5.3 A). 
However, in the existing studies on dysferlin, different domain boundaries have been 
predicted. For example, three dysferlin studies were conducted using the C2C domain 
spanning three different regions (residue 345 – 574, 378 – 528 and 366 – 515, respectively 
(Abdullah et al., 2014; Llanga et al., 2017; Therrien et al., 2009). For our study which 
requires properly folded protein and pursues structural characterization, accurate boundary 
identification of dysferlin C2 domains is needed. 
 
First, we carried out secondary structure prediction and sequence alignment. We used the 
online program JPred (http://www.compbio.dundee.ac.uk/jpred4) and YASPIN 
(http://www.ibi.vu.nl/programs/yaspinwww) for secondary structure predication of the 
dysferlin C2B and C2C domains. In the prediction for C2B domain from residue K216 to 
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D348, the first six β strands were predicted by the two programs consistently and the β-
strands were shown to be connected by random coils (Figure 5.1 A). In contrast, in the 
prediction by YASPIN, there were sequence preferences for one more β strand element at 
the end of the sequence and three α helix structures between β4 -5 and β6 -7. In the 
prediction of C2C domain from residue G378 to C521, there were also six β strands 
predicted by both programs and YASPIN identified two more β strands. Further, two 
programs each predicted one α helix in different positions (Figure 5.1 B). In principle, the 
C2 domains are expected to present eight β sheets, so the predictions do not give high 
reliabilities. Nonetheless, the above results helped us to locate the approximate segments 
of the C2B and C2C domains. Meanwhile, a sequence alignment of the C2B and C2C 
domains was performed along with secondary structure information obtained from 
dysferlin C2A and PLC-δ1 (Essen et al., 1997) crystal structures to map the putative 
calcium binding residues and structurally conserved residues. Residues important for the 
structure of β-strands and intervening loops of the domains were aligned according to an 
amino acid consensus obtained from the structural alignment of dysferlin C2A and PLC-
δ1. As shown in Figure 5.1 C, there is a lot of sequence conservativity within the region 
encompassing the first six β strands. For example, a number of hydrophobic residues were 
aligned well in the β sheet regions and several aspartate and asparagine residues were 
indicated to be analogous in loop 1 – 3 which likely correspond to the calcium binding sites. 
In comparison, the regions after β6 showed weaker sequence preservation with fewer 
conserved amino acid residues. This aligns closely with the secondary structure prediction 






Figure 5. 1 Secondary structure prediction and sequence alignment of dysferlin C2B 
and C2C domain. 
(A) (B) Secondary structure prediction of amino acid sequences corresponding to dysferlin 
C2B (A)  and C2C (B) domain using online prediction program Jpred 
(http://www.compbio.dundee.ac.uk/jpred/) and Yaspin 
(http://www.ibi.vu.nl/programs/yaspinwww/). The secondary structure elements are 
shown: H, α helix; E, β sheet; -, disorder/loop. Putative β sheets are marked on the top of 
the sequences. (C) Alignment of dysferlin C2B and C2C domain with C2A and PLC-δ1C2 
domain. Hydrophobic residues that are highly conserved in β sheet regions are highlighted 
in yellow. Conserved residues in the loop regions are highlighted in white with a blue 
background. The arrows above the sequence correspond to residues that possess β strand 




programs (Figure 5.1 A - B). We suspect that there might be larger structural variations 
between the C2 domains’ sequences within this region, which causes difficulty to identify 
the accurate boundaries. 
 
To attain more insights into designing the C2B and C2C constructs, we combined the above 
results with a computational model performed by our collaborator (Dr. Lance Stewart and 
Dr. David Baker, University of Washington, U.S.). The model simulated the 3D structure 
of the entire dysferlin protein. The C2B and C2C domains modeled both show an anti-
parallel β-sandwich arrangement connected by four loops at the top of the structures, 
typical of the C2 domain fold (Figure 5.2 A - B). The domain boundaries are identified to 
be K216 to D348, and G378 to C521, respectively. Of note, the C2C domain model 
demonstrates a much longer loop region comprising an α-helix fold. This explains the extra 
residues in the C2C loop 1 observed in the sequence alignment (Figure 5.1 C). Together, 
the starting residue of the C2B and C2C domains align perfectly in the three methods 
described above, and the computational simulation helped us determining the end points 
of the domains. 
 
More importantly, the simulated model also shows that C2B and C2C domain together 
adopt an arched-shaped arrangement joined by a linker sequence that forms an α-helix and 
packs against the two domains. The N and C termini of both domains are located at the 
bottom of the overall structure, whereas the putative calcium binding loops on the top 
(Figure 5.2 C). This proposed model is supported by a few studies. In a limited proteolysis 









Figure 5. 2 Modeling of dysferlin C2B, C2C, and DysF domains.  
Predicted structures of dysferlin C2B domain (A) and C2C domain (B) by collaborator’s 
modeling. The N- and C-terminal residues are labeled red dots and residue numbers. (C) 
Modeling of the C2B-C2C module showing C2B and C2C domains together adopt an 
arched-shaped arrangement joined by a linker sequence (gray) that forms an α-helix and 
packs against the two domains. (D) Modeled DysF domain, containing a β-sheet motif 
encompassing residue W926 to E1067 (orange) with an extension of a second “DysF” like 





closed conformation (Woolger et al., 2017), consistent with the cellular function of the 
C2B-C2C motif in regulating dysferlin plasma membrane expression (Evesson et al., 2010). 
Further, the modeled C2B-C2C conformation is similar in structure to the tandem C2 
domains (C2A-C2B) of extended synaptotagmin (Schauder et al., 2014; Xu et al., 2014), 
which is evolutionarily conserved to dysferlin. Thus, C2B-C2C could be regarded as a 
single domain and the folding of each domain may be dependent on the other. 
 
Additionally, the DysF domain, encompassing residue W926 to E1067, was predicted to 
be associated with the C2B-C2C module by our collaborator. It is proposed that the DysF 
domain resembles the SMP domain of extended synaptotagmin that makes contact with the 
C2A-C2B motif and mediates lipid binding. The crystal structure of DysF domain shows 
it consists of two long antiparallel β-strands, one at each terminus, connected with a long 
loop (Sula et al., 2014) (Figure 5.2 D), which is similar to parts of the β-barrel structure of 
the SMP domain of extended synaptotagmin (Schauder et al., 2014). It is also suggested 
that the fragment covering residue T886 – T925 could be an extension of the structure of 
DysF domain or a second “DysF” like domain, and interacts with C2B-C2C module 
together with DysF domain (Figure 5.2 D).  
 
On the basis of all the above information, by utilizing restriction-free cloning method using 
the full-length DYSF gene and vectors containing different affinity tags, the following 
constructs were generated (Figure 5.3 B):  
(i) C2B domain (216 - 348). 






















Figure 5. 3 Overview of dysferlin C2B and C2C constructs generated by RF cloning. 
(A) Domain architecture of full-length dysferlin demonstrating the domain boundaries of 
C2B, C2C and DysF domains. (B) Schematic representation of the constructs generated in 
this study. Three different affinity tags were incorporated at N terminus for each construct, 
including His6 tag, His-SUMO (small ubiquitin-like modifying protein) tag and GST 




(iii) C2BC (216 - 521).  
(iv) C2BC-DysF (216 - 521+ 886 - 1067).  
For each fragment, three different affinity tags were incorporated at N terminus, including 
His6 tag, His-SUMO (small ubiquitin-like modifying protein) tag and GST (Glutathione S-
transferase) tag. All twelve constructs were successfully cloned and transformed into 
BL21-CodonPlus (DE3) E. coli expressing cell line.  
 
5.3.2 Dysferlin C2B and C2C domains show low solubilities 
Initially, all the constructs were tested for expression and solubility using the same 
conditions for the wild-type C2A domain described in Chapter 2.2.1. However, though 
expressed well, all proteins were found to be completely insoluble. Therefore, small-scale 
expression screening was performed for each construct by varying multiple conditions as 
follows: 
(i) Culture condition: LB and DYT medium were used as the culture for cell growth. 
(ii) Induction condition: Different concentrations of IPTG (0.05 to 0.5 mM) were used to 
induce protein expression.  
(iii) Growth temperature: Cells were grown at 37 ˚C and 16 ˚C following IPTG induction 
for 5 hours and 20 hours, respectively.  
(iv) Buffer conditions: Buffers containing different salt concentrations, w/o addition of 
detergents, and at different pH were used to resuspend the harvested cells prior to lysis. 
 
The cell lysate was separated, by centrifugation, into soluble fractions (supernatant) and 











Figure 5. 4 Representative experiments of test expression and soluble expression 
showing insolubility of the dysferlin C2B and C2C domains. 
His-C2B, His-C2C and His-C2BC were expressed in E. coli cells and the total protein (W), 
supernatant (S) and pellet (P) were checked by SDS-PAGE gel. For each protein, variable 
conditions were tested. (A) Different buffer conditions: (1) 25 mM Tris, 1 mM DTT, 5 mM 
NaCl, pH 7.5. (2) 25 mM Tris, 1 mM DTT, 3 mM CaCl2, pH 7.5. (3) 25 mM Tris, 1 mM 
DTT, 100 mM NaCl, 5% glycerol, pH 7.5.  (4) 25 mM Tris, 1 mM DTT, 100 mM NaCl, 
2% Triton X-100, pH 7.5. (B) Different growth temperatures: (1) 37 ˚C following IPTG 
induction for 5 hours. (2) 16 ̊ C following IPTG induction for 20 hours. (C) Different IPTG 
concentrations: (1) Induced by 0.5 mM ITPG. (2) Induced by 1 mM IPTG. All of them 





C2B, His-C2C and His-C2BC. Figure 5.4 A shows results of four buffer conditions tested 
for His-C2B consisted of various NaCl concentrations added with different types of 
detergents (e.g. Triton X-100). The SDS-PAGE gels of His-C2C and His-C2BC 
demonstrate the expression and solubility of the proteins grown under different 
temperatures and induced by different concentrations of IPTG, respectively (Figure 5.4 B 
- C). It can be clearly seen that all the three proteins showed high levels of overexpression 
with heavy bands of expected molecular weight (MW) on SDS-PAGE gels. However, none 
of the constructs produced soluble protein, as almost the entire portion was found to 
precipitate in the cell pellet as insoluble fractions, and we barely detected any protein in 
the supernatant.  
 
Extensive tests were also carried out for the same proteins employed with SUMO and GST 
tag, as well as all the other constructs including C2BC-DysF. Unfortunately, most of the 
constructs exhibited severe insolubility issue similar to the ones discussed above, which 
hindered further purification. Nonetheless, by performing expression screening, two 
candidates, His-SUMO-C2B and GST-C2BC-DysF, showed promising possibilities for 
solubilization among the twelve, which are described below. 
 
5.3.3 Solubilization and purification of His-SUMO-C2B 
In attempt to test the expression and solubility of His-SUMO-C2B, we discovered that the 
pH of lysis buffer had a significant influence on the protein solubility. Using a buffer at 
physiological pH  (7.5), no evident protein could be observed in the supernatant. In contrast, 
by increasing the pH (9.5), a clearly visible band corresponding to the expected MW 
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appeared in the soluble fraction (Figure 5.5 A). Next, LB and M9 minimal medium were 
tested as the growth culture using the buffer condition at pH 9.5. Both beautifully showed 
specific bands in the soluble fractions, suggesting that it is promising in attaining labeled 
His-SUMO-C2B protein from minimal media for NMR studies (Figure 5.5 B). 
Interestingly, we also discovered that once the protein has been partially solubilized from 
the cell lysate using higher pH buffer, it stays soluble safely at pH 7.5 in the subsequent 
purification steps. To explain this, we reasoned that as a putative membrane binding protein, 
C2B domain associates with the bacterial cell membrane, thus precipitates along with the 
membrane as the cell debris by centrifugation. High pH contributes to the disruption of the 
association and extraction the protein off the membrane. This strategy has also been 
suggested by past studies (Smith, 2011). 
 
In order to obtain His-tagged recombinant His-SUMO-C2B protein, the supernatant 
containing the protein was loaded onto a Ni2+-charged IMAC (HisTrap FF column) 
following bacterial overexpression and cell lysis. A concentration of 10 mM imidazole was 
added to both binding and wash buffers to interfere with the weak binding of other proteins. 
Before elution, wash with a gradient concentration of imidazole was conducted to remove 
more background impurity. The His-SUMO-C2B protein was then eluted with a higher 
concentration of imidazole. A Coomassie-stained SDS-PAGE gel of the fractions is 
presented in Figure 5.5 C showing that the His-SUMO-C2B protein was successfully 














Figure 5. 5 Solubilization and purification of His-SUMO-C2B 
(A) Test expression of His-SUMO-C2B and the total protein (W), supernatant (S) were 
checked by SDS-PAGE gel. Buffers containing 50 mM Tris, 300 mM NaCl, 10 mM 
imidazole, 0.1 % Triton X-100, 5% glycerol at pH 7.5 and 9.5 were respectively used. A 
visible band corresponding to the expected MW appeared in the soluble fraction at pH 9.5. 
(B) LB and M9 minimal medium were tested as the growth culture using the buffer 
condition at pH 9.5. (C) Purification of His-SUMO-C2B by HisTrap FF chromatography 
monitored by SDSPAGE stained with Coomassie blue. Cell lysate was obtained following 
cell lysis and ultracentrifugation and loaded onto HisTrap FF column. His-SUMO-C2B 




After the first purification step, Ulp1 protease was added attempting to cleave the SUMO 
tag. Ulp1 is known as SUMO protease, highly specific for the SUMO protein fusion, 
recognizing the tertiary structure of SUMO and removing it from recombinant proteins. 
Severe precipitation was seen immediately after the addition of Ulp1 protease. The 
precipitate was discarded following centrifugation and the supernatant was analyzed by 
SDS-PAGE. As shown Figure 5.6 A, before centrifugation, three main bands could be 
recognized which presumably correspond to Ulp1, His-SUMO and C2B, indicating the 
SUMO-tag was successfully cleaved by Ulp1. After the elimination of insoluble fraction, 
the lowest band disappeared from the supernatant due to precipitation. A HisTrap FF 
column was then applied and two proteins were eluted by imidazole (Figure 5.6 A). Since 
the molecular weights of SUMO tag and C2B are fairly close (13.3 and 14.9 kDa), a sample 
from one of the elution fractions was sent for electrospray ionization mass spectrometry 
(ESI-MS). The mass spectrum showed the main species corresponds to the mass of His-
SUMO tag (13.3 kDa); no peak indicative of cleaved C2B protein was found in the 
spectrum (Figure 5.6 B). Different buffer conditions were tested for the cleavage reaction, 
however, no soluble C2B protein could be attained. This issue is seemingly due to the fact 
that the protein is either not properly folded or exists as soluble aggregates in partially 
folded forms (Raran-Kurussi and Waugh, 2016). Therefore, the SUMO tag was kept for 
the subsequent experiments.  
5.3.3 Folding of dysferlin C2B domain  
To examine the folding of His-SUMO-C2B, the 1H15N-HSQC spectrum was recorded by 











Figure 5. 6 Ulp1 cleavage of His-SUMO-C2B. 
(A) Ulp1 protease was added to purified His-SUMO-C2B (first lane) and the precipitate 
was discarded following centrifugation and the supernatant was analyzed (second lane). A 
HisTrap FF column was then applied and two proteins were eluted by imidazole. Fraction 
5 was taken for mass spectrometry. (B) Mass spectrum showing the main species 




spectrum of His-SUMO-C2B demonstrated a mixture of well-dispersed strong signals and 
resonances with very low intensities (Figure 5.7 A).  Then His-SUMO empty vector was 
expressed and uniformly 15N-labeled. The 15N-labeled His-SUMO protein was purified and 
1H15N-HSQC spectrum was collected. By superimposing the spectrum of His-SUMO-C2B 
and His-SUMO,  it can be clearly seen that a majority of strong signals from His-SUMO-
C2B overlapped with those of His-SUMO (Figure 5.7 A), indicating the SUMO tag is 
properly folded with no structural change linked with C2B domain. On the other hand, a 
few resonances can be observed in the spectrum of His-SUMO-C2B that do not derive 
from His-SUMO. These signals are centralized from 7.00 to 8.25 ppm over 1H dimension 
and the signal intensities are strikingly lower than those of His-SUMO. In addition, the 
number of resonances in the spectrum (~30) is much smaller than the number of amides in 
the C2B domain (133 residues). These observations suggest that the C2B domain may be 
largely unfolded or aggregated without stable secondary structures.  
 
The folding state of His-SUMO-C2B was also checked by circular dichroism. Unlike the 
CD spectra of dysferlin C2A domain that exhibits a prominent negative peak at 215 nm, 
indicative of β sheet structure, the spectra of His-SUMO-C2B showed maximal negative 
signal around 205 nm (Figure 5.8 A). SUMO contains secondary structures of β strands 
and α helices, which likely contribute to the small negative peak at 225 nm. Therefore, the 
negative peak at 205 nm represents predominant existence of unstructured components 
which presumably belongs to the C2B domain. The CD data demonstrates good agreement 
with the NMR results, as well as the fact that C2B domain precipitates after the cleavage 










Figure 5. 7 1H-15N HSQC spectra of His-SUMO-C2B and His-SUMO. 
(A) 1H-15N HSQC spectrum of uniformly 15N-labeled His-SUMO-C2B. (B) Overlaid 
HSQC spectra of His-SUMO-C2B (black) and His-SUMO (cyan). The buffer conditions 




















Figure 5. 8 Secondary structure and Ca2+-binding of His-SUMO-C2B. 
(A) Circular dichroism spectra of His-SUMO-C2B (black) and dysferlin C2A domain (red) 
from 250 – 200 nm. The measurements were taken at 25 °C in the buffer conditions of 20 
mM KH2PO4, pH 7.5. The buffer background was subtracted. (B) ITC analysis of Ca2+ 
binding to His-SUMO-C2B showing no binding. Data was collected at 25 °C with 25 mM 






predicted to adopt an arched-shaped arrangement as an intact module through interdomain 
interactions (Figure 5.2 C). Thus, we reasoned that folding of the C2B domain might 
require connection with C2C domain or other binding partners within dysferlin.  
 
Previous study reported that dysferlin C2B domain binds to one Ca2+ ion (Abdullah et al., 
2014). Here Ca2+ titration to His-SUMO-C2B was performed by ITC. The ITC data showed 
minute heat change upon titration of large amount of calcium (Figure 5.8 B), suggesting 
His-SUMO-C2B is Ca2+ insensitive. Nevertheless, this result should be considered with 
caution for the unfolded state of C2B domain might affect its Ca2+ binding property. 
 
5.3.4 Interaction study between dysferlin C2A and C2B domain  
Interaction between C2 domains has been revealed for the C2A and C2B domain of 
synaptotagmin 1 and the association was shown to play an important role in regulating 
exocytosis (Evans et al., 2016; Fuson et al., 2007). Till now, cooperation between dysferlin 
C2 domains has not been examined yet. We queried whether there is interdomain 
interaction between the C2A and C2B domain of dysferlin since both domains have been 
generated. Although the C2B domain was found to remain largely unfolded, it is possible 
that it folds upon association with its binding partner, which is a common feature of many 
intrinsically disordered proteins (Wright and Dyson, 2009). 
 
A preliminary interaction study was performed by NMR spectroscopy. First, 1H15N-HSQC 
spectra of 15N-labeled apo-C2A alone, and apo-C2A in the presence of 0.5 equivalents of 
unlabeled His-SUMO-C2B were collected. Upon addition of His-SUMO-C2B, chemical 
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shift changes were clearly seen for peaks corresponding to residues T14, I19, A26 and K32, 
while most of other peaks remained unchanged (Figure 5.9). Subsequently, 1H15N-HSQC 
spectra of 15N-labeled Ca2+-C2A in the absence and presence of 0.5 equivalents of 
unlabeled His-SUMO-C2B were recorded. Superimposition of two spectra showed 
changes of many peaks, including chemical shift change of I19, H72, R77, R79, K32, T35 
and K36 (Figure 5.10). Moreover, some peaks in the spectrum of Ca2+-C2A disappeared, 
accompanied with appearance of new peaks upon addition of His-SUMO-C2B. All these 
findings suggest that His-SUMO-C2B interacts with the C2A domain in both apo and Ca2+-
bound state. By mapping the residues that showed the largest chemical shift changes on the 
structure of dysferlin C2A domain, it was found that almost all the residues are located on 
the one side of the β sandwich (Figure 5.11). Specifically, the β sheet groove formed by 
β2, 3, and 5, and the Ca2+-binding loops (loop 1-3) are where these residues lay on and are 
likely to be the binding interface. Therefore, it is tempting to propose that His-SUMO-C2B 
binds to C2A domain and the binding results in conformational changes of the β strands on 
one side, as well as the Ca2+-binding loops.  
 
Again, these results should be interpreted with caution for two reasons: (1) Although there 
is no evidence showing interaction between C2 domains and SUMO protein, this 
possibility cannot be ruled out. A control experiment examining interaction between the 
SUMO tag and C2A domain is necessary. (2) In our study, only 0.5 equivalents of His-
SUMO-C2B was added into the C2A sample due to the difficulty of obtaining concentrated 















Figure 5. 9 NMR spectra showing interaction of apo-C2A with SUMO-C2B. 
Overlaid 1H-15N HSQC spectrum of apo-C2A (black) and apo-C2A mixed with His-
SUMO-C2B (orange). Chemical shift changes of peaks corresponding to T14, I19, A26 






















Figure 5. 10 NMR spectra showing interaction of Ca2+-C2A with SUMO-C2B. 
Overlaid 1H-15N HSQC spectrum of Ca2+-C2A (black) and Ca2+-C2A mixed with His-
SUMO-C2B (pink). Chemical shift changes of peaks corresponding to I19, K32, T35, K36, 
H72, R77 and R79 are indicated with arrows. Peaks that disappeared upon addition of His-
SUMO-C2B are labeled in dashed boxes (V69, V27 and K33). New peaks that are yet to 

















Figure 5. 11 Identification of the His-SUMO-C2B binding region on dysferlin C2A.  
Residues experiencing significant chemical shift changes in the NMR spectra upon His-
SUMO-C2B binding are mapped on the C2A domain structure, and represented in sticks 
and explicitly labeled. All the residues are located on the one side of the β sandwich. In 
particular, A26, V27, K32, K33, and V69 are on the β sheet groove formed by β2, 3, and 






positions (Figure 5.9 - 5.10). In the future, a titration experiment needs to be performed 
which allows us to follow the peak movements for pursuing accurate results.  
 
5.3.5 Expression and purification of GST-C2BC-DysF 
Extensive test expression was carried out for GST-C2BC-DysF, and growth at 37 ˚C and 
16 ˚C following IPTG induction was found to yield most soluble protein. Different buffer 
conditions were also tested and one example is demonstrated in Figure 5.12 A. Generally, 
at physiological pH (7.5), although a large portion of the protein precipitated, some could 
be seen in the soluble fraction. The solubility of GST-C2BC-DysF does not seem to be 
salt-dependent, the amounts of soluble protein were similar on SDS-PAGE gel in all the 
buffer conditions. PBS buffer was then used as the lysis buffer for protein purification.  
 
In the large-scale purification, using a glutathione-linked sepharose column (GSTrap FF), 
one protein showing a molecular weight approximate to GST-C2BC-DysF (82 kDa) was 
eluted (Figure 5.12 B). To examine whether it was the desired protein, Prescission protease 
was added to the eluted protein. Prescission protease is widely used for specifically 
cleavage of GST tag. Results are shown in Figure 5.12 C: In addition to the bands 
indicative of GST-C2BC-DysF (82 kDa) and Prescission protease (50 kDa), two new bands 
were shown on the gel, corresponding to the molecular weight of C2BC-DysF (56 kDa) 
and GST tag (26 kDa). These preliminary tests indicate that GST-C2BC-DysF could be 












Figure 5. 12 Solubilization and purification of GST-C2BC-DysF 
(A) Test expression of GST-C2BC-DysF in different buffer conditions. The cells were 
grown at 37 ˚C and 16 ˚C following IPTG induction. The total protein (W), supernatant (S) 
were checked by SDS-PAGE gel. The buffer used are as follows: (1) 20 mM KH2PO4, pH 
7.5. (2) 25 mM HEPES, 150 mM NaCl, pH 7.5. (3) 25 mM Tris, 300 mM NaCl, pH 7.5. 
(4) PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3). Band 
corresponding to the expected MW (82 kDa) is indicated with the black arrow. (B) 
Purification of GST-C2BC-DysF using a glutathione-linked sepharose column (GSTrap 
FF). One protein showing a molecular weight approximate to GST-C2BC-DysF was eluted. 
(C) Prescission protease cleavage of GST-C2BC-DysF showing the protein was mostly 
cleaved. Bands indicative of uncleaved GST-C2BC-DysF (82 kDa), Prescission protease 





However, a workable concentration of C2BC-DysF has not been attained yet, as the protein 
precipitated at much low concentrations. Further optimization for more production needs 





5.4.1 Insolubility issue of C2B and C2C domains 
In this chapter, I pursued study on the dysferlin C2B and C2C domains by combining 
experimental and computational approaches. A considerable amount of effort was made 
and the major bottleneck this study encountered was the insolubility of the proteins. As a 
structure predominantly composed of β sheets with hydrophobic residues, it is not 
surprising for a C2 domain to be insoluble in solution. In addition, the lipid binding 
properties of C2 domains can possibly drive association with E. coli membranes during 
protein expression, causing difficulty in extracting the protein. Although we were not able 
to produce enough soluble proteins required for structural characterization, this work 
represents an important step forward in designing the C2B and C2C proteins with more 
precise domain boundaries. The two workable constructs that were generated, His-SUMO-
C2B and GST-C2BC-DysF, looked promising for future study if optimization is made.  
 
Further directions are suggested as follows: (1) In the process of protein purification, 
unfolding and subsequent refolding could be carried out. For example, previous studies on 
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the C2 domains of cytosolic phospholipase A2 (cPLA2) and plant phospholipase D (PLD) 
used 6 M guanidine HCl (GndHCl) and 8 M urea to successfully extract the proteins from 
inclusion bodies and refolded the proteins with gel filtration column (Nalefski et al., 1998; 
Zheng et al., 2000). Mild denaturation is also recommended (e.g. extreme pH, low 
concentrations of GndHCl or urea), as we noticed significantly increased solubility of C2B 
and C2C domains under pH 11 (data not shown). (2) Methods to disrupt the association of 
C2 domains with E. coli membranes could be developed. In our work, we found that a 
combination of detergent and high pH led to release of the C2B domain from the bacterial 
membrane. A study on perforin C2 domain obtained properly folded protein by mutating 
four hydrophobic aromatic residues in the loops (Trp427, Tyr430, Tyr486, and Trp488) 
that were assumed to contribute to the interaction with E. coli membranes (Yagi et al., 
2015). The computational models of dysferlin C2B and C2C domains both show the 
presence of hydrophobic aromatic residues on the loops. Thus, the above approach could 
be worthwhile to conduct in the future. 
 
5.4.2 Interplay between C2 domains 
In addition to the Ca2+ and lipid binding properties, there has been a number of studies 
providing evidence for the interdomain interactions between C2 domains, such as the C2A 
and C2B domain of synaptotagmin 1 (Evans et al., 2016; Fuson et al., 2007). Besides, the 
C2 domains dimerization has been reported for RIM1α C2B domain (Guan et al., 2007), 




Our preliminary NMR data suggested a possible interaction between the dysferlin C2A and 
C2B domains and identified the binding region on the C2A domain (Figure 5.11). 
Interestingly, the binding site on dysferlin C2A domain shows high resemblance to that of 
the Munc 13-1 C2A homodimer (Lu et al., 2006). The Munc13–1 C2A domain forms a 
stable homodimer and the X-ray crystal structure shows that the dimerization is mediated 
by the concave surfaces of the β-sheets formed by strands 3, 2, 5, and 6 of each monomer. 
These surfaces pack in an antiparallel orientation, twisting around each other. The binding 
interface arises from the formation of multiple hydrophobic, ionic, and hydrogen-bonding 
interactions between side chains of both monomers (Figure 5.13 A). By overlapping the 
structures of Munc13–1 C2A monomer with the dysferlin C2A domain, the binding sites 
on the two domains were found in the same region: the concave surfaces formed by β2, 3, 
5 and 6 (Figure 5.13 B). More particularly, some residues on the dysferlin C2A domain, 
that were identified to be important for binding to the C2B domain, aligned well with the 
binding residues in Munc13–1 C2A homodimer. This finding indicates that the ability of 
the C2 domains to homodimerize/heterodimerize is possibly shared in a wide variety of 
proteins. We hypothesize that the dysferlin C2A domain dimerizes with C2B domain in a 
Ca2+-independent manner. The functional significance of this dimerization is not clear. One 
guess is that it may compete with the C2B-C2C module in response to Ca2+ , or with other 
protein interactions of the C2A domain. Also, the concave surfaces formed by β2, 3, 5 and 
























Figure 5. 13 Munc 13-1 C2A homodimer and superposition of Munc 13-1 C2A 
monomer and dysferlin C2A domain. 
(A) Ribbon diagram of the Munc13–1 C2A domain homodimer formed by two monomers 
(blue and orange) showing a top view of the β-barrel like structure. The β-strands are 
labeled with numbers, and the N- and C-termini are indicated with N and C, respectively. 
(PDB: 2CJT) (B) Superposition of the structures of Munc 13-1 C2A monomer (orange) 
and dysferlin C2A domain (green). The side chains of residues involved in intermolecular 
contacts of Munc13–1 C2A domain homodimerization and dysferlin C2A-C2B interaction  
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6.1 Background  
 
Dysferlin is a 230 kDa cytosolic-facing, membrane bound protein that includes seven C2 
domains (C2A-C2G), three Fer domains (FerA, FerB, and FerI) and two DysF domains 
(Sula et al., 2014). It is a membrane repair protein involved in the trafficking of proteins 
and vesicles around injured membranes in skeletal muscle cells. Failure to repair injured 
sarcolemmal membranes leads to muscular dystrophy, a degenerative disorder that results 
in increasing weakness and gradual wasting of skeletal muscles.  
 
The N-terminal C2A domain of dysferlin appears to be the major portion responsible for 
responding to calcium influx upon membrane damage and the activation of dysferlin. The 
C2A domain was identified to bind phospholipids in a Ca2+-dependent fashion, mediating 
the fusion of lysosomes with the plasma membrane (Han et al., 2012; Therrien et al., 2009). 
The C2A domain also plays a regulatory role in interaction with other membrane repair 
proteins, such as AHNAK and MG53 (Huang et al., 2007; Matsuda et al., 2012). A crystal 
structure of the C2A domain was reported (Figure 2.11 B) (Fuson et al., 2014), yet there 
is much to be learned about the Ca2+ binding properties of the domain. Further, the 
importance of the C2A domain in dysferlin has been emphasized from a clinical standpoint 
as substitutions (e.g. W52R, V67D) in this region lead to limb-girdle muscular dystrophy 
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type 2B (LGMD2B) or Miyoshi myopathy (MM) (Krahn et al., 2009). However the 
molecular basis of pathogenic mechanisms still remains unclear.  
 
Additionally, little information is available about the other C2 domains of dysferlin as well 
as the interdomain interactions. A limited proteolysis study suggested that C2B-C2C may 
function as an intact module and exist in a closed conformation (Woolger et al., 2017), 
consistent with the cellular function of the C2B-C2C motif in regulating dysferlin plasma 
membrane expression (Evesson et al., 2010). Another study demonstrated that all seven 
dysferlin C2 domains interact with Ca2+ with various binding affinities and stoichiometries 
(Abdullah et al., 2014). However, a comprehensive study on the structures and interactions 
of the other C2 domains with precise domain boundary determination is required .  
 
6.2 New insights into dynamics and Ca2+ binding of the dysferlin 
C2A domain 
In chapter 2, the work focused on the dynamics of the C2A domain on the basis of its NMR 
structure in the Ca2+-free state. By employing a series of NMR methods, high flexibility 
within the loop region was identified to be a remarkable feature of the dysferlin C2A 
domain, which is rarely seen in other C2 domain containing proteins. A comparison is 
shown in Figure 2.11, which also highlights the powerful applications of NMR 
spectroscopy over other methods in probing protein dynamics. It was also proved that a 
striking decrease in the flexibility occurs upon calcium binding, in line with the finding 




For EF-hand proteins, binding of calcium leads to a dramatic conformational change from 
“closed” to “open” (Ikura, 1996). In comparison, the mechanism of Ca2+ binding to C2 
domains has for long been recognized to be different. Ca2+ immobilizes the structure of C2 
domains but does not produce a significant structural change from a well-defined 
conformation to another (Shao et al., 1998). The main effect of Ca2+ binding on the C2 
domain is to change the electrostatic potential of loop region rather than its structure. Our 
data further confirmed this knowledge and also suggested new pictures of calcium-
dependent membrane repair process. The high flexibility in the apo-state may be 
functionally significant considering the major function of the C2A domain, which is 
calcium-sensitive membrane binding (Bansal et al., 2003; Han and Campbell, 2007). In the 
resting state of a cell when the dysferlin C2A domain is Ca2+-free, the dynamics of the C2A 
domain may prevent it from binding to the lipid membrane. Unlike exocytosis, which 
occurs when the local [Ca2+] rises into the 10-100 μM range (Hille et al., 1999), membrane 
repair process is activated at a higher [Ca2+] concentration due to the millimolar range of 
[Ca2+] in the extracellular space. The remarkable flexible property of dysferlin C2A may 
be important for maintaining its exclusive function of membrane repair, so that it is not as 
readily triggered by low [Ca2+] as proteins involved in exocytosis (e.g. synaptotagmin). It 
is hypothesized that only upon the influx of calcium from the extracellular space as a result 
of membrane disruption, the C2A domain binds calcium and adapts a more ordered and 
rigid conformation, triggering membrane repair through lipid binding.  
 
In chapter 3, the detailed Ca2+ binding properties of the dysferlin C2A domain was studied. 
Comparison of the binding sites, affinities and binding modes with other C2 domains was 
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discussed in Chapter 3.4. It is indeed fascinating that C2 domains exhibit a diverse array 
of Ca2+ binding properties that serve for the specific biological function. This work pursued 
a thorough characterization on the molecular mechanisms of Ca2+ binding to the C2A 
domain. Here, I would like to expand the discussion on the two striking findings. 
 
In the previous crystal structure of the C2A domain (Fuson et al., 2014), there is a single 
Ca2+ coordinated to one of the six domains in the asymmetric unit and D16 was modeled 
to be a coordinating residue for another Ca2+ ion. Further, an ITC study showed that D16A 
substitution caused elimination of Ca2+ binding (Abdullah et al., 2014), which seems to 
support the postulation that D16 is a ligand for Ca2+-binding. However, in our crystal 
structure of the Ca2+-bound dysferlin C2A domain which contained four molecules in the 
asymmetric unit with two Ca2+ ion bound to each molecule, D16 does not bind to either of 
the Ca2+ ion. The oxygens of its side chain are beyond the maximum possible distance 
between ligand oxygen atoms and the calcium ion (Figure 3.11 A). This work for the first 
time identified the importance of the non-coordinating residue of C2 domains. Subsequent 
mutagenesis study showed consistent results with the previous literature. We attributed this 
observation to the change of the electrostatic potential of the loop region (Figure 3.11 E - 
F). By examining the sequence of dysferlin C2A with other C2 domain, it can be seen that 
the dysferlin C2A domain contains an additional aspartic acid in loop 1 compared to most 
of other C2 domains (D16, D18 and D21) (Figure 1.4). Our work has helped clarify the 
contribution of each aspartic acid and recognized “electrostatic potential” as a critical factor 




Another interesting finding was how substitution of a single residue can mimic the effect 
of Ca2+ ion. This was validated by our observation that C2AD71K shares structural 
similarities with wild-type Ca2+-C2A judging by their NMR spectra and the model we 
proposed (Figure 3.14). In fact, several previous studies on synaptotagmin have suggested 
the similar idea by testing the protein function in synaptic transmission (Stevens and 
Sullivan, 2003; Striegel et al., 2012; Yoshihara et al., 2010). Our work here provides strong 
supporting evidence for this idea on the molecular basis. It would be interesting to probe                                                                                                                                           
the lipid binding properties of wild-type C2A in both apo and Ca2+-bound state as well as 
C2AD71K, C2AD18K, C2AD21K and C2AD16K. We predict that some of the substituted proteins 
would have the ability to bind negatively charged phospholipids in a similar manner as 
Ca2+-C2A. Moreover, for some substitutions, the membrane repair activity of dysferlin 
might be preserved even the Ca2+-binding for the C2A domain is abolished.                                                                                                                                                                                                                                
                                                                                                                              
In summary, our work has provided novel insights for understanding the mechanisms of 
dysferlin-mediated membrane repair. In the resting state when the intracellular Ca2+ 
concentration is extremely low, the electrostatic repulsion caused by negative charged 
residues in the loops (D16, D18, D21, D71 and E73) inhibits the interaction between the 
C2A domain and membrane. Ca2+ influx due to membrane disruption results in an 
electrostatic switch of the loops from negative to positive, targeting the protein to the 
membrane, thus facilitates membrane fusion.                                                             





6.3 The tertiary folding of dysferlin C2A, C2B and C2C domains 
 
In chapter 5, the research delved into the other parts of dysferlin attempting to characterize 
the structure and folding of the C2B and C2C domain. Unlike most of the C2 domain-
containing proteins usually consist of one or two C2 domains such as synaptotagmins, the 
ferlin family proteins harbour five to seven C2 domains (Peulen et al., 2019). The tertiary 
folding of these domains is poorly understood: whether they are in linear arrangement or 
folded together through interdomain interactions?  
 
Our NMR data provided the first evidence for the possible interaction between the C2A 
and C2B domain (Figure 5.9 – 5.11). Interestingly, the binding region on the dysferlin 
C2A domain was found to highly overlap with the binding interface of the Munc 13-1 C2A 
homodimer (Lu et al., 2006). Furthermore, although we have not been able to generate 
workable C2B-C2C construct, the computational model performed by our collaborator 
simulated the 3D structure of the C2B-C2C module on the basis of the C2A-C2B structure 
of extended synaptotagmin (Figure 5.2) (Schauder et al., 2014). The simulated model 
shows that C2B and C2C domain together adopt an arched-shaped arrangement joined by 
a linker sequence that forms an α-helix and packs against the two domains. The N and C 
termini of both domains are located at the bottom of the overall structure, whereas the 
putative calcium binding loops on the top. This C2B-C2C module was additionally 
supported by a limited proteolysis study on dysferlin, where C2B-C2C was found to exist 




Based on all the above knowledge, a model that depicts the tertiary folding and interdomain 
association between C2A, C2B and C2C domain is proposed. In this model, the crystal 
structure of dysferlin C2A domain was aligned with one of the monomer in the Munc 13-
1 C2A homodimer. The dysferlin C2B-C2C structure was taken from the computational 
simulation and the C2B domain was aligned with the other monomer of the Munc 13-1 
C2A homodimer. Figure 6.1 demonstrates the result generated by PyMOL, showing the 
tertiary folding of the C2A, C2B and C2C domain. The C2A domain forms a heterodimer 
with C2B and the dimerization is mediated by the concave surfaces of the β-sheets of each 
domain. The two domains pack in an antiparallel orientation, twisting around each other. 
In this way, the C2A domain falls into the groove formed by the C2B-C2C module with 
the Ca2+-binding loops faced inward to the bottom of the groove. Figure 6.1 B clearly 
shows that the three C2 domains overall adopt a compact closed conformation.  
 
The closed conformation formed by the C2A, C2B and C2C domains indicates that the 
three domains may function in an autoinhibitory manner. Autoinhibition of protein 
activities mediated by C2 domains have been identified in some proteins including Nedd4, 
protein kinase C (PKC), and Smurf2 (Antal et al., 2015; Wang et al., 2010; Wiesner et al., 
2007). For example, it was shown that the C2 domain mediates the autoinhibition of 
Nedd4-1 and Nedd4-2 through association with the HECT domain. Calcium disrupts 
binding of the C2 domain to the HECT domain and activates the E3 ubiquitin ligase activity 
of Nedd4 by releasing the autoinhibition. Here, we hypothesize that in the resting state of 
a cell when dysferlin is Ca2+-free, the C2A, C2B and C2C domains form a closed 


















Figure 6. 1 Proposed model of the tertiary folding of the C2A, C2B and C2C domains 
of dysferlin.  
(A) Cartoon representation of the tertiary structure formed by the dysferlin C2A (red), C2B 
(blue), and C2C (cyan) domain. The bound Ca2+ ions of the C2A domain are shown as 
green spheres. The linker between the C2A and C2B domain is not shown in the figure. 
The C2B and C2C domain is joined by a linker sequence shown in grey. (B) Surface 




domain from binding to the lipid membrane. When cell membrane disruption occurs with 
Ca2+ entry into the cytoplasm, the C2A, C2B and C2C domains changes the conformation 
from “closed” to “open”, releasing the C2A domain. Meanwhile, Ca2+ binding to the C2A 
domain targets it to the membrane of the cell or repair vesicles. Membrane anchoring in 
both N- and C-terminus of dysferlin “drags” the lipids close to each other, thereby 
mediating membrane fusion between vesicles as well as with plasma membrane (Figure 
6.2). Additionally, since the apo-C2A is highly flexible and more unstructured, the 
autoinhibition mechanism may also protect it from degradation in cells. This model 
revealed an activation mechanism of dysferlin and established a connection of intracellular 
calcium signaling to regulation of membrane repair. Hopefully the model could be further 




The work in this thesis has greatly achieved the four objectives raised in Chapter 1.7 and 
contributed valuable information regarding the membrane repair mechanisms mediated by 
dysferlin. The calcium binding of the dysferlin C2A domain and the details on the 
stoichiometry, affinities, binding mode as well as structural information provided novel 
insights into the Ca2+ binding of C2 domains. Assessment of dysferlin C2A domain under 
pathological conditions has helped better understand the pathogenesis of muscular 
dystrophy on a molecular level. Finally, investigation of the C2B and C2C domains laid 
important groundwork for the subsequent studies of dysferlin structure and its function. In 
all, structural and mechanistic research here will have a significant impact on the 






Figure 6. 2 Proposed model for autoinhibition and activation of dysferlin through 
releasing the C2A domain from C2B-C2C domain.  
 
Dysferlin is localized by its C-terminal transmembrane domain to cytoplasmic vesicles and 
the plasma membrane. In the resting state of a cell when dysferlin is Ca2+-free, the C2A 
(red), C2B (blue) and C2C (cyan) domains form a closed conformation which prevents the 
C2A domain from binding to the membrane. On injury of the membrane, Ca2+ influx raises 
the intracellular Ca2+ concentration, which leads to a conformational change from “closed” 
to “open”, releasing the C2A domain. Ca2+-binding to the C2A domain targets it to the lipid 






Abdullah, N., Padmanarayana, M., Marty, N.J., and Johnson, C.P. (2014). Quantitation of 
the Calcium and Membrane Binding Properties of the C2 Domains of Dysferlin. Biophys. 
J. 106, 382–389. 
Antal, C.E., Callender, J.A., Kornev, A.P., Taylor, S.S., and Newton, A.C. (2015). 
Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII. Cell Rep. 
12, 1252–1260. 
Bansal, D., Miyake, K., Vogel, S.S., Groh, S., Chen, C.-C., Williamson, R., McNeil, P.L., 
and Campbell, K.P. (2003). Defective membrane repair in dysferlin-deficient muscular 
dystrophy. Nature 423, 168–172. 
Evesson, F.J., Peat, R.A., Lek, A., Brilot, F., Lo, H.P., Dale, R.C., Parton, R.G., North, 
K.N., and Cooper, S.T. (2010). Reduced Plasma Membrane Expression of Dysferlin 
Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway. J. 
Biol. Chem. 285, 28529–28539. 
Fuson, K., Rice, A., Mahling, R., Snow, A., Nayak, K., Shanbhogue, P., Meyer, A.G., 
Redpath, G.M.I., Hinderliter, A., Cooper, S.T., et al. (2014). Alternate Splicing of 
Dysferlin C2A Confers Ca2+-Dependent and Ca2+-Independent Binding for Membrane 
Repair. Structure 22, 104–115. 
Han, R., and Campbell, K.P. (2007). Dysferlin and muscle membrane repair. Curr. Opin. 
Cell Biol. 19, 409–416. 
Han, W.-Q., Xia, M., Xu, M., Boini, K.M., Ritter, J.K., Li, N.-J., and Li, P.-L. (2012). 
Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in 
coronary arterial endothelial cells. J. Cell Sci. 125, 1225–1234. 
Hille, B., Billiard, J., Babcock, D.F., Nguyen, T., and Koh, D.-S. (1999). Stimulation of 
exocytosis without a calcium signal. J. Physiol. 520, 23–31. 
Huang, Y., Laval, S.H., van Remoortere, A., Baudier, J., Benaud, C., Anderson, L.V.B., 
Straub, V., Deelder, A., Frants, R.R., den Dunnen, J.T., et al. (2007). AHNAK, a novel 
component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin 
during skeletal muscle regeneration. FASEB J. 21, 732–742. 
Ikura, M. (1996). Calcium binding and conformational response in EF-hand proteins. 
Trends Biochem. Sci. 21, 14–17. 
Krahn, M., Béroud, C., Labelle, V., Nguyen, K., Bernard, R., Bassez, G., Figarella-
Branger, D., Fernandez, C., Bouvenot, J., Richard, I., et al. (2009). Analysis of the DYSF 
mutational spectrum in a large cohort of patients: DYSF Mutational Spectrum in a Large 
Cohort. Hum. Mutat. 30, E345–E375. 
 
 208 
Lu, J., Machius, M., Dulubova, I., Dai, H., Südhof, T.C., Tomchick, D.R., and Rizo, J. 
(2006). Structural Basis for a Munc13–1 Homodimer to Munc13–1/RIM Heterodimer 
Switch. PLOS Biol. 4, e192. 
Matsuda, C., Miyake, K., Kameyama, K., Keduka, E., Takeshima, H., Imamura, T., 
Araki, N., Nishino, I., and Hayashi, Y. (2012). The C2A domain in dysferlin is important 
for association with MG53 (TRIM72). PLoS Curr. 
Peulen, Rademaker, Anania, Turtoi, Bellahcène, and Castronovo (2019). Ferlin 
Overview: From Membrane to Cancer Biology. Cells 8, 954. 
Schauder, C.M., Wu, X., Saheki, Y., Narayanaswamy, P., Torta, F., Wenk, M.R., De 
Camilli, P., and Reinisch, K.M. (2014). Structure of a lipid-bound extended 
synaptotagmin indicates a role in lipid transfer. Nature 510, 552–555. 
Shao, X., Fernandez, I., Südhof, T.C., and Rizo, J. (1998). Solution Structures of the Ca2+ 
-free and Ca2+-bound C 2 A Domain of Synaptotagmin I: Does Ca2+ Induce a 
Conformational Change? †. Biochemistry 37, 16106–16115. 
Stevens, C.F., and Sullivan, J.M. (2003). The Synaptotagmin C2A Domain Is Part of the 
Calcium Sensor Controlling Fast Synaptic Transmission. Neuron 39, 299–308. 
Striegel, A.R., Biela, L.M., Evans, C.S., Wang, Z., Delehoy, J.B., Sutton, R.B., Chapman, 
E.R., and Reist, N.E. (2012). Calcium Binding by Synaptotagmin’s C2A Domain is an 
Essential Element of the Electrostatic Switch That Triggers Synchronous Synaptic 
Transmission. J. Neurosci. 32, 1253–1260. 
Sula, A., Cole, A.R., Yeats, C., Orengo, C., and Keep, N.H. (2014). Crystal structures of 
the human Dysferlin inner DysF domain. BMC Struct. Biol. 14, 3. 
Therrien, C., Di Fulvio, S., Pickles, S., and Sinnreich, M. (2009). Characterization of 
Lipid Binding Specificities of Dysferlin C2 Domains Reveals Novel Interactions with 
Phosphoinositides †. Biochemistry 48, 2377–2384. 
Wang, J., Peng, Q., Lin, Q., Childress, C., Carey, D., and Yang, W. (2010). Calcium 
Activates Nedd4 E3 Ubiquitin Ligases by Releasing the C2 Domain-mediated Auto-
inhibition. J. Biol. Chem. 285, 12279–12288. 
Wiesner, S., Ogunjimi, A.A., Wang, H.-R., Rotin, D., Sicheri, F., Wrana, J.L., and 
Forman-Kay, J.D. (2007). Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 
through Its C2 Domain. Cell 130, 651–662. 
Woolger, N., Bournazos, A., Sophocleous, R.A., Evesson, F.J., Lek, A., Driemer, B., 
Sutton, R.B., and Cooper, S.T. (2017). Limited proteolysis as a tool to probe the tertiary 
conformation of dysferlin and structural consequences of patient missense variant L344P. 
J. Biol. Chem. 292, 18577–18591. 
 
 209 
Yoshihara, M., Guan, Z., and Littleton, J.T. (2010). Differential regulation of 
synchronous versus asynchronous neurotransmitter release by the C2 domains of 















































Poster	 presentation:	 “Membrane	Repair	 and	Trafficking	 by	Dysferlin	 Complex”.	 Harold	 B.	
Stewart	Research	Symposium.	London,	Ontario,	Canada.	January	2016.	
	















International	 Meeting	 of	 the	 European	 Calcium	 Society	 (Junior	 travel	 award:	 400	 €),	
Hamburg,	Germany,	September	2018.	
	
Poster	presentation:	 “Impact	of	muscular	dystrophy	causing	mutations	on	 the	 folding	and	
stability	 of	 dysferlin	 C2A	 domain.”	 Annual	Meeting	 of	 The	 Biophysical	 Society	 of	 Canada,	
Mississauga,	Ontario,	Canada.	May	2019	
	
Oral	presentation:	“Mutations	of	Dysferlin	C2A	Domain	Associated	with	Calcium	Binding	and	
Muscular	Dystrophy”		
Maud	L.	Menten	Fall	Symposium,	London,	Ontario,	Canada.	September	2019	
	
Oral	presentation:	“Using	NMR	to	investigate	the	dynamics	and	calcium-binding	mechanisms	
of	dysferlin	C2A	domain”	
32th	Moot	NMR	Symposium,	Ottawa,	Ontario,	Canada.	October	2019	
	
	
WORK	&	VOLUNTEER	EXPERIENCE		
	
Research	Intern	AvocadoCore	(EdTech	Startup).	September	2017	-	present	
•Conduct	marketing	research	for	the	private	sector.	
•Write	and	implement	new	research	proposals	in	collaboration	with	the	business	and	
development	team.	
	
Teaching	assistant	(Biochemistry	2280,	3380	-	The	University	of	Western	Ontario)	
•	Answered	questions	of	lecture	topics	on	the	OWL	forum.	
•	Conducted	tutorial	lectures	for	2rd	year	undergraduate	students.		
•	Evaluated	and	critiqued	essays	and	lab	reports.	
•Taught	in	laboratory	classes	on	topics	of	biochemistry	and	post-lab	tutoring	in	close	
communication	with	a	group	of	10	students.	
	
Presentation	Moderator	London	Health	Research	Day.	April	2019	
•Moderated	the	featured	platform	presentations	by	introducing	platform	speakers	and	
moderating	question	and	answer	period	after	each	talk.	
	
Event	assistant	TAP	Centre	for	Creativity.	March	2017	-	September	2017	
•Volunteered	in	organizing	and	participating	5	local	arts	and	cultural	performances.	
 
